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Abstract 
Biomimetic PEG Hydrogels for ex vivo Hematopoietic Stem Cell Expansion 
by 
Maude Lucille Rowland 
Hematopoietic stem cells (HSCs) are commonly used in the treatment of blood 
cancers, like leukemia, and other cancers where radiation or chemotherapy damages the 
native HSC population. The development of a novel system to study and maintain HSCs 
ex vivo would give researchers and clinicians the ability to investigate the basic biological 
processes of HSCs, improve current treatment regimens, and explore their use in new 
therapies. The work in this thesis focuses on the development of a synthetic PEG 
hydrogel scaffold that accurately mimics aspects of the HSC microenvironment and can 
expand clinically relevant HSC populations. 
PEG hydrogel well surfaces were covalently functionalized with bioactive factors 
known to be critical in controlling HSC fate in vivo. In initial studies, 32D cells, a 
myeloid progenitor, were cultured in the wells for 6 days. On surfaces with the adhesive 
RGDS peptide sequence, 32D cell adhesion increased concurrently with RGDS surface 
concentrations. With the immobilization of two niche cytokines, SCF and SDFla, onto 
hydrogel surfaces, 32D cells demonstrated significant increases in adhesion and 
spreading. These results confirmed that hematopoietic cell behavior could be controlled 
through the design of the bioactive PEG scaffold. 
In studies with a primary hematopoietic cell population (c-kit+, lin-), the effects of 
bioactive molecules on cell expansion and differentiation were investigated after 2 weeks 
111 
in culture. The adhesive peptides sequences, RGDS and CS 1, and four niche proteins, 
SCF, SDFla, JAGl, and IFNy, were covalently tethered to hydrogel well surfaces. 
Primary cells proliferated significantly on gels containing SCF and IFNy though only 
SCF was capable of preventing HSC differentiation. Cells cultured on surfaces 
functionalized with JAGl and SDFla did not proliferate extensively, but they were able 
to maintain primitive HSC populations. Primary c-kit cells were also encapsulated 
within biodegradable PEG hydrogels and cultured for 2-5 weeks. Cells remained viable 
for 5 weeks in culture, and preliminary results indicated minimal cell differentiation. In 
this work, biomimetic PEG hydrogels were successfully employed to expand HSC 
populations in both two and three dimensions. The ability to generate large populations 
of primitive HSCs ex vivo has broad clinical and research implications. 
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Chapter 1: Introduction 
1.1 The Need for ex vivo Hematopoietic Stem Cell Expansion 
45,000 patients worldwide receive potentially life-saving bone marrow transplants 
each year, though many more who could benefit from this procedure are unable to 
receive a transplant due to a limited number of suitable donors (1). Hematopoietic stem 
cells (HSC) in bone marrow transplants replace diseased or damaged blood and immune 
cells. Transplanted HSCs home to the bone marrow, engraft, and begin hematopoiesis, 
the process of becoming mature blood and immune cells. These procedures are most 
prominently carried out to treat multiple myeloma, non-Hodgkin's lymphoma, and acute 
leukemia, all cancers of the immune system or blood cells (2). They have also been 
effective in treating blood diseases like sickle cell anemia and 13-thalassaemia, various 
autoimmune diseases (e.g. Crohn's disease, multiple sclerosis), as well as cancers where 
radiation treatment or chemotherapy damages the immune system (1, 3-9). Additionally, 
research is underway to expand the use of HSC therapy to treat genetic disorders, 
neurological disorders, diabetes, liver diseases, muscular dystrophies, acute myocardial 
infarction, and myocardial chronic ischemia (10-17). 
HSCs have the potential to treat a wide variety of debilitating diseases, but they 
are not used extensively in clinical applications outside of cancer. This is due to a lack of 
available HSCs resulting from a limited number of donors, the low level of HSCs in bone 
marrow and peripheral blood, and the inability to culture HSCs successfully. The 
development of a system to study and maintain these cells in vitro would give researchers 
and clinicians the ability to investigate basic biological processes of HSCs, explore their 
use in new therapies, and improve current treatment regimens. The work in this thesis 
focuses on the development of a synthetic scaffold for these purposes. 
1.2 HSC Transplants 
Currently, HSCs for transplantation can come either from the patient himself 
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(autologous) or from a donor (allogeneic). Autologous transplants are the most common, 
but they are only possible in cases where the immune cells and blood cells themselves 
remain healthy despite the disease, but after aggressive treatment (like radiation), the 
immune system is lethally harmed or compromised (14). Approximately 30,000 
autologous transplants occur annually as opposed to 15,000 allogeneic transplants (2). 
Table 1.1 displays the number of autologous and allogeneic transplants that have been 
performed for various diseases in the past forty years and registered with the Center for 
International Blood and Marrow Transplant (18). Before an allogeneic transplant can be 
performed, a donor who is a "match" to the patient must be found. This means that cells 
from both the donor and patient must express similar types of proteins on their surfaces. 
Typically "matches" are found in family members such as a sibling, but the existence of a 
bone marrow registry has made transplants from nonrelated donors possible. It is 
especially important to match when doing HSC transplants because the implanted 
immune cells are capable of attacking the patients' native cells, an outcome termed graft 
versus host disease (GVHD) (19). This undesired reaction is possible because all 
mammalian cells express major histocompatibility complex (MHC) proteins, which serve 
to identify them as non-foreign to immune system cells (20). There are three important 
MHC proteins in matching HSC donors and recipients: human leukocyte antigen (HLA)-
A, HLA-B, and HLA-DR (19, 20). Every person has two alleles of these proteins, one 
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from each parent. Thus, a perfect match is termed a 6:6 match, and siblings have a one in 
four chance of being a 6:6 match (19). There are at least 20 varieties of each HLA, 
meaning that there are approximately 3 billion different possible combinations of the six 
significant HLAs. As a result, not every patient can receive HSCs from a 6:6 match, and 
5:6, 4:6, and 3:6 matches must also be used. As less perfect matches are used, the 
likelihood of rejection or GVHD increases concurrently (2, 19). Though GVHD is not a 
desirable outcome, one possible patient benefit is the graft versus tumor (GVT) effect (3, 
21). In the GVT effect, donor immune cells actually attack and kill any malignant cells 
they encounter within the body. 
Table 1.1: Distribution of diseases treated with HSC transplants from 1970-2007. As 
reported to the Center for International Blood and Marrow Transplant through 2007. Adapted 
from (18). 
D. Allogeneic Autologous tsease Transplants Transplants 
Sarcoma (soft tissue, bone, and 38 698 
Inherited erythrocyte abnormalities 4,836 5 
3,378 4 
4 
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1.3 Transplantation Process 
To prepare for an HSC transplant, the patient first receives myeloablation: high 
dose radiation or chemotherapy to ablate bone marrow cells, suppress the immune 
response, and kill malignant cells (19). Some patients cannot withstand the severity of 
myeloablation, and as a result, a new technique has been established that uses lower 
doses of radiation or chemotherapy, nonmyeloablative regimens, to suppress the immune 
system and decrease the chance of rejection. Since 2006, approximately 40% of 
allogeneic transplants utilize nonmyeloablative regimens (3). This procedure relies on 
implanted HSCs to kill cancer cells, and results in complete or partial remission in more 
than half of patients (3, 19, 22-25). 
HSCs are typically collected from the donor's peripheral blood or bone marrow in 
the pelvis (19). However, HSCs can also be harvested from newborn umbilical cord 
blood. Cord blood HSCs are less likely to cause an immune response in imperfect 
matches as compared to equal mismatches in bone marrow HSCs. However, there are 
not as many stem cells in cord blood so adults must pool cord blood from more than one 
donor (21, 26). This increases the risk of GVHD because two types of non-self cells in 
the patient are capable of attacking the host tissue. Cord blood HSCs also take longer to 
home to and repopulate the bone marrow cavity (19, 21). 
Harvested HSCs are filtered to remove debris such as bone fragments and may be 
processed to remove T -cells that could initiate GVHD (21 ). The purified cells are then 
infused into the patient intravenously. If the transplant is successful, the HSCs will 
migrate to the bone marrow cavity and begin hematopoiesis, repopulating the immune 
system (19). A schematic of the transplantation process is shown in Figure 1.1. 
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Figure 1.1: Bone marrow transplantation process. Image adapted from (19). 
Survival rates after transplantation vary widely depending on the type of 
transplant, donor age, recipient age, and stage of the disease but rates of remission and 
survival are still higher than alternative treatments. The main concerns are infection after 
transplant-since the patient will have no functional immune system for about two weeks 
post-transplant, rejection, GVHD, and relapse (21). Autologous transplants are usually 
more successful (approximately 90 % survival rate) due to the fact that the patients' own 
cells are used, eliminating the risk of rejection and GVHD. Overall, transplants for non-
malignant diseases have a survival rate of 70-90% if the HSCs come from an HLA 
identical sibling and 36-65% if the HSCs are received from an unrelated 6:6 match. The 
survival rates for acute leukemias are 55-68% if the donor is a HLA identical sibling and 
26-50% if the donor is an unrelated HLA identical match (21 ). Because a variety of 
factors can contribute to the success of a transplant, the US Department of Heath and 
Human Services maintains a database of patient outcomes that can be sorted by disease, 
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donor type, patient age, patient race, patient gender, and cell source to serve as a resource 
to patients and healthcare providers (27). 
1.4 Challenges Facing HSC Therapy 
As aforementioned, one of the main obstacles facing HSC treatment is the limited 
number ofHSCs available. Donors are in short supply, and finding a perfect match is 
difficult. Collecting HSCs from the pelvis is risky for the donor, but peripheral blood 
collection does not yield as many cells. HSCs from a single newborn's cord blood are 
insufficient and must be combined with other donations to successfully repopulate the 
patient. Even if large numbers of cells are implanted, only about 1 0% of the implanted 
cells are capable of self-renewal and repopulation, processes that are necessary for the 
transplant to be successful (28). 
In addition, it is difficult to expand HSCs ex vivo because they do not readily self-
renew, and they quickly begin to differentiate in culture. As a result, cultured cells 
cannot currently be used for therapy. Many research groups have begun to develop new 
methods for expanding self-renewing HSCs ex vivo. This could make HSCs from one 
donor or from a single cord blood isolation available to multiple patients and allow 
patients to receive higher HSC doses and/or multiple treatments more easily. Previous 
work has shown that higher numbers of implanted HSCs are more successful in therapies 
(29). The ability to culture HSCs ex vivo would also allow scientists to study the basic 
biological processes of the cells more easily. Having an available cell source would 
make large-scale experiments possible and reduce the frequency of primary cell harvests. 
For these reasons, this thesis will concentrate on the development of a bioactive polymer 
scaffold for the maintenance ofHSCs ex vivo. The system immobilizes important 
signaling molecules into the polymer matrix to mimic the HSC microenvironment. 
1.5 Hematopoietic Stem Cell Biology 
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In order to engineer a successful ex vivo culture system, it is important to consider 
the biology of HSCs. HSCs are a type of adult stem cell typically found in the bone 
marrow cavity of long bones. They were first identified when they formed colonies in 
the spleens of irradiated mice after a bone marrow transplant (30, 31 ). These multi potent 
cells represent 1/20,000 of the total bone marrow cell population and can differentiate 
into all blood and immune cells in a process called hematopoiesis (1). Hematopoiesis is a 
continual process but is upregulated at times of stress such as at high altitudes and after 
injury (19, 32). 
A 
B 
c 
D 
Figure 1.2: Stem cell fates in the niche. [red cells are hematopoietic stem cells (HSC), green 
cells are hematopoietic progenitor cells (HPC)]: A. HSC remains quiescent, B. HSC divides 
asymmetrically , one daughter cell remains an HSC and the other daughter cell begins to 
differentiate, C. HSC divides symmetrically and both daughter cells remain undifferentiated, D. 
HSC divides symmetrically and both daughter cells begin to differentiate. Figure adapted from 
(33) . 
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HSCs possess a special characteristic called self-renewal, meaning that HSCs are 
capable of repopulating themselves and remaining in a multi potent state. Self-renewing 
HSCs can repopulate all blood cell lineages in irradiated hosts (34). However, HSCs are 
typically in a quiescent state and divide infrequently, approximately once every sixty 
days (35). The specific signals that regulate HSC self-renewal and differentiation remain 
the subject of scientific investigation and debate ( 19). It is hypothesized that it is not one 
signal but a combination of environmental cues and interactions that regulate HSC fate. 
The complexity of this system makes it difficult to control HSC behavior using standard 
tissue culture techniques. 
There are two hypotheses that address the question of how HSCs self-renew. In 
divisional asymmetry, the HSC divides in such a way that one daughter cell receives all 
of the information to begin differentiation, and the other daughter cell remains in an 
undifferentiated state. In environmental asymmetry, the two daughter cells are identical 
and receive the signals that determine their fate from the external environment. 
Typically, one daughter cell remains an HSC and the other begins to differentiate (34). 
In symmetrical division, HSCs divide, and both daughter cells remain stem cells. It is 
theorized that HSCs can switch between symmetrical and asymmetrical divisions 
depending on physiological conditions (36, 37). Figure 1.2 pictorially depicts the fate of 
HSCs within the bone marrow: quiescence, self-renewal, and differentiation (32) 
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Figure 1.3: Differentiation pathway of HSCs. To the left of the colored cells, are matching 
colored ellipses indicating the surface markers that the cells express. Image adapted from (38) . 
11 
12 
Studying HSC function is complicated by the fact that the isolation of pure HSC 
populations from bone marrow is difficult. Many groups define HSC populations by a 
combination of surface markers that the cells express, all of which contain HSCs as well 
as a variety of progenitor cells. A specific combination of signaling lymphocytic action 
molecule (SLAM) family receptors has been used to describe HSCs: CD150+, CD48-, and 
CD41- (39, 40). Another group, the KSL population, is defined as c-kit, stem cell 
antigen 1 (Sea-l)+ and lin- (39, 40). lin- cells are negative for a combination of lineage 
markers that are representative of differentiated HSCs. These include: Ter-119 (erythroid 
cells), Gr-1 (granulocytes), Mac-1 (monocytes), B220 (B cells), IL-7 Receptor (BandT 
cells), CD4 (T-cells), and CD8 (T cells) (40-43). Endoglin+, Sea-l+, and Rhodamine10w 
also define a population of long term repopulating stem cells (20, 41, 44). Another 
population, side population HSCs, is defined by its ability to efflux Hoechst dye ( 45). 
Figure 1.3 shows how the surface markers of murine and human HSCs change as they 
differentiate down myeloid and lymphoid pathways. 
However, none of these populations contain a pure population of self-renewing 
HSCs; they contain long-term and short-term reconstituting stem cells (LT-HSC and ST-
HSC respectively) as well as multi potent progenitors (MPP) (34, 41, 46-48). L T-HSCs 
can renew extensively as opposed to ST -HSCs, which have a limited ability to self-
renew, and MPPs, which do not self-renew (49-51). By combining different populations 
ofHSCs, the percentage oflong-term repopulating (self-renewing) cells can increase (41, 
46, 47). Self-renewal is an important and critical process because it is the self-renewing 
HSCs that engraft in the bone marrow and repopulate the immune system, making 
transplantation successful. In fact, one self-renewing HSC can repopulate the entire 
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hematopoietic system of a mouse (43, 47, 52-55). There are also other HSC functions 
that must be maintained for therapies to work: mobilization and homing (Figure 1.4) (56). 
Figure 1.4: Models for HSC mobilization and homing. The protein stromal derived factor 1 a 
(SDF1 a) plays a critical role in both of these processes. Image adapted from (56). 
Mobilization is the HSCs' response to injury or foreign invasion (34). During this 
process, proteolytic enzymes cleave adhesion molecules that keep the HSCs attached to 
stromal cells in the bone marrow cavity. This allows the HSCs to differentiate and move 
into the circulation where they can migrate to sites in the body where they are needed. 
The expression of c-kit and very late antigen 4 (VLA-4), both important adhesion 
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integrins, is decreased, and the production of matrix metalloproteases (MMPs) 2 and 9, 
which cleave adhesion molecules is increased on mobilized HSCs (57, 58). Granulocyte 
colony stimulating factor (G-CSF) triggers osteoclasts to resorb bone and release 
calcium, which also induces mobilization (59). Cyclophosphamide can also mobilize 
HSCs (34). HSCs that are unable to mobilize would be incapable of responding to injury 
or invasion by foreign bodies. 
Homing is the ability of implanted or circulating HSCs to find their way to the 
bone marrow cavity (34). Transplanted HSCs must be able to be home to succeed in 
therapies because it is at this site that they receive signals for both self-renewal and 
differentiation. Several integrins (VLA-4 and VLA-5) and selectins (E and P) are critical 
in homing (34). Homed HSCs are found close to osteoblasts expressing osteopontin, N-
cadherin, and bone morphogenic protein receptor 1 (BMPR-1)(34). In addition, there is 
an increase in the expression ofC-X-C chemokine receptors type 4 (the receptors for 
stromal derived factor 1a.) on the surface ofHSCs during homing (28). Both 
mobilization and homing require signals that are coordinated by the HSCs' natural 
microenvironment or niche. 
1.6 The Hematopoietic Stem Cell Microenvironment 
In the design of a system for ex vivo HSC culture, it may be important to 
accurately recapitulate the native microenvironment. The HSC niche is defined as a 
"spatial structure in which [hematopoietic] stem cells are housed and maintained by 
allowing self-renewal in the absence of differentiation" (28). To preserve the delicate 
balance between quiescence, self-renewal, and differentiation, HSCs receive signals from 
their in vivo microenvironment. The majority of signals originate from membrane bound 
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proteins- via cell-cell interactions, local extracellular matrix components, and soluble 
molecules such as growth factors and cytokines (32). It has been proposed that stem cell 
potency relies heavily on extrinsic cues in the niche as opposed to intrinsic signals within 
the cell (32). To support this theory, researchers have shown that progenitor cells may be 
able to revert back to a stem-cell state when placed back into the niche (60, 61). Thus, 
the ability to control or mimic these cues ex vivo may retain HSCs in a multi potent state, 
which is critical if the cells will be used therapeutically. 
Figure 1.5: The HSC microenvironment or niche. The HSC niche is divided into two s_ub-
niches: the endosteal niche-where HSCs interact with osteoblasts-and the vascular nrche-
where HSCs interact with endothelial cells. The functions of each niche are still under 
investigation, but it is known that several molecules and stromal cells regulate HSC fate. Image 
adapted from (62). 
The niche was first discovered in a Steel Dickie mouse that had a mutation in the 
gene encoding for membrane bound stem cell factor (SCF). This mutation resulted in 
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changes to the niche and the inability of the mouse to maintain HSCs in vivo (34, 63). 
The niche is located in the bone marrow cavity, though HSCs can also be found in 
peripheral blood ( -1 circulating HSC for every 1 00 located in the niche) and the liver and 
spleen after bone marrow injury (34). The presence ofHSCs in circulation is thought to 
be important in repopulating areas of damaged bone marrow and thymus (1, 19, 28, 39, 
64, 65). The HSC niche is divided into two sub-niches: the endosteal (or osteoblast) niche 
and the vascular niche as seen in Figure 1.5. These niches cooperate to ensure HSC self-
renewal and hematopoiesis, though it is unclear precisely where these two processes take 
place within the niches (34, 66). 
In general, it is thought that HSCs remain quiescent in the endosteal niche and 
when mobilized, due to stress or injury, they will migrate to the vascular niche where 
they begin to differentiate and leave the niche to circulate. In contrast, self-renewal could 
occur in the vascular niche because these cells would be in closer proximity to 
vasculature meaning they could act more quickly upon injury. The endosteal niche 
would then replenish the vascular niche by supplying it with HSCs (34). It has also been 
proposed that the sites for HSC self-renewal and differentiation are not predetermined. 
These events can occur in either the vascular or endosteal niche and depend more on the 
cells' proximity to specific stromal cells (67). 
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Figure 1.6: Proposed relationships between HSC sub-niches. A. Niches are spatially distinct 
but function similarly, B. Niches are spatially distinct but serve different roles in HSC 
maintenance, C. No sub-niches, HSCs are influenced by osteoblasts and endothelial cells in one 
larger niche, D. Unidentified cells maintain HSCs outside of endosteal or vascular zone. Image 
adapted from (66). 
Figure 1.6 summarizes theoretical relationships between the sub-niches as well as a 
scenario challenging the idea of specific sub-niches and describing one comprehensive 
niche. The uncertainty surrounding the properties and functions of the sub-niches 
demonstrates another potential application of a synthetic niche environment. A system 
that is capable of recapitulating the cellular and molecular organization of both niches 
could help elucidate the distinct differences and similarities between the two. 
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Figure 1.7: A model of the interface between an HSC and a specialized niche osteoblast. 
The interaction between osteoblasts is complex and has been well characterized. However, 
there are still many unknowns. Image adapted from (34). 
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Several different cell types compose the niche and many are specialized to control 
HSC behavior. These include fibroblasts, bone marrow endothelial cells (BMEC), 
mesenchymal stem cells (MSCs ), spindle-shaped N -cadherin-expressing osteoblasts 
(SNOs), and CXCL12-abundant reticular (CAR) cells (34, 39, 56, 68). CXCL12 will be 
referred to by its other common name, stromal cell derived factor la (SDF-la), in any 
subsequent discussion of the protein. These cells help to coordinate HSC behavior 
through secreted factors as well as cell-cell signaling. 
The interactions between HSCs and SNOs are very complex and have been the 
most studied (Figure 1.7) (34, 39, 56, 68). The precise signaling pathways that control 
quiescence, self-renewal, and mobilization are still the subject of research and are most 
likely a combination of various signaling molecules. These molecules include soluble 
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factors (such as cytokines ), membrane bound receptors, extracellular matrix proteins, and 
transcription factors (34 ). Though there is a multitude of signaling factors, we will only 
elaborate on a few of the most important. 
SNOs (and other niche cells) express Jaggedl (JAG 1), the ligand for Notch 
family receptors (1, 69). Notch receptors are expressed by HSCs and have been shown to 
prevent the differentiation of other cell types (1, 70, 71). Notch1 prevents HSC 
differentiation by maintaining the expression of GAT A2, a transcription factor (72). 
However, Notch signaling is not necessary for HSC survival, indicating the redundancy 
of some ofthe signaling pathways (73-76). 
Angiopoietin-1 (ANG1) on SNOs and TIE2 on the HSCs interact causing HSC 
quiescence and preventing apoptosis (1 ). Although this interaction prevents 
differentiation, it also prevents self-renewal (77). ANG 1 can also encourage the adhesion 
ofHSCs to SNOs through the TIE2ligand (78). 
Wnt signaling is also thought to promote self-renewal though the source of Wnt 
signaling molecules, osteoblast or vascular niche, is unknown (79-81 ). Hematopoietic 
progenitors can be expanded in vitro through the activation of Wnt signaling, and 
inhibiting Wnt signaling results in a lack ofHSC growth in vitro and reduced 
repopulation abilities in vivo (34, 81 ). It is believed that Wnt signaling acts through 
HoxB4 (discussed later) and Notch1 pathways though the exact intracellular mechanisms 
are unclear ( 48, 81 ). 
SDF1a has been shown to be important for both HSC retention and migration. It 
is expressed by both SNOs and BMECs and interacts with CXCR4 on HSCs (34). 
Membrane bound SDF1a can retain HSCs in the niche by binding to CXCR4 while 
20 
soluble SDFla can induce mobilization by activating IL-8, MMP-2, and MMP-9leading 
to the migration of HSCs out of the bone marrow and into the vasculature (28, 56). 
Similarly, stem cell factor (SCF) has distinct effects on HSCs in its differing 
forms. Membrane bound SCF expressed on SNOs can cause HSC adhesion through the 
c-kit integrin on HSCs (28, 56). Though SCF does not seem to be necessary for the 
initial expansion ofHSCs, it is critical for long-term maintenance and self-renewal (34). 
SCF can also stimulate adhesion by activating VLA-4 and VLA-5 integrins on HSCs, 
changing their shape (34). Osteoblasts without membrane bound SCF are unable to 
maintain HSCs in vivo (82, 83). 
N-cadherin is expressed by both SNOs and HSCs (84, 85). N-cadherins in HSCs 
localize to their side of attachment to the SNOs (85). N-cadherin interactions between 
SNOs and HSCs are thus thought to aid in anchoring HSCs in the endosteal niche and, 
along with 13-catenin, HSC asymmetrical division (34, 86). However, the subset of the 
HSC population that is capable of repopulation does not express N -cadherin suggesting it 
is not necessary for HSC maintenance (87). 
Osteopontin (OPN), secreted from osteoblasts, also regulates HSC fate. Soluble 
OPN induces apoptosis in HSCs, and OPN deficient mice have a higher HSC population 
due the fact that there is a decreased level of apoptosis (34, 86). Osteopontin may also 
help maintain HSC quiescence (88). 
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Table 1.2: Molecules implicated in HSC adhesion within the niche. Table adapted from (89). 
Major Stromal Adhesion Molecules 
lgCAM: immunoglobulin cen adhesion molecule, GP: glycoprotein, HSPG: heparan sulfate proteoglycan, 
CSPG: chondroitin sulfate proteoglycan, pil: phosphatidyl inositillinked, L: lymphoid precursor, E: 
erythroid precursor, M: macrophage precursor, Meg: megakaryocytic precursor 
Other ECM components such as fibronectin (FN) and hyaluronic acid (HA) help 
to keep the HSCs anchored in the endosteal niche through various integrins. An 
unidentified integrin on the HSCs adheres to FN, and VLA-5 on the HSCs adheres to HA 
(See Figure 1.7). Table 1.2 shows many ofthe major adhesion molecules that help HSCs 
adhere to either the ECM or stromal cells (89). 
The concentration of different ions in the niche can also play a role in HSC 
behavior. Calcium gradients may be involved in HSC homing and retention ofHSCs in 
the niche (90). The concentration of oxygen increases moving from the endosteal to the 
vascular niche, and lower oxygen levels are associated with HSC quiescence (39, 77, 91). 
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There are several other factors affecting HSCs that have been studied. Interferon-
y (IFN-y), an inflammatory cytokine, is believed to negatively regulate hematopoiesis and 
promote HSC differentiation (92). It has been shown to promote the proliferation of L T-
HSCs in vitro but leads to reduced engraftment capabilities (93). In addition, p21 (a 
gene) maintains quiescence, cmyc (also a gene) maintains the balance of HSC self-
renewal and differentiation, and HoxB4 (a transcription factor) encourages self-renewal 
(39, 77, 91). The enumeration and detailed description of every molecule within the HSC 
niche are outside the scope of this work. However, it is important to keep in mind the 
complexity of the niche and variety of signaling pathways present when designing an ex 
vivo expansion system. In fact, many niche components have been incorporated into 
current HSC expansion strategies 
1. 7 HSC Expansion Strategies 
1. 7.1 Advantages of and Obstacles to ex vivo HSC Expansion 
The expansion of HSCs has the ability to improve HSC therapy in several ways. 
First, in vitro culture would effectively increase the number of available donors because 
peripheral blood HSCs could be collected for both autologous and allogeneic transplants 
and expanded in place of harvesting HSCs from bone marrow in a more risky procedure. 
Cord blood would also be a more worthwhile source of HSCs because therapeutic 
numbers could be generated ex vivo eliminating the need for pooling. Also, HSCs would 
be readily available in cases where multiple HSC transplants are necessary such as when 
a patient receives successive rounds of damaging chemotherapy. Furthermore, the in 
vitro culture of stem cells would allow for concurrent gene therapy strategies and prevent 
rejection, graft v. host disease, and the need for immunosuppressant drug regimens (94). 
Ex vivo expansion would also provide a way to conduct large-scale experiments 
with HSCs. Many of the molecular mechanisms governing HSC behavior are still not 
well understood. By creating a culture system, scientists could more easily study these 
cells (1, 95). An increased knowledge ofHSCs could potentially help improve and 
broaden therapeutic applications (1). 
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Unfortunately, there are many hurdles to the culture ofHSCs in vitro. As 
aforementioned, it is difficult to isolate HSCs. Harvested tissue contains numerous cell 
types, and current processing strategies are unable to produce pure HSC populations. 
This means that culture systems also support the maintenance of more differentiated cell 
types, which can mask the effects of the system on more primitive cells. Furthermore, 
though HSCs are capable of adhering to other cells and ECM components within the 
niche, they are typically non-adherent or weakly adherent in in vitro settings (96). Thus, 
culture on 2D surfaces is problematic, as the cells are highly mobile and readily leave the 
surface. 
In addition, homeostatic conditions that are precisely controlled in the niche allow 
HSCs to proliferate while maintaining a pool of HSCs that remains undifferentiated. The 
signals that drive these processes are highly complex and have not been fully 
characterized. This makes it very difficult to mimic the niche accurately and maintain 
HSCs in a primitive state. In turn, once the cells have been expanded, there are several in 
vitro and in vivo assays that must be conducted to evaluate the success of the system. 
The expression of specific surface markers does not necessarily signifY that the cells are 
capable of repopulation. Several research groups have addressed these challenges in 
attempts to culture HSCs in the laboratory. 
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1.7.2 Evaluation of Expanded HSCs 
Expansion approaches have included cytokine cocktails (43, 97-107), coculture 
with niche stromal cells (34, 68, 96, 108-119), and engineered surfaces (94, 96, 120-125), 
as well as the use of synthetic polymer scaffolds (125-132). All ofthese systems used the 
same techniques to evaluate the potential of expanded HSCs. One of the simplest 
evaluation methods is to use flow cytometry analysis. In this assay, expanded cells can 
be stained with fluorescently tagged antibodies to surface markers defining HSC 
populations described in Section 1.5. The cells then flow through the pathway of a laser 
in a single cell stream to excite the fluorophores. The emission data for each cell is 
stored and can be analyzed to determine the expression profile of each marker within the 
cell population. However, this information should also be coupled with an assay that has 
a functional output. 
The colony forming unit (CFU) assay can be used to determine pluripotency but 
cannot assess homing ability (133). In the CFU assay, progenitors are seeded within 
methylcellulose medium. Methylcellulose supports the growth of 3D cultures due to its 
viscosity. Cells are allowed to proliferate/differentiate and their ability to form various 
colonies signifies their differentiation potential. Colonies are observed and identified 
using an inverted microscope. Cells that are more primitive form colonies composed of 
multiple cell types. However, this technique can be subjective because different 
laboratories have developed their own scoring protocols, making it difficult to compare 
data from various laboratories. Also, some colonies form more quickly than others so 
various timepoints are typically evaluated (134). 
The long-term culture initiating cell (LTC-IC) assay is used to quantify the 
number of cells that are capable of long-term repopulation. These cells are termed LTC-
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ICs and are very primitive. To perform this assay, cells are seeded onto an irradiated 
feeder layer and kept in culture for a few weeks. They are then seeded in methylcellulose 
for the CFU assay. Colonies are counted, and if colonies are formed, the cells are marked 
as positive. L TC-IC frequency is calculated based on the number of seeded cells and 
applying Poisson statistics (134). 
The best method to evaluate HSC potential is to perform a repopulation assay. In 
this assay, expanded cells are injected into an irradiated mouse and their ability to 
repopulate the host mouse indicates their potential. A variation of this assay is the 
competitive repopulating units assay. Donor bone marrow is mixed with cells from a 
genetically distinguishable control. The ability of the donor to repopulate the recipient is 
evaluated in both assays by looking at the percent of the donor's cells in the bone marrow 
compared to the number of control cells in the marrow (134). This is done using flow 
cytometry. In long term repopulating assays, bone marrow is retransplanted from the 
primary recipient into secondary recipients and from secondary to tertiary recipients. 
Stem cells that retain their potency should be able to repopulate the secondary and 
tertiary recipients (34 ). 
1. 7.3 Cytokine Cocktails 
Many different cytokines have been added to the media to encourage HSC/HPC 
expansion. Thrombopoietin (TPO) induces the self-renewal ofHSCs both in vitro and in 
vivo (97, 98). This is thought to be because TPO stimulates Ho:xB4 expression, which in 
turn encourages self-renewal (135). TPO may also play a role in suppressing HSC 
apoptosis (100). A combination ofSCF and TPO was also shown to be effective in 
promoting HSC self-renewal compared to combinations of SCF and IL-3 or SCF and IL-
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6 (101). Fibroblast growth factor (FGF) also promotes the expansion and the long-term 
growth of HSC/HPCs in culture (1 05). Both Jagged 1 and Wnt proteins can also lead to 
expansion ofHSCs when added to the media (102, 103). 
Flt3 has also been added to the media particularly in combination with TPO and 
SCF. Flt3 is thought to be early acting, involved in homing, and a survival factor. It 
induces the proliferation of human HSCs and when added with SCF it can improve 
engraftment ( 43, 104, 1 07). However, it has been shown that the Flt3 receptor (F1k2) is 
not expressed by L T-HSCs; populations expressing the receptor do not self-renew and are 
only capable of lymphoid reconstitution (50, 136). This suggests that Flt3 acts on a more 
differentiated population of hematopoietic cells. 
The addition of cytokines to the media is a simple method to expand HSCs, but its 
simplicity is also its limitation. Many of the cytokines that are added to the media to 
encourage expansion and aid in survival, such as SCF, are also implicated in the 
differentiation pathways of HSCs. Though the addition of these signaling molecules can 
help the cells to proliferate, it concurrently triggers their differentiation. The half-life of 
these molecules is also very short because they are cleaved by proteases, and they must 
be replenished every few days, which can be very expensive (137). Furthermore, all of 
the factors that are added to the media are in a soluble form, which can have very 
different effects than if they are presented in a membrane bound form. One way to 
overcome these limitations is to use a feeder layer of cells to reproduce the multitude of 
signaling molecules that are present in the niche and the cell-cell interactions that are 
lacking in a system containing only soluble factors. 
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1. 7.4 Coculture 
Coculturing HSCs with other cell types found in the niche can also promote 
expansion. Several different types of endothelial cells have been used including BMEC 
(96), human umbilical vein endothelial cells (113, 119), and yolk sac endothelial cells 
(1 08, 1 09). HSCs have been shown to adhere to these endothelial cells and expand in 
culture significantly. Other stromal cells have seen similar results including NIH 3T3 
fibroblasts (114, 115), osteoblasts (111, 117), and mesenchymal stem cells (68, 116, 
118). 
It is not entirely clear whether HSCs need to be in contact with stromal cells to 
survive and expand or if soluble factors released from these cells are capable of 
sustaining HSCs and encouraging their expansion. It has been shown that cell-cell 
contact is critical for the expansion ofHPCs on osteoblasts (111). However, other studies 
show that contact is unnecessary and that soluble factors are enough to expand HSCs 
(110, 112). 
The main problem with utilizing a coculture system is the lack of control that 
researchers have over the system. Although, the feeder cells can be manipulated 
genetically to secrete or express certain proteins, the interactions between the cells are so 
complex that it is difficult to parse out which signaling pathways are driving particular 
HSC processes. In addition, stromal cells could also signal undesired responses in HSCs, 
and it is hard to predict and/or prevent this. 
1.7.5 Biomimetic Surfaces and Scaffolds 
To better control the presentation of signaling molecules to HSCs without the use 
of other cells, several different types of surfaces have been fabricated for HSC expansion. 
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In one study, several surfaces, all approved for blood contact, were tested for human HSC 
biocompatibility and expansion. These included glass, stainless steel (SS) 316, SS 304, 
Teflon perfluoroalkoxy (PF A), Teflon fluorinated ethylene propylene (FEP), 
polytetrafluoroethylene (PTFE), polymethylpentene (PMP), polycarbonate, Barex 
(polyacetonitrile-methylacrylate), polyethylene (PE), high density PE (HDPE), 
polypropylene, acetyl polyformaldehyde, cellulose acetate, polyethylene terephthalate 
(PET), polysulfone, titanium, and aluminum (94). Teflon PFA, Teflon FEP, PMP, and 
titanium all did well in the expansion of human HSCs. SS 304, PTFE, HDPE, PET, and 
polysulfone all performed poorly. Overall, the investigators found that the expansion of 
primitive progenitor cells (those able to form CFU-GM-a combination of granulocyte 
and macrophage-colonies) was very sensitive to the material (94). 
ECM proteins have also been coated onto polystyrene plates to test their effects 
on HSC adhesion. In one study, several different cell lines and ECM proteins were 
tested. Overall, they found that ECM proteins can encourage adhesion, and that the 
glycoproteins (fibronectin, vitronectin, and laminin) supported the largest percentages of 
cell adhesion (96). However, they also discovered that the cell lines responded very 
differently to the same ECM protein. For example, 80% ofNALM-6 cells (B-cell 
lymphoma line) adhered to fibronectin as opposed to only 30% ofKG1a cells (acute 
myelogenous leukemia). These results indicate the need for caution when presuming that 
the findings of studies with hematopoietic cell lines will apply to primary HSC 
populations. 
FN has been widely studied in the expansion of HSCs/HPCs and has been shown 
to encourage the largest area of adhesion (120). When cultured in FN coated flasks, 
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human CD 34+ cells were able to expand and maintained their ability to engraft (121). In 
another study, human CD34+ cells also lost their clonogenic ability in the absence ofFN 
(122). HPC adhesion to immobilized fibronectin has also been shown to stimulate 
proliferation whereas nonadherent cells stop in Gl/S phase (123, 124). Two different 
peptide sequences derived from FN, CS-1 (LDV) and RGD, have also been used to 
successfully expand human umbilical cord HSCs (125). 
The manipulation of surfaces is a fairly simple and versatile process. Many 
different molecules from the HSC niche can be tethered to surfaces. It is also possible to 
pattern them in specific arrangements to mimic their in vivo presentation, which is not an 
option with the addition of soluble cytokines or coculture techniques. However, surfaces 
are limited in their ability to translate into three dimensions. While surfaces are useful 
for studying basic cell-protein interactions and signaling pathways, it is difficult to 
recapitulate native bone marrow tissue accurately in only two dimensions. The HSC 
niche is a three-dimensional structure with multiple components, and the spatial 
arrangement of the various cell types and extracellular matrix components (ECM) affects 
the fate of HSCs in vivo. The creation of a synthetic HSC niche comprised of various cell 
types, signaling moieties, and appropriate ECM proteins has the potential to maintain 
these cells in vitro (34, 62). Outside of the niche, HSCs rapidly differentiate due to the 
absence of signals balancing the processes of self-renewal and differentiation. A three-
dimensional system that recapitulates the in vivo HSC microenvironment may be able to 
control both of these events. 
The use of polymer scaffolds in the design of such a system has great potential, 
yet it has not been studied extensively. Scaffolds not only provide mechanical support to 
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cells, but ideally they can be "selectively functionalized with regulatory cues" and the 
presentation of these molecules can be spatially controlled (32). RGD, LDV, and FN 
covalently conjugated to PET films showed successful ex vivo expansion of CD34+ cells 
(125, 129). After ten days of culture, Jiang et al. observed a 600 fold increase in total 
nucleated cells on surfaces with CS1 and 500 fold increase on surfaces with RGD though 
only obtained successful engraftment of cells cultured on CS1 (125). Feng et al. cultured 
cells in both 3D and 2D PET scaffolds with surface immobilized FN. In ten days, cells 
expanded 200 fold in three-dimensions as compared to 100 fold in two-dimensions and 
maintained their ability to repopulate irradiated hosts (129). 
Several different electrospun nanofibrous scaffolds (Figure 1.8) have also been 
developed to promote HSC adhesion and proliferation (126, 130, 131 ). Ma et al. 
electrospun a copolymer of poly(DL-lactide-co-glycolide) and collagen and coated it with 
E-selectin to capture HSCs; they were able to significantly increase the number of 
captured cells by 40% compared to controls (126). Chua et al. electrospun surface-
aminated PES nanofibers to encourage HSC adhesion and expansion and obtained almost 
200 fold expansion after 10 days compared to only 50 fold on TCPS (131 ). In another 
study, Chua et al. investigated the effects of various spacer types and lengths for the 
surface conjugation of amine groups to PES on HSC proliferation and differentiation 
potential. They found that the type of spacer used heavily influenced the expansion of 
HSCs (130). 
Bagley et al. used tantalum-coated porous biomaterials to culture HSCs in three 
dimensions and observed a 7 fold increase in HSCs after 6 weeks in culture. Expanded 
cells retained their multipotency as demonstrated by the ability to form myeloid, 
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erythroid, and lymphoid progeny, though the in vivo repopulation ability of the cells was 
not evaluated (132). Despite their successes, none of these scaffolds has been effective in 
maintaining HSCs in culture for longer than a few weeks because they were unable to 
sufficiently mimic the complexity of the niche environment. 
Figure 1.8: HSCs from umbilical cord blood cultured on surface aminated nanofibers. A. 
HSCs formed colonies on the nanofiber surface after 8 days (designated by black arrows) B. 
HSCs within the colonies on the nanofiber surface. Figure adapted from (130). 
There is still a great need to develop novel scaffolds for HSC/HPC culture and 
expansion. The work in this thesis draws from research characterizing the HSC 
microenvironment and applies it to the design of a novel poly( ethylene glycol) based 
hydrogel scaffold. Recent work by Kobel eta/. and Lutolf eta/. demonstrated the utility 
of poly( ethylene glycol) diacrylate (PEG-DA) microwell arrays for studying the effects 
of specific proteins on the proliferation kinetics of single HSCs in a high-throughput 
manner (127, 128). In their system, they immobilized specific proteins, such as FGF, 
onto the surfaces of hydrogel wells and observed proliferation rates of single cells as well 
as their ability to engraft after multiple cell divisions. I have adapted this idea for the 
expansion of large populations of HSCs ex vivo. The following studies investigate the 
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potential of engineered niche components to manipulate HSC behavior in both two and 
three dimensions. The ability to control HSC fate ex vivo will improve current treatments 
that employ these multi potent cells and allow for development into new areas of research. 
These precisely designed materials will also provide researchers with a platform on 
which to study basic HSC biology. 
Chapter 2: Hematopoietic Cell Behavior on Hydrogel Surfaces 
Containing Immobilized Fibronectin-derived Peptide Sequences 
2.1 A Hydrogel System for HSC Expansion 
The development of an ex vivo culture system for primary HSCs would greatly 
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expand the clinical applicability of these cells. Currently, HSC therapy is limited by the 
inability to obtain large populations of these cells and maintain them in culture. The 
work in this thesis focuses on the development of a PEG hydrogel culture system that 
mimics aspects of the native bone marrow microenvironment. It is hypothesized that 
through the recapitulation of in vivo signaling processes, the ability to control HSC fate 
will be possible. We have designed a novel hydrogel well system for the culture of 
hematopoietic stem and progenitor cells. The surfaces of these wells can be 
functionalized with multiple biomolecules. This chapter investigates the effects of the 
short adhesive peptide sequences RGD and LDV on hematopoietic cell adhesion, 
spreading, proliferation, and differentiation. 
2.1.1 Hydrogels 
Hydro gels have been used for several years in the fields of tissue engineering 
(138-144) and drug delivery (139, 145-149) and have been investigated for other uses in 
diagnostics and biosensing (150). They have garnered attention due to their similarity to 
native tissues, which has been attributed to their high water content, and excellent 
biocompatibility (150). Hydrogels owe their structure to a network of polymer chains 
that are chemically crosslinked or physically entangled (151, 152). The hydrophilicity of 
polymer chains causes the gels to absorb high amounts of aqueous solutions, and in turn, 
the gels swell extensively (138). Hydrogels can be formed from both natural and 
synthetic polymers. 
Natural hydrogels can be generated from collagen, hyaluronic acid, fibrin, 
alginate, agarose, and chitosan (148). These hydrogels have intrinsic cytocompatibility 
and bioactivity, and many are naturally degraded by cells. However, hydrogels formed 
from natural polymers are typically weaker than synthetic matrices, though they can be 
chemically modified to increase their structural stability (150). In addition, researchers 
have less control over the biological properties of natural polymers as opposed to 
synthetic polymers. 
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Researchers can easily tune the mechanical, biological, and chemical properties of 
synthetic hydrogels. Synthetic hydrogels can be formed from poly(hydroxyethyl 
methacrylate) (PHEMA), poly(vinyl alcohol) (PVA), poly(ethylene glycol) (PEG), 
poly(acrylic acid), poly(methacrylic acid), and poly(acrylamide) (150). Figure 2.1 shows 
the chemical structures of these polymers. The mechanical properties of synthetic 
hydrogels can easily be controlled by altering the molecular weight of the polymer, the 
weight percent of the polymer, and/or the number of crosslinking sites on the polymer 
backbone (153). Synthetic polymers can be engineered to be biodegradable or 
nondegradable by the selection of the crosslinking process or the inclusion of degradable 
elements. For example, PV A readily degrades by hydrolysis if it is physically 
crosslinked but can be rendered nondegradable by chemical crosslinking (150). In 
addition, "smart" hydrogels can be formed that are responsive to changes in pH or 
temperature. One example ofthis is poly(N-isopropylacrylamide) (pNIPAAm), which 
can cycle between a swollen and collapsed state in response to temperature. (150). 
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pNIP AAm has been investigated for uses in in vivo drug delivery where it exists in a 
swollen form at room temperature and collapses at body temperature to release a drug 
(154, 155). Copolymers composed of one or more synthetic (or natural) polymer can also 
be synthesized to take advantage of various properties of each polymer. 
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Figure 2.1: Chemical structures of synthetic polymers that can form hydrogels. Image 
adapted from (150). 
2.1.2 Poly( ethylene glycol) Hydrogels 
One type of synthetic hydrogel that has been used extensively in medical 
applications is PEG. PEG is non-toxic, non-immunogenic, and approved by the United 
States Food and Drug Administration for a number of applications. PEG resists protein 
adsorption and subsequent nonspecific cell adhesion (156, 157). Due to this property it 
has often been used as a "stealth" material to coat implanted devices and other materials 
to render them protein resistant and prevent immune rejection (150). 
One PEG derivative, PEG diacrylate (PEG-DA) can be crosslinked rapidly via its 
acrylate groups. In an aqueous PEG-DA prepolymer solution, the PEG chains attract 
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water molecules causing the hydrophobic acrylate groups to cluster together and form 
micelles; this process prepares the polymer for subsequent crosslinking. There are two 
common strategies for the covalent crosslinking ofPEG-DA: photopolymerization and 
Michael-type addition (Figure 2.2). 
i. 
B 
Figure 2.2: Methods to crosslink PEG chains and form hydrogel networks. A 
Photopolymerization. i. PEG diacrylate (PEG-DA) synthesis. ii. UV light generates free radicals 
from the photoinitiator. iii. PEG-DA organizes into micelles in solution. iv. The addition of free 
radicals initializes the crosslinking of acrylate groups flanking each PEG chain. v. The reaction 
terminates upon the annihilation of two free radicals. B. The PEG hydrogel structure that forms as 
a result of the process shown in A C. Michael-type addition. The reaction of dithiols and esters 
results in crosslinking of the PEG chains. This reaction can be catalyzed through an increase in 
pH and/or temperature. Images in A and B were adapted from (158) and in C from (159). 
Photopolymerization uses the combination of a photoinitiator and light (UV or white) to 
initialize and accelerate free radical polymerization (160-162), a process that has been 
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shown to be cytocompatible (34, 163). Michael-type addition can also be used to form 
PEG-DA hydrogels through the reaction of free thiols and esters in an additive reaction 
(164, 165). This process proceeds slower than free radical polymerization, but utilizing a 
base catalyst and increasing the temperature can speed the reaction (165). 
PEG-DA hydrogels are one of the most commonly used synthetic polymers in 
tissue engineering. These hydrogels can be designed to mimic the native ECM 
environment and provide a structural support for cells in the formation of new tissues 
(150). Though unmodified PEG hydrogels are biologically inert, there have been many 
approaches to modify the gel with bioactive elements (166-168). The ability to select the 
biomolecules that are covalently tethered to the matrix allows for complete control over 
the cell environment. Adhesive peptide sequences, such as RGDS, have been 
successfully immobilized onto PEG hydrogel surfaces to promote cell adhesion and 
spreading (161, 168-171). In addition, larger molecules such as growth factors and other 
proteins can be covalently incorporated into PEG hydrogels to drive cell behavior (172-
175). The spatial arrangement of these molecules within a photopolymerized hydrogel 
can be controlled in both two and three dimensions using photolithography and laser 
scanning lithography techniques (176-180). 
PEG-DA hydrogels can also be rendered biodegradable by incorporating 
proteolytically degradable peptide sequences into the PEG chain backbone (167, 181, 
182) (Figure 2.3). Chapter 7 provides more information regarding the selection of 
peptide sequences. Cells release matrix metalloproteases (MMPs), which can degrade 
the sequences specifically and in tum break down the hydrogel (167, 183). Cells migrate 
through the matrix and remodel the scaffold as they organize into a three-dimensional 
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tissue-like structure. The advantage of this degradation scheme over hydrolytically 
degradable hydro gels is the ability to tune the degradation of the synthetic scaffold with 
the reorganization of the native tissue. 
PEG-Peptide-PEG 
J- PEG-Peptide Light 
h'-r ~ PEG-Protein 
~) Cell 
Photoi nitiator 
~EGchain = Degradable Peptide 
Figure 2.3: General schematic for encapsulation of cells within a bioactive, proteolytically 
degradable PEG hydrogel 
2.1.3 Hydrogel Wells for Stem Cell Culture 
Culturing cells within hydrogel wells is advantageous for HSC culture because it 
allows the cells to be contained. HSCs are highly mobile and during in vitro culture will 
migrate significantly (127, 128). In previous work, PEG hydrogel wells were developed 
for the culture of various types of stem cells (Figure 2.4). Moeller et al. and Karp et al. 
fabricated hydrogel microwells for the culture of embryoid bodies from embryonic stem 
cells and were able to obtain more homogenous differentiation (184, 185). 
Jongpaiboonkit et al. cultured encapsulated mesenchymal stem cells within wells of a 
PEG hydrogel microarray to simplify the analysis of material properties on MSC viability 
(186). In these studies, researchers used the hydrogels as a way to contain cells or gels 
containing encapsulated cells, and microarrays of hydrogel wells were utilized for high-
throughput processing and/or analysis. The gel wells in these studies did not contain 
bioactive elements and thus, on their own, would not be applicable for HSC culture. 
However, they do utilize a base PEG-DA hydrogel system, which can easily be 
functionalized with bioactive molecules as aforementioned, particularly peptides and 
proteins critical in HSC function. 
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Figure 2.4: PEG hydrogel well fabrication techniques. A. Karp eta/. molded a 
poly(dimethylsiloxane) (PDMS) stamp against the prepolymer solution (yellow) and crosslinked 
with UV light to create microarrays for embryonic stem cell culture. Image adapted from (184) . B. 
Jongpaiboonkit et a/. used a Teflon mold to create PEG wells to evaluate the effects of different 
material properties on the viability of encapsulated mesenchymal stem cells. Image adapted from 
(186). C. Lutolf eta/. inked a PDMS stamp with PEG-ProteinA and then used this as a mold to 
create hydrogel wells whose surfaces were functionalized with ProteinA. ProteinA was then 
reacted with different proteins (to which it has a high binding affinity) such as the chimeric protein 
Fc-N-Cadherin. The surface proteins were visualized by tagging first with primary antibodies and 
secondly with fluorescent secondary antibodies. Image adapted from (127). 
Lutolf et al. demonstrated the ability to functionalize hydrogel well surfaces for 
the study the effects of specific molecules on single HSC proliferation kinetics. Figure 
2.4C shows a schematic of this work. The ability to control the spatial presentation of 
biomolecules is critical in containing HSCs in the well. When hydrogel wells were 
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functionalized with bioactive molecules throughout their bulk, HSCs were able to migrate 
up the gel walls (32, 127). By only functionalizing the surfaces of the gel wells, cells are 
unable to attach to the PEG-DA gel walls and leave the gel surface. This helps to 
maintain the interactions between HSC surface receptors and molecules presented on the 
gel surface. 
One disadvantage of the system described by Kobel et al. and Lutolf et al. is the 
chemistry that is utilized (127, 128). Their systems use Michael-type addition to 
crosslink the polymer. In this application, Michael-type addition works well, but the 
translation to 3D necessitates a polymerization process that is more rapid to ensure that 
encapsulated cells are homogenously distributed throughout the matrix (187). 
Photopolymerization not only offers a way to quickly form covalently bonded hydrogels, 
but the use of light in the crosslinking process also allows patterning in two- and three-
dimensions (176-180). This could prove critical in controlling the spatial presentation of 
specific adhesive ligands or niche proteins to HSCs. 
In addition, this system investigated the proliferation of single cells; the wells 
were used as a tool to gain a better understanding of the kinetics of HSC proliferation and 
the effects of cell division on engraftment potential. Knowledge gained from the system 
will benefit the design of future culture systems and could potentially be used in the 
scale-up of this particular system. However, in its current form, the cells wells are too 
small to be plausible for generating the large populations of HSCs that are required for 
therapeutic applications. 
The system described in this thesis modifies the hydrogel well work performed by 
Lutolf et al. and Kobel et a/. In place of Michael-type addition, hydro gels were 
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crosslinked using photopolymerization due to the advantages described previously. The 
inert PEG-DA hydrogel was modified with several biomolecules that are present in the 
niche and known to affect HSC behavior: RGDS and CSl (Chapter 2), SCF (Chapter 3), 
SDFla (Chapter 4), JAGl (Chapter 5), and IFNy (Chapter 6). Proteolytically degradable 
PEG hydro gels were also used for three-dimensional culture of HSCs, which will be 
discussed in greater detail in Chapter 7. The use of PEG hydrogels that are easily tunable 
allows precise control of the mechanical, chemical, and biological properties of the gel. 
2.1.4 Fibronectin-derived Adhesive Peptide Sequences: RGD and CSl 
Work in the current chapter focuses on the covalent incorporation of short 
adhesive peptide sequences onto hydrogel well surfaces. One of the key regulators of 
HSCs in the niche is adhesion to ECM proteins, specifically fibronectin (FN). These 
interactions are not only important in cell adhesion and spreading but are also implicated 
in many signaling pathways within the cells, such as hematopoiesis and proliferation 
(122, 125, 188, 189). As HSCs differentiate they lose their ability to bind to FN (122). 
In vitro, HSC adhesion to FN has proven critical in maintaining the regenerative 
capabilities of HSCs during expansion ( 121, 190, 191 ). Additionally, F eng et al. 
demonstrated that FN that was covalently immobilized onto a poly( ethylene 
terephthalate) (PET) scaffold, as opposed to adsorbed onto the scaffold, resulted in 
increased HSC expansion (129). 
HSCs adhere to FN through several cell surface integrins. The VLA-5 (very late 
antigen-S, a5~1) integrin binds to the minimal essential amino acid sequence, RGD, of 
FN, and the VLA-4 (very late antigen-4, a4~1) integrin binds to the CS-1 (LDV) segment 
ofFN (192-194). These short peptide sequences can be utilized in vitro to mimic whole 
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FN. HSCs adhere differentially to various portions ofFN. It is thought that more 
primitive hematopoietic cells bind to the CS 1 portion of FN and less significantly to the 
RGD segment (125). Studies have been contradictory on which section is important for 
the growth of hematopoietic cells in culture, and both CS 1 and RGDS have been used to 
trigger HSC proliferation (122, 191). 
Cyclic forms of the RGD and CS 1 peptides have been used in solid lipid 
mono layers to successfully promote the adhesion of hematopoietic progenitor cell lines 
(194, 195). RGD and CSI have also been tethered to PEGylated glass surfaces, via 
avidin-biotin binding, and have succeeded in promoting hematopoietic cell adhesion 
(188). When conjugated to PET substrates, RGD and CSI promoted the expansion of 
hematopoietic cells (125). 
2.1.5 Selection of Hematopoietic Cells 
To evaluate the effects of the peptide sequences on adhesion, proliferation, and 
differentiation, two different cell types were utilized. Various parameters of the hydrogel 
system were optimized through the culture of 32D Clone 3 (32D) cells on the gel 
surfaces. 32D cells are a semi-adherent, IL-3 dependent, myeloid progenitor cell line 
conventionally used to study the effects of knocking down specific genes on 
hematopoietic cell function. With these cells, we assessed cell adhesion, spreading, and 
proliferation. 
Primary murine HSC populations were also cultured within hydrogel wells. A c-
kit+, lineage marker negative (lin·) population of whole bone marrow was magnetically 
isolated. This population was selected as a derivation of the KSL (c-kit+, Seal+, lin·) 
population. As aforementioned, the KSL population is a heterogeneous population of 
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hematopoietic stem and progenitor cells containing a significant number ofLT-HSCs that 
are capable of reconstitution (39, 40). In fact, 100 KSL cells are capable of repopulating 
a lethally irradiated host (196). The reason for selecting only two of the markers was 
primarily to allow for manual sorting within a sterile laminar flow hood. The c-kit, lin-
selection also resulted in the collection of several million cells enabling us to evaluate a 
broad array of hydrogel and culture parameters easily. Though this population contains a 
heterogeneous mixture of cells and limited numbers of L T -HSCs, critical information 
regarding HSC self-renewal and differentiation can still be revealed from the culture of 
these cells. In addition, through the inclusion of biomolecules specific to the niche onto 
the hydrogel surface more primitive HSC populations can potentially be selected for, and 
it is possible that placing progenitors into the synthetic hydrogel niche could promote 
them to return to a less differentiated state ( 60, 61 ). The presence of more differentiated 
cell types in the culture system should not hinder the repopulation capabilities of L T-
HSCs as whole bone marrow is typically used in bone marrow transplants. However, 
there is a concern that more differentiated cell types may overtake the culture, and thus, 
critical analysis of the expanded cells is necessary. 
2.2 Materials and Methods 
All materials were obtained from Sigma unless otherwise noted. 
2.2.1 Polymer Synthesis and Characterization 
2.2.1.1 JJ~<T-1>~ 
Poly( ethylene glycol) diacrylate was synthesized by reacting 6 kDa poly( ethylene 
glycol) (PEG) (Fluka) with acryloyl chloride at a molar ratio of 4:1 (PEG:acryloyl 
chloride) and triethylamine (TEA) at a molar ratio of2:1 (PEG:TEA) in anhydrous 
dichloromethane (DCM) to acrylate both ends of the PEG chains (Figure 2.5). The 
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resulting product was then rinsed with K2C03 and phase separated overnight to remove 
hydrochloric acid. The organic layer containing the PEG-DA was collected and dried 
with MgS04• The PEG-DA solution (in DCM) was rotary evaporated, and then PEG-DA 
was precipitated in diethyl ether. The precipitate was filtered and lyophilized. A sample 
of the resultant polymer was dissolved in chloroform, and acrylation was confirmed with 
proton nuclear magnetic resonance analysis. 
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Figure 2.5: PEG-Diacrylate synthesis Poly(ethylene glycol) is reacted with acryloyl chloride and 
TEA in DCM. The reaction solution is subsequently phase separated in K2C03, dried, and 
precipitated in diethyl ether. The final product is lyophilized and stored at -20 oc 
2.2.1.2 PEG-RGDS for 32D Cell Studies 
For studies with 32D cells, 3400 MW acrylate PEG-succinimidyl carboxymethyl 
(PEG-SCM, Laysan, Arab, AL) was reacted with RGDS peptide (American Peptide, 
Sunnyvale, CA) at a molar ratio of 1:1.1 (PEG-SCM:RGDS) with diisopropylethylamine 
(DIPEA) at a 1:2 molar ratio (PEG-SCM:DIPEA) in dimethylsulfoxide (DMSO) 
overnight at 4 oc (Figure 2.6). The resulting product was purified by dialysis and 
lyophilized. The conjugation was verified using gel permeation chromatography (GPC). 
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Figure 2.6: PEG-RGDS synthesis. RGDS was reacted with Acrylate-PEG-SCM overnight in 
DMSO to form a heterobifunctional PEG chain with an acrylate group on one end and a bioactive 
peptide sequence, RGDS, at the other end. 
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2.2.1.3 PEG-RGDS and PEG-CSJ (PEG-LDV) for Primary Cell Studies 
An alternative PEG derivative was used to PEGylate RODS and CS 1 in 
experiments conducted with primary cells. 3400 MW Acrylate PEG-Succinimidyl 
valerate (PEG-SV A, Laysan) was reacted with the RODS or CS 1 (EILDVPST) peptides 
(American Peptide) at molar ratios of 1.1:1 (PEG-SV A:Peptide) (Figure 2. 7). The 
reactions were performed in phosphate buffered saline (PBS) overnight at 4 °C while 
maintaining the pH at 8.0. The next day the pH was restored to 7.4, and the solution was 
dialyzed against milliQ water to remove unconjugated peptide. The solution was then 
lyophilized and stored at -80°C. The conjugation efficiency was quantified with GPC. 
+ NH2-CS 1-COOH 
Acrylate-PEG-SVA 
Acrylate-PEG-CS1 
PBS 
pH =8.0 
~ 
Figure 2.7: PEG-CS1 synthesis. The peptide sequence EILDVPST (the CS1 portion of 
fibronectin) was reacted with Acrylate PEG-SVA in PBS at pH 8.0 to form PEG-CS1. The carbon 
molecule spacers between the PEG chain and the reactive SVA group slow reaction with water in 
the aqueous buffer. The same reaction can be performed with the RGDS peptide sequence. 
2.2.2 PEG Hydrogel Wells 
2.2.2.1 Fabrication of PEG-DA Hydrogel Wells 
To form PEG-DA hydrogel wells, microfabrication techniques were used to 
create photoresist pillars as previously described (197). Briefly, SU-8 2100 photoresist 
(Microchem, Newton, MA) was spincoated onto Piranha (7:3 v/v solution of H2S04: 30% 
H202) etched glass slides. The photoresist was then exposed through a high-resolution 
(20,000 dpi) transparency mask (CAD/ Art Services, Bandon OR) using a Mask Aligner 
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(SUSS, Garching, Germany). The resulting photoresist masters had 500 J..tm high pillars 
with pillar diameters of 5.34 mm. 
SU-B Photoresist~ 
Glass slide~ 
uv Light 
PEG·D 
Teflon~ 
Spacer 
Note: not to scale 
Circle Diameter = 5 mm 
Expose 
• • • 
• • • 
~Develop 
~Mold 
Figure 2.8: Microfabrication of PEG-DA hydrogel wells. To generate PEG-DA wells, SU-8 
2100 photoresist was spin coated onto glass slides. The photoresist slab was then exposed with 
UV light through a high-resolution photomask. After removing the unexposed photoresist, PEG-
DA was molded between two glass slides, one containing SU-8 pillars, separated by a Teflon 
spacer to generate PEG-DA wells. 
To form hydrogel wells, PEG-DA was dissolved in HEPES buffered saline (HBS) 
(10% w/v) at pH 7.4, and the photoinitiator 2,2-dimethoxy-2-phenyl acetophenone (300 
mg/ml in n-vinylpyrrolidone, NVP) was added to the polymer solution at 10 J..tl/ml. The 
PEG solution was then filtered in a laminar flow hood using a poly( ether sulfone) (PES) 
0.22 J..tm syringe filter. The polymer solution was placed into a mold consisting of two 
glass slides coated with SigmaCote, one with SU-8 pillars, separated with a 1 mm PTFE 
spacer and clamped together. The polymer was crosslinked using long wavelength UV 
light (365 nm, 10 mW/cm2) for 45 s/3.75 cm2 creating a PEG-DA base hydrogel with 
wells. A schematic of the process can be seen in Figure 2.8 (not to scale). 
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2.2.2.2 Surface Conjugation of Hydrogel Wells with PEG-Peptides 
PEG-DA hydrogel wells were soaked in sterile PBS with 0.1% NaN3 overnight to 
allow for swelling and maintain sterility. A PEG-RGDS solution containing 10 J.!Vml 
acetophenone was added to each hydrogel well to achieve a concentration of250 J.tg/cm2. 
A gel containing 4 wells was exposed to UV light for three min. (Figure 2.9). After UV 
exposure, gels were placed in well plates with sterile PBS containing 0.1% NaN3. This 
process was repeated for each concentration ofPEG-RGDS (2.5 and 25 J.tg/cm2) and 
PEG-CS 1 (25 J.tg/cm2). To remove any NaN3 before cell seeding, gels were soaked twice 
in fresh PBS for one hr. at 37°C. Gels were subsequently soaked in media for 1 hr. at 
37°C to prepare them for cell seeding. 
Figure 2.9: Surface conjugation of hydrogel wells. A solution of PEG-peptide and 
photoinitiator was made and added to wells (1 0 ~I). Groups of four gel wells were than exposed 
to UV light for 3 min. The resulting gel was soaked in PBS with NaN3 overnight to prevent 
contamination and allow diffusion of free peptide from the gel surface. 
2.2.2.3 Quantification of Peptide Concentration on Gel Surfaces 
To determine the efficiency of the surface conjugation reaction (i.e. the 
percentage of peptide that is successfully immobilized on the gel surface), a ninhydrin 
assay was conducted as previously described (179). Briefly, PEG-RGDS (synthesized 
with PEG-SV A) was conjugated to hydrogel well surfaces. A standard curve was created 
using known concentrations ofPEG-RGDS in solution and PEG-DA gel wells. 
Individual gel wells were then degraded in 6 M HCl for 3 hrs. at 150°C. Samples were 
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rotary evaporated and subsequently lyophilized to remove the acid. Dry samples were 
dissolved in 0.1 M sodium citrate buffer (pH 5.0), and the ninhydrin reagent was added. 
Samples were boiled for 15 min., and absorbance was read at 570 nm. 
2.2.3 Cell Maintenance 
2.2.3.1 32D Cell Culture 
Murine 32D clone 3 cells (32D cells, ATCC, Manassas, VA) were cultured in 
RPMI-1640 media (Invitrogen, Carlsbad, CA) supplemented with 2 mM L-glutamine, 
10% IL-3 culture supplement (Becton Dickinson, Franklin Lakes, NJ), 10% heat-
inactivated fetal bovine serum (FBS), 100 U/L penicillin, and 100 mg/L streptomycin. 
Cells were maintained at 37 °C at 5% C02• Media was refreshed every 2 to 3 days, and 
cells were subcultured when they reached a concentration of 1 million cells/mi. 
2.2.3.2 Isolation and Culture of Murine c-kil, lin- Cells 
C57/B6 mouse strains were bred and maintained at Baylor College of Medicine. 
The Institutional Animal Care and Use Committee (IACUC) ofBCM approved all 
experiments using animals. To obtain murine bone marrow, 8-12 week old C57/B6 mice 
were sacrificed by isofluorene exposure followed by cervical dislocation. The femurs and 
tibias were removed and maintained in cold HBSS+ medium (HBSS, 10 mM HEPES, 2% 
FBS). The ends of bones were cut to expose the bone marrow cavity, which was flushed 
with DMEM+ medium (DMEM, 10 mM HEPES, 2% FBS) into 50 ml conical tubes 
using a 26 G needle equipped syringe. To eliminate tissue debris, the solution was 
filtered through a 40 J.lm nylon cell strainer (BD) and centrifuged at 200 x g for 8 min. at 
4°C. To lyse red blood cells, the pellet was resuspended in 5 ml PharMlyse (BD) diluted 
1: 10 in DIHzO and incubated 5 min. at room temperature. Cells were counted using a 
hemacytometer. 
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The whole bone marrow cells were then centrifuged for 5 min. at 200 x g and 
resuspended in recommended media (PBS containing 2% FBS, 1 mM 
ethylenediaminetetraacetic acid (EDTA), and 1% Gentomycin-Amphotericin (GA, 
Invitrogen)) at a concentration of lx108 cells/mi. Cells were then negatively sorted 
magnetically with the mouse hematopoietic progenitor cell enrichment kit as per the 
manufacturer's protocol (StemCell Technologies, Vancouver, BC, Canada). The 
collected cells (lineage negative) were then counted, centrifuged at 200 x g for 5 min., 
and resuspended in recommended media at a concentration of lx108 cells/mi. Cells were 
then positively sorted magnetically with the CD117/c-kit positive selection kit as per the 
manufacturer's protocol (StemCell Technologies). After the final magnetic sort, c-kit, 
lin- cells were resuspended in StemSpan media (Stem Cell Technologies) supplemented 
with 50 ng/ml stem cell factor (R&D, Minneapolis, MN) and 1% GA. A portion of these 
cells as well as a portion of the c-kif, lin- population were set aside and stained for flow 
cytometry analysis. 
The reserved cells were centrifuged and resuspended in fluorescence activated 
cell sorting (F ACS) buffer (PBS containing 1% bovine serum albumin, and 0.1% NaN3) 
at a concentration of 1 x 1 06 cells/mi. They were subsequently stained with fluorescently 
tagged primary antibodies for one hr. at 4°C: rat anti-mouse Seal (tagged with 
fluorescein isothiocyanate, FITC) (Abeam) at a concentration of 2 J.tl/1 06 cells and rat-
anti mouse lineage marker cocktail (allophycocyanin, APC) (BD) at a concentration of20 
J.tlll 06 million cells. Since the antibody staining occurred immediately following the 
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magnetic sort, c-kit positive cells should still possess their magnetic nanoparticle tag, 
which also contains a fluorescent phycoerythrin (PE) label. Cells were washed twice 
with FACS buffer by centrifugation for 10 min. at 200 x gat 4°C. Cells were then fixed 
in 4% paraformaldehyde in PBS for 15 min. at room temperature. Cells were centrifuged 
for 5 min. at 200 x g at room temperature and resuspended in cold PBS at a concentration 
of 1 06 cells/mi. The stained cells were stored at 4 °C protected from light until analysis. 
A control group of cells from each population underwent the same process except for the 
antibody staining. 
2.2.3.3 Cell Seeding into Hydrogel Wells 
32D cells were seeded into the hydrogel wells at 5000 cells/cm2. The 
experimental groups consisted of wells with 2.5, 25, and 250 J..Lg/cm2 RGDS. PEG-DA 
wells (0 J..Lg/cm2 RGDS) served as controls. Each group consisted of 4 gel wells. Cells 
within hydrogel wells were maintained in culture for 6 days at 3 7°C with 5% C02. 
c-kit, lin- cells were seeded in gel wells ([RGDS]=25 J..Lg/cm2 or [CS1]=25 
J..Lg/cm2) at 13,000 cells/cm2. PEG-DA gel wells with (0 J..Lg/cm2 RGDS) and a 96-well 
FN plate served as controls. Each group consisted of 4 gel wells. Media was added 
around gels to keep them hydrated. Cells within hydrogel wells were maintained in 
culture for 14 days at 37°C with 5% C02 with changes of media every 2-3 days. Media 
was removed by vacuum aspiration around the gel but not within the gel well while the 
plate was kept flat. 250 J..Ll of media was added to the plate by gently pi petting 1 drop of 
media into the gel well and adding the rest around the gel well. In the FN plates, 50 J..Ll of 
media was removed and 75 J..Ll of media was added to each well. After culture, the cells 
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from each group were combined so that enough cells were available for flow cytometry. 
The experiment was conducted a total of three times. 
2.2.4 Evaluation of Hematopoietic Cells in Culture 
2.2.4.1 Evaluation of 32D Cell Adhesion 
Cell adhesion is a critical process in the HSC microenvironment. HSCs use cell 
surface integrins to lodge in the niche and retain their differentiation potential. To 
evaluate 32D cell adhesion, gels were rinsed by the addition of fresh media after 48 hrs. 
in culture to eliminate non-adherent cells. Nine phase contrast images of each well were 
captured using a Zeiss Axiovert 135 inverted microscope (Zeiss, Oberkochen, Germany) 
and Jenoptik ProgRes C5 charge-coupled device (CCD) camera (Jenoptik, Jena, 
Germany). Eight hydrogel wells made up each group: three surface concentrations of 
RGDS (2.5, 25, and 250 ~g/cm2) and a PEG-DA control. Cells were counted using 
ImageJ software (NIH, Bethesda, MD). Images were first changed to 8-bit, and the "find 
edges" function was used to outline the cell perimeters. The images were then 
thresholded individually to highlight the cells, and the "analyze particle" feature was run 
to count cells larger than 100 pixels. Images were thresholded individually due to the 
varying degree of background resulting from the PEG gels. 
2.2.4.2 Evaluation of 32D Cell Spreading 
To determine the effects ofRGDS on 32D cell spreading, cells were fixed with 
4% paraformaldehyde, permeabilized with 0.1% Triton-X, and blocked in PBS 
containing 1% bovine serum albumin after 6 days in culture. Cells were then stained 
with Alexa-Fluor 488 phalloidin (Invitrogen), which stains actin filaments, and 
counterstained with DAPI, which stains cell nuclei. The stained cells were imaged using 
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epifluorescent microscopy on a Zeiss Axiovert 135 inverted microscope equipped with an 
EXFO X-Cite 120 Fluorescent Illumination System (EXFO, Quebec, Canada) and a 
Jenoptik ProgRes CS CCD camera. Cell size was determined using the phalloidin images 
and ImageJ software. The image processing followed the same steps as when counting 
the cells except the "close edges" and "fill holes" functions were employed prior to the 
"analyze particles" function to ensure that all of the pixels were counted when 
determining cell size. Cell nuclei were used to locate cells, and the "skeletonize" tool 
was used to distinguish individual cells when cells were in contact or overlapped. Five 
images from each hydrogel well were analyzed and each group contained eight gel wells. 
The number of cells per image varied due to differences in 32D cell adhesion. 
2.2.4.3 Evaluation of Hematopoietic Cell Expansion 
32D cells in the phase images were counted using ImageJ software to determine 
the total cell number in hydrogel wells after 2, 4, and 6 days in culture. The percent 
change in cell number over 48 hrs. was calculated for each well by comparing the cell 
number at days 4 and 6 to days 2 and 4 respectively. 9 images were counted per well, 
and each group contained 8 gel wells. 
To monitor c-kit+, lin- cell growth and morphology, images were taken every 48 
hrs. Expansion was determined after 14 days by removing cells from the surfaces of the 
hydrogel or FN plates by rinsing each well 20 times with media. Cells were then counted 
with a hemacytometer. Four wells composed each group during each experiment. These 
four wells were combined for analysis purposes, due to time restraints and the 
requirement of large populations for flow cytometry. The experiment was conducted a 
total of three times. 
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2.2.4.4 Colony Forming Unit Assay 
To evaluate the functional potential of expanded c-kit+, lin- cells to differentiate 
down multiple lineages, a colony forming unit (CFU) assay was performed. 10,000 cells 
from each surface were resuspended in 1 ml of methylcellulose media (MCM) 
supplemented with erythropoietin, IL-3, IL-6, and stem cell factor (Stem Cell 
Technologies) as well as 1% GA to prevent contamination. The MCM containing cells 
was pipetted into 48-well non-tissue culture treated plates. Empty wells were filled with 
milliQ water to prevent dehydration of the MCM. The plates were kept in an incubator at 
3 7°C and 5% C02, and colonies were counted, characterized, and imaged after 10-14 
days in culture. Figure Al in the Appendix contains images and brief descriptions of 
each type of colony that was counted. Throughout the incubation period, MCM was 
added to wells that were beginning to dry out or wells that were consuming media 
rapidly. Due to extensive dehydration during one experiment, the results of the CFU 
assay are from two studies. 
2.2.4.5 Flow Cytometry Analysis 
To determine the expression of primitive cell surface markers on expanded cell 
populations, the remaining cells from the gel surfaces and plates were stained for flow 
cytometry as described previously in Section 2.2.2.2. They were also stained with a rat 
anti-mouse c-kit antibody (tagged with PE) in addition to the Seal and lineage marker 
antibodies. According to the manufacturer, StemCell Technologies, the magnetic 
nanoparticle should be purged from the cell surface due to antigen renewal within 1-2 
days of sorting. Cells were washed twice with 1 ml ofF ACS buffer by centrifugation for 
10 min. at 200 x gat 4°C. Cells were then fixed in 4% paraformaldehyde in PBS for 15 
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min. at room temperature. Cells were centrifuged for 5 min. at 200 x g at room 
temperature and resuspended in cold PBS at a concentration of 1 million cells/mi. The 
stained cells were stored at 4°C until analysis. A group of cells obtained from a flask 
underwent the same process except for the antibody staining to serve as a control. The 
purpose of this control was to determine the level of fluorescent intensity that 
distinguished between positive and negative antibody staining. This knowledge aided in 
the set-up of gates on the flow cytometry plots. 
Flow cytometry was performed on a BD F ACScanto (BD). Positive CompBeads 
containing an anti-rat IgG antibody and negative CompBeads (BD) were incubated with 
primary antibodies individually or a control (no antibody) for 20 min., centrifuged for 5 
min. at 200 x g, and resuspended in F ACS buffer at a concentration of~ 1 million 
beads/mi. These beads served as positive controls and negative controls to determine 
compensation levels on the machine. Compensation controls ensure that signal from the 
various fluorophores does not get collected incorrectly. After these controls were 
evaluated, an unstained cell sample was run to determine where the gates would be set for 
the various fluorophores. A primary gate was set-up to exclude cell debris and 
aggregates as well as other contaminants such as dust. A secondary gate was set at low 
fluorescent intensities for APC to count lineage negative cells. Thirdly, a dot-plot of 
Seal vs. c-kit for the lineage negative population was set up to determine the number of 
c-kit, Seal+, lin- cells. For each group, 20,000-30,000 cells were counted. 
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2.2.5 Statistical Analysis 
One-way ANOVAs and Tukey's post-hoc analyses were performed to evaluate 
statistical differences between groups in all studies using a 95% probability level 
(p<0.05). 
2.3 Results and Discussion 
2.3.1 Polymer Synthesis and Characterization 
PEG-DA, PEG-RODS, and PEG-CSl were synthesized in the laboratory and 
characterized using NMR and GPC analysis. According to the NMR data, the degree of 
acrylation on the PEG-DA chains was >80%. The GPC plots ofPEG-RGDS (SCM) and 
PEG-CS 1 (SV A) (Figure 2.1 0) showed conjugation efficiencies of greater than 90%. 
This was also observed when using PEG-SVA to synthesize PEG-RODS. These findings 
are consistent with previous work in the laboratory. 
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Figure 2.10: GPC plots of PEG-RGDS and PEG-CS1. After conjugation to RGDS (A) or CS1 
(B) , the peak of the PEG chain shifts left indicating an increase in molecular weight. Larger 
molecular weight molecules travel more quickly through the column because they are not trapped 
within the beads packing the column length. The units of they-axis are relative signal intensity. 
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The ninhydrin assay determined that 37.7% ± 5.9% of the 500 ~g/cm2 PEG-
RGDS, 50.6% ± 21.4% of the 250 ~g/cm2, and 76.1% ± 22.6% of the 125 ~g/cm2 are 
conjugated to the surfaces of the hydrogel well. As the amount of peptide increased, 
there was a corresponding decrease in percent conjugation. The same phenomenon has 
previously been reported (179). This can be attributed to a saturation of the free acrylates 
on the surface with acrylated peptide. There is a finite area on the gel well and due to 
steric hindrance, not all molecules that are added to the surface can crosslink into the 
hydrogel matrix. These results emphasize that the addition of more peptide to the surface 
does not necessarily lead to an increase in crosslinking to the surface. It was assumed 
that surface conjugation efficiencies for PEG-CS 1 would be of a similar magnitude due 
to relative similarity in size and amino acid makeup. In the following sections, the 
groups are distinguished by the initial RGDS concentrations (2.5, 25, and 250 ~g/cm2) to 
avoid confusion, though the true surface concentrations are approximately 50% of this. 
The degree of conjugation is higher than what has previously been reported. 
Hahn et al. observed that only about 1 0% of the initial peptide concentration was actively 
immobilized onto gel surfaces (179). This may be due to the fact that previous surface 
conjugation techniques did not utilize the well system. Instead, hydrogel rectangular 
slabs were used as the base and a solution of PEG-peptide was added to the entire gel 
surface. The well system restrains the PEG-peptide solution to a smaller area and allows 
focusing of the highest intensity UV light across the entire area to be modified. In 
addition, in previous work a different PEG derivative was utilized to PEGylate the 
peptides. The differences in the purity or chemistry of the molecules may affect their 
abilities to crosslink to the hydrogel surface. These factors may both contribute to the 
ability to reach higher conjugation efficiencies using this system. 
2.3.2 Primary Cell Isolation 
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To determine the purity of the c-kit+, lin- immediately following magnetic sorting, 
a portion of the sorted cells were stained for flow cytometry. Figure 2.11 shows the flow 
cytometry plots that were generated from these cells. The magnetic sorting resulted in a 
population in which approximately 70% of the cells were lin- and 76% were c-kit+. Of 
the cells that were lin-, an estimated 82% were c-kit+. This number was deemed sufficient 
for the following studies, but in the future, more washes could be performed to obtain a 
purer population. 
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Figure 2.11: Flow cytometry analyses of c-kit+, lin· cells immediately following magnetic 
sort. A. Particles were gated to eliminate debris and aggregates. B. Cells were gated to include 
those that were lin-. C. A plot of all cells showing the fluorescence intensities of the Sca1 and c-
kit markers. Cells were gated to delineate between positive and negative cells. D. A plot of 
lineage negative cells gated similarly to those in C. Numbers on the graphs indicate the 
percentage of cells falling within that gate. Units on unlabeled axes are relative fluorescent 
intensity. 
2.3.3 32D Cell Adhesion 
The adhesion of 32D cells to RGDS functionalized hydro gels was evaluated 
because adhesive interactions ·within the HSC niche have been shown to affect HSC fate. 
Figure 2.12 shows the number of adherent cells on the PEG-RGDS hydrogels after 48 
hrs. As the RGDS concentration is increased, there is a corresponding increase in 
adherent 32D cells. At the low concentration (2.5 ~-tg/cm2), there was minimal cell 
adhesion comparable to that seen on PEG-DA hydrogels, indicating that this amount of 
RGDS is insufficient to enable surface adhesion. 
7000 
* 
6000 4 
5000 .., 
N 
E 
u 
1::: 4000 ' Q) 
.Q 
E 
::J 
z 3000 
Q; 
(J 
Q 
N 2000 M 
1000 
0 
0 2.5 25 250 
RGDS Concentration (JJg/cm2) 
Figure 2.12: 320 cell adhesion on bioactive PEG hydrogels after 48 hrs. 320 cells were 
cultured on gels with increasing amounts of RGOS on the well surfaces. As the surface 
concentration of RGOS increased, there was a corresponding, significant increase in adherent 
320 cells. Bars represent mean± standard deviation . (*denotes significance compared to all 
other groups, n=4, p < 0.05) 
At the high concentration of RGDS (250 ~-tg/cm2), there is a significant increase in cell 
adhesion compared to all other groups. This suggests that 3 2D cells require binding to 
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multiple RGDS molecules to adhere to the gel surfaces with enough strength to withstand 
the rinsing process. When the starting RGDS concentration was raised above 250 
~-tg/cm2 , an increase in 32D cell number was not observed (data not shown). This is 
60 
probably due to saturation ofthe surface with RGDS as described in Section 2.3.1. There 
are not enough free acrylates to incorporate all of the RGDS molecules, and thus the 
difference in surface concentrations between a starting solution with 500 J.tg/cm2 of 
RGDS and that of 1000 J.tg/cm2 is minimal. As a result, cells adhere similarly on these 
surfaces. 
RGDS was selected for incorporation onto the hydrogel surfaces to investigate the 
ability to mimic the in vivo interactions between HSCs and the ECM using the hydrogel 
system. In the niche, hematopoietic cells express the VLA-5 integrin, which binds 
specifically to the RGD sequence found in FN. With more available RGD on the surface, 
more 32Ds were able to bind and individual cells were able to bind to the surface with 
multiple integrins resulting in an increase in adherent cells on gel surfaces. The same 
trend has been observed in previous work ( 171, 198). Chollet et al. immobilized cyclic 
RGDS molecules onto PET surfaces and found that raising the surface RGDS 
concentration led to augmented endothelial cell and osteoblast adhesion and the 
production of more focal contacts (198). Gonzalez et al. utilized PEG hydrogels with 
bulk modified RGDS to culture neutrophils and could increase the percentage of 
neutrophils that adhered to the gel by increasing the RGDS concentration (171). The 
work in this chapter demonstrates a similar ability to affect hematopoietic cell adhesion 
by altering the surface RGDS concentration. Adhesive interactions retain cells in the 
HSC niche and help maintain them in a multipotent state. As cells differentiate they lose 
the ability to adhere to FN and travel out of the niche to sites of injury (191, 199-202). 
Thus, the ability to promote cell adhesion to our synthetic niche is critical to the 
successful expansion of clinically relevant HSCs. 
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2.3.4 32D Cell Spreading 
The morphology of adherent 32D cells was observed and quantified using the 
fluorescent DAPI/phalloidin images of 32D cells on PEG-RGDS surfaces (Figure 2.13). 
Qualitatively, the cells do not spread on the gels to a high degree and appear very round 
in shape, similar to those seen on the unmodified PEG-DA gels. A quantification of this 
data shows that the average cell area is slightly significantly higher on the medium RGDS 
concentration (25 Jlg/cm2) compared to all other groups (Figure 2.14), though the total 
number of cells on the surface after staining was low. The increase in cell size could 
result from the fact that during the staining process, which has multiple rinse steps, 
numerous cells were washed from the surfaces. On the medium RGDS concentration, it 
is likely that only cells that were more spread and attached to the surface with multiple 
integrins were able to remain on the surface. The standard deviations are large due to the 
heterogeneity of the 32D cell population. The data can also be plotted as histograms to 
obtain a better sense ofthe cell sizes (Figure 2.15). A similar cell size distribution can be 
seen between the low and high RGDS (250 Jlg/cm2) concentrations with cell sizes 
clustered between 100-300 Jlffi2• The medium RGDS concentration (25 Jlg/cm2) is 
shifted slightly right with cell sizes from 200-400 Jlm2, which correlates with the data 
shown in Figure 2.14. 
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Figure 2.13: 320 cell spreading on RGDS surfaces. The nuclei of cells were stained with 
DAPI (blue) and the actin filaments with phalloidin (green). Cells did not spread extensively on 
the surfaces, but on the surfaces with RGDS there is more actin surrounding the cell nuclei. On 
the high RGDS surfaces some of the cells started to extend filopodia. (Scale bars= 50 1-1m) 
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Figure 2.14: 320 cell area on hydrogel surfaces. The average cell size on the hydrogels was 
significantly higher on gels with 25 1Jg/cm2 RGDS, though the total cell number was low. The 
large standard deviations result from the heterogeneity of the cell population , which is comprised 
of cells of varying sizes. Bars = mean ± standard deviation. (* denotes significance compared to 
all other groups, n= 20 (0 1Jg/cm2) , 58 (2.5 1Jg/cm2) , 130 (25 1Jg/cm2), 863 (250 1Jg/cm2) , p < 0.05) 
In addition, at the medium RGDS concentration, cells were stimulated to proliferate 
(discussed later) and thus detached from the surface to divide making them particularly 
vulnerable to being washed away during staining. This is consistent with what was seen 
on the gel surfaces in terms of the percent change in cell number. 
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Figure 2.15: 320 cell area distribution on differing surface RGDS concentrations. The cell 
area profile was fairly consistent on all three RGDS concentrations with most cells in the 100-
300 J.,Jm 2 range. On the medium RGDS concentration, there was a significant shift in cell size of 
about 100 J.,Jm 2 resulting in cells centered around 200- 400 J.,Jm 2. (RGDS concentrations: 2.5 
J,~g/cm 2 , 25 J,~g/cm 2 , 250 J,~g/cm 2) 
2.3.5 Hematopoietic Cell Proliferation 
The effects ofRGDS on 32D cell proliferation were investigated to determine the 
role the peptide plays in this process. The gels with the high concentration of RGDS 
(250 f.!g/cm2) had the greatest number of cells after 6 days. However, the percent change 
in cell number over 48 hrs. is slightly lower, 33 ± 14.5%, than that observed on the 
medium concentration (25 J..tg/cm2) , 48.1 ± 10.2% (Figure 2.16). The percent changes in 
cell number on PEG-DA and the lowest concentration ofRGDS (2.5 f.!g/cm2) are much 
lower, 16.3 ± 0.6% and 22.8 ± 1.3% respectively. 32D cell adhesion to fibronectin has 
previously been shown to trigger cell proliferation, and we have shown the ability to 
65 
induce this response with the short RGDS peptide at concentrations of 25 J.lgicm2 (124). 
At the high concentration of RGDS the percent change in cell number drops, but the drop 
is not significant. Overall, the higher concentrations of RGDS (25 J.lg/cm2 and 250 
J.lg/cm2) promote more cell proliferation than PEG-DA and 2.5 J.lg/cm2• 
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Figure 2.16: Change in 320 cell number over 48 hrs. Cells proliferated at a faster rate on 
surfaces containing RGDS. The medium concentration of RGDS produced a significantly higher 
percent increase in cells compared to PEG-DA and the low concentration of RGDS. At high 
RGDS concentrations (250 j.Jg/cm 2) the change in cell number was greater than on PEG-DA or 
low concentrations of RGDS but significantly lower than on medium concentrations of RGDS. 
Bars are mean± standard deviation. (*denotes significance compared to PEG-DA and 2.5 
j.Jg/cm2 RGDS, n=4, p < 0.05) 
As a result, in studies with primary cells, the medium concentration of RGDS (25 
J..Lg/cm2) was used; this concentration was also used for the CS 1 peptide. On gels with 
RGDS and CS 1, c-kit+, lin- cells attached and proliferated. Figure 2.17 shows 
representative images of wells at varying timepoints. Over time, some of the cells have a 
definitive change in morphology and size, which may be indicative of differentiation. 
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Figure 2.18 shows the percent change in cell number on RGDS and CSl gels compared 
to PEG-DA and FN controls. 
CS1 RGDS 
Day 1 
Day7 
Day 13 
Figure 2.17: c-kit+, lin" primary cells on hydrogel surfaces with RGDS and CS1. Cells 
proliferated over time and most of the population remained round with a cell diameter of 
approximately 10 !Jm. Some of the cells did increase in size and start to spread more on the gel 
surface, which could be an indicator of differentiation. (Scale bars = 100 !Jm) 
On RODS functionalized gels, the cells proliferated significantly compared to the PEG-
DA control but none of the other differences were significant. Interestingly, the cells did 
not expand to a great extent on the FN plate. This could be due to a strong adherence to 
the plate similar to that seen with 32Ds on high RODS concentrations. It may also be 
due to physical differences between the FN plate and the hydrogel such as stiffness or 
ability to adsorb proteins from the media. 
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The proliferation rate likely varied amongst cells within the heterogeneous cell 
populations on the gel and plate surfaces as more differentiated cell types typically 
proliferate much faster than self-renewing, undifferentiated HSCs (127). During analysis 
of single cell proliferation kinetics, Lutolf et al. found that cells that proliferated more 
slowly within hydrogel wells in response to surface immobilized biomolecules were more 
likely to retain the ability to reconstitute the immune system of an irradiated mouse (127). 
Thus, lower proliferation rates could signify that a larger portion of the cell population on 
FN is in a less differentiated state. Alternatively, higher proliferation rates could also 
indicate that the fibronectin-derived peptides encouraged self-renewal to a greater extent 
than FN itself. There is a greater percent change in cell number in all groups compared to 
on PEG-DA controls. Fibronectin and peptide sequences derived from it have both been 
shown to be capable of supporting HSC self-renewal, and in these studies, both surfaces 
are promoting proliferation to some extent (121, 124, 125, 129, 191, 203). However, it is 
unclear whether the FN alone has reduced proliferative activity compared to RGDS and 
CS 1 due to the ability of FN to maintain the cells in a less differentiated, slower 
proliferating state or because the RGDS and CS 1 are more potent in their ability to 
trigger HSC self-renewal. To further investigate these theories, the expanded cells were 
evaluated for differentiation potential. 
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Figure 2.18: Total cell expansion on surface immobilized RGDS and CS1 . Total cell number 
increased significantly on surfaces with PEG-peptides compared to PEG-DA and FN after 14 
days in culture. (RGDS, CS1 concentrations= 25 ~g/cm2) Bars are mean± standard deviation. 
(*denotes significance compared to PEG-DA, n=3, p < 0.05) 
2.3.6 Primary Cell Differentiation 
2.3. 6.1 Colony Forming Unit Assay 
To first evaluate the differentiation potential of expanded cells, a functional 
analysis was performed. Colony forming unit (CFU) -GEMM, -GM, -G and -M colonies 
(where G=granulocyte, M=macrophage, E=erythrocyte, GM= granulocyte and 
macrophage, and GEMM=granulocyte, erythrocyte, macrophage, and megakaryocyte) 
formed from the cells in the PEG-RGDS, PEG-CSl and FN groups (Figure 2.19). 
69 
100 -
90 
80 
70 
!! 60 
"i (.) 
.. 
0 50 _, 
-fn 
.! 40 ~ c 
0 
0 (.) 30 -1 
20 
10 
0 
RGDS CS1 PEG-DA FN 
Figure 2.19: Colonies formed after 14 days in methylcellulose media following expansion. 
Cells from the RGDS and CS1 samples formed more primitive GEMM colonies than PEG-DA and 
FN controls. Cells from PEG-DA surfaces formed fewer colonies and displayed a reduced ability 
to form both GM and GEMM colonies. Bars are mean, n=2. ( CFU-M=Macrophage, CFU-
G=Granulocyte, CFU-GM=Granulocyte/Macrophage, CFU-GEMM=Granulocyte, 
Erythrocyte, Megakaryocyte, Macrophage) 
All colonies were able to form in all sample groups albeit to different degrees. In terms 
of total colonies, all the samples had statistically similar numbers of colonies. The 
distribution of the colonies can be better seen in Figures 2.20 and 2.21. 
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Figure 2.20: Distribution of colonies formed from cells expanded on gels with surface 
immobilized CS1 and RGDS. More primitive GM and GEMM colonies form in the RGDS and 
CS1 groups. The percentage of GEMM colonies is minimal on PEG-DA and FN. However, the 
percentage of primitive colonies (both GM and GEMM) is not significantly different between any 
of the groups. Bars are mean, n=2. (CFU-M=Macrophage, CFU-G=Granulocyte, CFU-
GM=Granulocyte/Macrophage, CFU-GEMM=Granulocyte, Erythrocyte, Megakaryocyte, 
Macrophage) 
The number ofGEMM colonies (stemming from the least differentiated cells) was higher 
in the RGDS and CSl groups than on FN, however, not significantly. The number of 
GM colonies was similar on CSl , RGDS, and FN. PEG-DA had very low levels ofGM 
and GEMM colonies. Most of its colonies were M. GEMM colonies and GM colonies 
are comprised of more than one cell type, meaning they are derived from cells that are 
less differentiated and more progenitor-like. The presence of these colonies at higher 
proportions in the RGDS and CS 1 groups may indicate that these samples were able to 
maintain the primary cells in a more undifferentiated state. However, the experiments 
must be repeated to gain significance. 
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Figure 2.21: Individual colony formation organized by colony type from cells expanded on 
RGDS and CS1 functionalized hydrogels. GEMM and GM formation was highest on CS1 and 
RGDS. Bars are mean ± standard deviation, n=2. There was no statistically significant 
difference between any of the groups. (A. CFU-GEMM=Granulocyte, Erythrocyte, 
Megakaryocyte, Macrophage, B. CFU-GM=Granulocyte/Macrophage, C. CFU-
G=Granulocyte, D. CFU-M=Macrophage) 
2.3.6.2 Flow Cytometry Analysis 
Flow cytometry analysis was performed to observe the expression of specific 
surface markers that define HSC populations. The flow cytometry plots show that a 
portion of the cells on all surfaces were no longer c-kit+, lin- after expansion and the 
percentage of cells that were c-kit+, lin- out of the total cells counted decreased (Figures 
2.22 and 2.23). The fact that there is a decrease in the percentage of total cells that are 
primitive (c-kit+, lin- and KSL populations) was expected. The initial population of cells 
was not a pure collection of primitive cells; it contained cells that were c-kif and lin+. In 
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addition, the c-kit+, lin- population is not a definitive set of markers for HSCs. Thus, the 
initial population contains LT-HSCs, ST-HSCs, as well as multipotent progenitors, and as 
aforementioned, progenitors are known to proliferate more quickly than undifferentiated 
cells (127). As a result, the percentage of primitive cells out of the total number of cells 
may decrease. Therefore, the absolute percent increase in specific cell populations was 
calculated. Any increase in these populations is significant because it means that the 
bioactive hydro gels are capable of maintaining primitive HSC populations. 
The quantity of c-kit, lin- and KSL cells increased in all groups indicating that 
these populations were able to self-renew on the gels even in the presence of many more 
differentiated cell types (Figures 2.24 and 2.25). Though the percent increase in the KSL 
population was lower on RGDS and CS 1 compared to controls, the differences were not 
significant. This data is somewhat contradictory to what was observed in the functional 
colony assay. The colony assay results suggest that RGDS and CSl are more supportive 
of HSC maintenance as indicated by the ability of cells from these groups to form a 
higher percentage of primitive colonies compared to FN and PEG-DA. It is unclear the 
reason for this disparity. One explanation is that the wide standard deviations in all 
samples are masking the true effects of the surfaces on HSC behavior. The standard 
deviations are likely due to the fact that the primary cell populations were harvested from 
different sets of mice. In addition, the surface markers that define these populations are 
not definitive for HSCs. The ability of cells to form various colonies or engraft into host 
bone marrow is not necessarily dependent on the expression of these markers. 
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Figure 2.22: Flow cytometry analysis of c-kit+, lin· cells after 14 days in culture on PEG-
RGDS. A. Particles were gated to eliminate debris and aggregates. B. Cells were gated to 
include those that were lin-. C. A plot of all cells showing the fluorescence intensities of the Sca1 
and c-kit markers. Cells were gated to delineate between positive and negative cells. D. A plot of 
lineage negative cells gated similarly to those in C. Numbers on the graphs indicate the 
percentage of cells falling within that gate. The data shows that many of the cells have gained 
lineage markers after culture. However, there is still a high percentage of c-kit+ cells, and there is 
a KSL population remaining after culture. 
Previous studies have shown that adhesion to FN leads to HSC expansion with 
increased success in engraftment (121, 125, 129, 203). During in vitro culture, cells 
capable of long-term repopulation are typically found in the adherent layers of the culture 
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(122). Both RGD and CS1 have also shown the ability to encourage expansion ofHSCs 
while maintaining their reconstitution ability, though typically adhesion to CS 1 through 
the VLA-4 integrin leads to better engraftment (125). Taking both the colony assay and 
the flow cytometry results into account, it appears that hydrogels with the fibronectin 
derived peptides RGDS and CS 1 immobilized on their surfaces are capable of preventing 
differentiation of primitive hematopoietic cells while supporting their self-renewal. 
Furthermore, the differences observed in cell proliferation on RGDS and CS 1 compared 
to FN may be due to the ability of FN to prevent differentiation by slowing cell 
proliferation. On FN plates, expanded cells could form all colonies and a portion of the 
population retained the surface marker expression profile of primitive HSCs. However, 
in the design of a culture system, the ability to expand HSC populations extensively is 
required. Because the peptide sequences promoted greater cell expansion compared to 
the FN plate (significantly on RGDS) while still maintaining the cells in an 
undifferentiated state, they were selected for use in the culture system. These peptides 
are also much easier to work with than large proteins. Their relatively small size (3.8 
kDa) compared to FN (>250 kDa) and other proteins means that they can be conjugated 
to hydrogel surfaces in combination with larger molecules without disrupting the ability 
ofPEGylated versions ofthe proteins to crosslink to the PEG matrix. In addition, the 
short peptide sequences are more stable than entire proteins with more complex 
structures. 
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Figure 2.23 Flow cytometry analysis of c-kit+, lin· cells after 14 days in culture on PEG-CS1. 
A. Particles were gated to elim inate debris and aggregates. B. Cells were gated to include those 
that were lin·. C. A plot of all cells showing the fluorescence intensities of the Sca1 and c-kit 
markers. Cells were gated to delineate between positive and negative cells. D. A plot of lineage 
negative cells gated similarly to those in C. Numbers on the graphs indicate the percentage of 
cells falling with in that gate. Similarly to cells from RGDS surfaces, many of the cells are lineage 
positive after expansion . However, there is still a high percentage of c-kit cells, and there is a 
KSL popu lation remaining after culture. The percentages of cells in each population are very 
similar to those seen in the RGDS sample. 
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Figure 2.24: Percent change in the c-kit•, lin· population after 14 days in culture. The c-ki( 
lin- population increased in all groups, and there was no significant difference between groups. 
(Bars are mean + standard deviation, n=3) 
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Figure 2.25: Percent change in the KSL population after 14 days in culture. The percent 
increase in the KSL cell population was fairly low on RGDS and CS1 compared to the controls 
though the differences were not significant. (Bars are mean + standard deviation, n=3) 
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2.4 Conclusions 
RGDS and CS 1 can be successfully conjugated to the surfaces of hydrogel wells 
and possess the ability to alter hematopoietic cell behavior in both a myeloid cell line 
(32Ds) and a primary hematopoietic progenitor population. 32Ds were able to adhere 
and proliferate in hydrogel wells, and altering the surface RGDS concentrations could 
control both of these processes. c-kit, lin- hematopoietic progenitor cells proliferated 
extensively within RGDS and CS 1 functionalized hydrogel wells, and these cells were 
able to form more primitive colonies than those cultured in control groups. There was an 
increase in the total number of c-kit, lin- and KSL cells after 14 days in culture 
signifying a population of cells with potential reconstitution ability. 
These studies demonstrate that the hydrogel well system is a viable option for 
hematopoietic cell expansion. The advantage of this system is the ability to functionalize 
the surfaces with specific niche proteins, which is not possible in a well plate. Due to the 
success of the fibronectin-derived peptides, hydrogels were next functionalized with 
RGDS and CS 1 in combination with several proteins that are known to affect HSC fate. 
The following chapters investigate the ability of these proteins to promote hematopoietic 
cell expansion while maintaining multi potency. 
Chapter 3: The Effect of Covalently Immobilized SCF on 
Hematopoietic Cell Fate in Hydrogel Wells 
3.1 Introduction 
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The HSC niche is comprised of stromal cells, which regulate HSC behavior by the 
secretion of cytokines and expression of transmembrane proteins. However, the 
coculture ofHSCs with stromal cells involves multiple signaling interactions. To isolate 
the effects of specific molecules on HSC fate, cell-cell interactions can be mimicked 
through the immobilization of individual molecules on hydrogel surfaces. This chapter 
focuses on the incorporation of stem cell factor (SCF) into the hydrogel matrix. SCF was 
selected due to its ability to spur HSC proliferation, promote hematopoiesis, and aid in 
HSC survival (104, 188, 204-209). SCF was surface immobilized onto hydrogel wells, 
and 32D cells and HSCs were cultured for 6 or 14 days respectively. We evaluated the 
effects of SCF on hematopoietic cell behavior by quantifying cell adhesion, spreading, 
proliferation, and differentiation potential. 
3.1.1 Stem Cell Factor 
Stem Cell Factor (SCF), also known as Steel factor or c-kit ligand, is a 28-30 kDa 
transmembrane glycoprotein (210). Figure 3.1 displays the structure ofthe protein as 
well as details the signaling pathways it initiates in mast cells. SCF exists in two forms: a 
248 amino acid sequence that is cleaved to generate the soluble 165 amino acid form of 
SCF and a 220 amino acid sequence that forms the membrane-bound form of the protein 
(209, 211, 212). The soluble form of the protein exists as a dimer; however, the 
monomers are not linked via disulfide bonds (210, 212-217). Osteoblasts and other 
stromal cells in the niche secrete SCF as well as present it on their surfaces. 
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Figure 3.1: SCF structure and signaling pathways. A. Structural representation of human 
SCF. The lower structure is a 90° rotation of the upper structure. The N and C termini and 
secondary structures are labeled; the ~-strands are orange, the helices are green, and the loop 
regions are grey. Schematic adapted from (218). B. The signaling pathways activated in mast 
cells when SCF binds to the c-kit receptor. Many of these same pathways are implicated in more 
primitive hematopoietic progenitors as well as HSCs and aid in proliferation, survival, and 
hematopoiesis. Image adapted from (219). 
Both forms of the protein bind to and activate c-kit, the tyrosine kinase receptor 
expressed on the surfaces of HSCs and other hematopoietic progenitors, which can 
trigger the proliferation and differentiation ofHSCs (220-223). 
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Soluble SCF has been used clinically to promote mobilization of stem cells (224-
226). Kovach eta/. treated hematopoietic cell lines with soluble SCF and demonstrated 
that soluble SCF did not alter the expression ofVLA-4 and VLA-5 integrins but did 
affect their avidity in a biphasic manner. SCF promoted adhesion at early timepoints 
followed by increased mobilization at later timepoints (220). Other studies have shown 
that SCF can enhance adhesion of hematopoietic cells to fibronectin (227-229). Soluble 
SCF is also commonly used in colony forming assays to promote the differentiation of 
murine HSCs into both myeloid and lymphoid progenitors (205, 207, 212, 230, 231). 
As opposed to soluble SCF, which is endocytosed and degraded, membrane or 
surface bound SCF has been shown to maintain c-kit activation and promote cell 
adhesion via the VLA-4 and VLA-5 integrins (208, 220, 232-234). Gunawan et al. used 
streptavidin-biotin binding to immobilize SCF onto glass surfaces coated with 
biotinylated PEG chains and observed that hematopoietic progenitors adhered to the 
surfaces in a dose-dependent manner (188). In addition, HSCs from mice lacking 
membrane bound SCF (Steel Dickie mice) are unable to self-renew (235). 
3.1.2 The Use of Stem Cell Factor in HSC Expansion 
In vitro, soluble and surface immobilized SCF have both been used to enhance 
HSC expansion and have been shown to prevent apoptosis and prolong hematopoiesis 
(188, 206, 208, 209). Soluble SCF has been added to media in combination with other 
cytokines and growth factors, such as thrombopoietin, Flt-3 ligand, Granulocyte 
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Macrophage Colony Stimulating Factor (CSF), Granulocyte-CSF, IL-3, IL-6, and IL-11, 
to maintain HSCs in long-term culture (204, 205, 207). A combination of soluble SCF 
and Flt-3 ligand promoted the expansion of hematopoietic progenitors for 2 to 3 days 
followed by successful engraftment in irradiated hosts ( 1 04 ). Due to its success, SCF is 
one of the most common components added to media in the in vitro culture of HSCs, 
though alone it is insufficient to maintain the HSCs in an undifferentiated state for long 
periods of time. 
The membrane bound form of SCF has been shown to promote hematopoiesis in 
culture longer than the secreted form as a result of sustained activation of the c-kit ligand 
(209, 236-238). Toksoz et al. genetically altered stromal cells to express either the 
membrane bound or soluble form of SCF and observed expansion in both groups, though 
membrane bound SCF promoted expansion for 1-2 weeks longer than the soluble form 
(209). Doran et al. successfully physioadsorbed SCF to the wells of tissue culture plates 
and observed increased expansion ofhematopoietic cell lines compared to similar SCF 
concentrations in a soluble form; in addition, c-kit expression on cells was at levels 
similar to low concentrations of soluble SCF, indicating low receptor saturation and/or 
internalization (206). 
Kishimoto et al. immobilized SCF on fragminlprotamine microparticle-coated 
plates to help preserve the bioactivity of SCF and mimic the role the ECM plays in 
binding cytokines. This study found that a hematopoietic cell line could bind to the 
particles and proliferated in response to the immobilized SCF. However, the binding of 
the SCF to the microparticles was transient, and the SCF was released after five days 
(137). These studies indicate the importance ofthe interactions between SCF and the c-
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kit receptor in HSC survival and maintenance. Toksoz et al. was able to present 
immobilized SCF to HSCs by expressing it in a feeder layer of stromal cells, but the use 
of another cell type during in vitro culture makes it difficult to have fine control over the 
system and the signaling events that take place. In addition, although both Doran and 
Kishimoto' s groups demonstrated the ability to immobilize SCF and maintain its 
bioactivity in a synthetic system and prolong activation of the c-kit receptor, SCF is 
ultimately cleaved from the surfaces. 
The PEGylation of SCF allows the protein to be displayed to cells in a manner 
that mimics the membrane-bound form of the protein. This is crucial because the soluble 
and membrane-bound forms of the protein play distinct roles in HSC function. In its 
soluble form, SCF is more likely to drive differentiation as the protein is endocytosed. In 
contrast, the membrane bound form allows for sustained activation of the c-kit receptor 
and maintains HSCs in a less-differentiated state for longer time periods. The 
presentation of immobilized SCF on hydrogel surfaces can replicate this interaction 
specifically and gives total control over the concentration of protein displayed to the 
HSCs. The following work investigates the effects of SCF on the adhesion, proliferation, 
and spreading of 32D cells as well as its efficiency in the expansion of primitive HSC 
populations. 
3.2 Materials and Methods 
All materials were obtained from Sigma unless otherwise noted. 
3.2.1 Polymer Synthesis and Characterization 
3.2.1.1 PEG-DA 
6kDa PEG-DA was synthesized as described in Section 2.2.1.1. 
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3.2.1.2 PEG-RGDS and PEG-CSJ 
PEG-RGDS for studies with 32Ds was synthesized as describe in Section 2.2.1.2. 
PEG-RGDS and PEG-CS1 for studies utilizing primary cells were synthesized as 
previously detailed in Section 2.2.1.3. 
3.2.1.3 PEG-SCF 
PEG-SCF was made using the same methods as PEG-CS 1 and PEG-RGDS for 
primary cell studies (described in detail in Section 2.2.1.3). Briefly, PEG-SVA was 
reacted with carrier-free murine SCF (R&D, Minneapolis, MN) at a molar ratio of 42:1 
(PEG-SVA:SCF) (Figure 3.2). The reactions were performed in PBS overnight at 4° C 
while maintaining the pH at 8.0. To determine if SCF was PEGylated, a Western blot 
was performed on the PEGylated and unPEGylated forms ofthe proteins using a 15% 
Tris-HCl precast polyacrylamide gel (BioRad, Hercules, CA). A rabbit polyclonal to 
SCF was used as the primary antibody (Abeam, Cambridge, MA). The secondary 
antibody, a goat polyclonal to rabbit IgG, was conjugated with horseradish peroxidase 
(Abeam). To detect the proteins, the ECL chemiluminescent Western blotting analysis 
system (GE Healthcare, Chalfont St. Giles, UK) was applied, and chemiluminescent 
images of the blot were captured on an LAS 4000 (Fuji, Tokyo, Japan). 
Acrylate-PEG-SVA 
Acrylate-PEG-Biomolecule 
PBS 
pH= 8.0 
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Figure 3.2: Reaction scheme for the PEGylation of SCF (or any biomolecule). Acrylate-
PEG-SVA reacts with free amines on biomolecules to form a heterobifunctional polymer that can 
covalently crosslink to the PEG hydrogel matrix. 
3.2.1.4 Bioactivity of PEG-SCF 
To evaluate the bioactivity ofPEG-SCF, 32D cells were seeded into TCPS plates 
at a density of 5000 cells/cm2 in three formulations of media: control media (RPMI-1640 
with 10% IL-3 supplement), control media with SCF (200 ng/ml) and control media with 
PEG-SCF (200 ng SCF /ml). After 24 hrs., the wells were imaged, and cell number was 
calculated using ImageJ software as described in Section 2.2.4.1. The imaging and 
analysis were repeated after 5 days, and the percent change in cell number during this 
time was determined. 
3.2.1.5 Surface Immobilization of SCF within PEG Hydrogel Wells 
6 kDa PEG-DA hydrogel wells were fabricated as detailed in Section 2.2.2. To 
functionalize the surfaces with biomolecules, solutions ofPEG-RGDS and PEG-SCF or 
PEG-CS 1 and PEG-SCF were made to obtain surface concentrations in the PEG wells of 
400 ng/cm2 (for PEG-SCF) and 250 or 25 J.tg/cm2 (for PEG-CS1 and PEG-RGDS). The 
photoinitiator 2,2 dimethoxy, 2-phenyl acetophenone (300 J.tg/ml, dissolved in NVP) was 
added at 10 J.tl per ml of polymer solution. 10 J.tl of the polymer solution was added to 
each well and groups of four wells were crosslinked with long wavelength UV light (365 
run, 10 mW/cm2) for 3 min. Figure 3.3 shows a schematic of this process. After 
crosslinking, gels were soaked and rinsed to prepare them for cell preparation as 
previously described in Section 2.2.2.2. 
UV light, 3 min 
Figure 3.3: Surface conjugation technique for multiple PEG-biomolecules. PEG-DA 
hydrogel wells are coated with a 10 j.JI droplet containing PEG-peptide, PEG-protein, and a 
photoinitiator. Gels containing 4 wells are placed under UV light for 3 min. to covalently 
immobilize the biomolecules on the gel surfaces. 
3.2.1.6 Quantification ofSCF on Gel Surfaces 
To confirm the surface protein concentrations, two concentrations of SCF (200 
and 400 ng/cm2) in combination with PEG-RODS (25 J.lg/cm2) were conjugated to the 
surfaces of hydrogel wells. After UV exposure, the 10 J..!l solution was removed from 
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each hydrogel well, and the gels were soaked in PBS. An enzyme-linked immunosorbent 
assay (ELISA, Quantikine ELISA kit for SCF, R&D) was performed on the aspirated 
liquid as well as the soak solutions as previously described and using PEGylated versions 
of the proteins for the standard curve (174). 
3.2.2 Cell Maintenance 
3.2.2.1 32D Cell Culture 
32D cells were maintained as explained in Section 2.2.3 .2. Briefly, 32D cells 
were cultured in RPMI-1640 with 1% penicillin-streptomycin, 10% heat-inactivated FBS, 
and 10% IL-3 culture supplement. Media was replenished every 2-3 days. Cells were 
subcultured upon reaching a concentration of 1 million cells/mi. 
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3.2.2.2 Primary c-kit, lin- Cell Isolation and Culture 
Whole bone marrow from 8-12 week old C57/B6 mice was isolated and processed 
in the manner described in Section 2.2.3 .2. c-kit lin- cells were isolated magnetically 
and cultured in StemSpan Media supplemented with 1% GA and 50 ng/ml SCF. 
3.2.2.3 Cell Seeding into Hydrogel Wells 
32D cells were seeded into the hydrogel wells at 5000 cells/cm2• The 
experimental groups consisted of wells with 400 ng/cm2 SCF and 25 J.tg/cm2 RGDS. 
PEG-DA and PEG-RGDS gels (2.5, 25, and 250 J.tg/cm2) served as controls. Each group 
consisted of 4 gel wells. Cells within hydrogel wells were maintained in culture for 6 
days at 3 7°C with 5% C02 with media renewal every 2 days. 
c-kit lin- cells were seeded in gel wells ([SCF]=400 ng/cm2, [RGDS]=25 J.lg/cm2 
or ([SCF]=400 ng/cm2, [CS1]=25 J.tg/cm2) at 13,000 cells/cm2. Gel wells with only 
RGDS or CS 1 (25 J.lg peptide/cm2) served as controls. Each group consisted of 4 gel 
wells. Media was added around gels to keep them hydrated. Cells within hydrogel wells 
were maintained in culture for 14 days at 3 7°C with 5% C02 as described in Section 
2.2.3.3. After culture, the cells from each group were combined so that enough cells 
were available for flow cytometry. The experiment was conducted a total of three times. 
3.2.3 Evaluation of Hematopoietic Cells in Culture 
The adhesion, proliferation, and spreading of 32D cells were evaluated as 
previously described in Sections 2.2.4.1 and 2.2.4.2 to determine the effects of SCF on 
these properties. 
c-kit lin- cell expansion and differentiation potential were quantified in the same 
manner as delineated in Sections 2.2.4.3-2.2.4.5. 
3.2.4 Statistical Analysis 
One-way ANOVAs and Tukey's post-hoc analyses were performed to evaluate 
statistical differences between groups in all studies using a 95% probability level 
(p<O.OS). 
3.3 Results and Discussion 
3.3.1 Polymer Synthesis and Characterization 
3.3.1.1 PEG-SCF 
The conjugation of SCF to PEG was confirmed with a Western blot. Figure 3.4 
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shows an image of the blot. In the SCF lane, there is an expected band near 18 kDa, the 
molecular weight of the soluble version of the cytokine. In the PEG-SCF lane, a smear is 
visible beginning at 28 kDa. The increase in molecular weight indicates that the SCF has 
been successfully conjugated to PEG chains with a polydisperse molecular weight, and 
many of the SCF molecules are attached to multiple PEG chains generating a range of 
molecular sizes. The presence of a band at 18 kDa in the PEG-SCF lane indicates that a 
portion of the SCF is unconjugated, though the low intensity of the band signifies that it 
is a small amount of protein. 
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Figure 3.4: Western blot confirming PEGylation of SCF. In the SCF lane, a band at 18 kDa 
corresponds to the molecular weight (MW) of the extracellular domain of SCF. In the PEG-SCF 
lane, there is a smear beginning at a MW of -28 kDa. The increase in MW confirms the addition 
of PEG chains to the SCF molecule, and the resulting smear indicates that some SCF molecules 
have multiple PEG chains. 
3.3.1.2 Bioactivity of PEG-SCF 
In order to ensure that SCF remained bioactive after PEGylation, a soluble form 
of the PEG-SCF was added to 32D cells in culture. The effects of SCF on 32D cell 
proliferation were then evaluated. The addition of both unmodified SCF and PEG- SCF 
to culture media resulted in significant increases in cell numbers compared to control 
wells without any form of the protein (Figure 3.5). There was no significant difference 
between the PEGy lated and unmodified forms of the protein suggesting that the PEG 
chains do not affect the bioactivity of the protein. 
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Figure 3.5: The bioactivity of SCF is maintained after PEGylation. 320 cells were cultured in 
media containing: no SCF, the natural occurring form of SCF, or the PEGylated SCF. The effects 
on 320 cell proliferation were evaluated. There was a significantly higher percent change in 320 
cell number after 5 days when SCF or PEG-SCF was added to the media. We saw no significant 
difference between the PEGylated and unPEGylated versions of the protein. Bars are mean ± 
standard deviation (* indicates significance compared to control, n=8, p < 0.05) 
3.3.1.3 Quantification of SCF on Gel Surfaces 
To determine the concentration of SCF on our surfaces, we performed an ELISA 
on the surface solution after crosslinking. The amount of SCF on the well surface after 
crosslinking an initial solution of 400 ng/cm2 (89.52 ng/well) was 73.5 ± 6.7 ng, which is 
approximately 80% of the initial protein in the crosslinking solution. This finding 
confirms that SCF can be immobilized onto hydrogel surfaces. 
3.3.2 32D Cell Adhesion 
Cell adhesion is a critical process in the niche because it retains HSCs within the 
bone marrow and allows interaction with numerous other cell types. The ability of SCF 
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to alter 32D cell adhesion to hydrogel surfaces was evaluated by imaging cells after 48 
hrs. in culture (Figure 3.6). Compared to the samples containing the medium 
concentration of RGDS (25 J.Lg/cm2), gels with surface immobilized SCF (also containing 
25 J.Lg/cm2 RGDS) have significantly more adherent 32Ds after 48 hrs.: 2278.9 ± 1775.6 
cells/cm2 on the RGDS compared to 6797.9 ± 1327.2 cells/cm2 on the SCF and RGDS 
combination. 
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Figure 3.6: 320 cells adhere significantly to gels with surface immobilized SCF. After 48 
hrs., there were significantly more 32Ds on surfaces with SCF and RGDS compared to surfaces 
containing only RGDS. Bars are mean± standard deviation (*denotes significance, n=4, p < 
0.05) 
These results are consistent with previous suggestions that fibronectin works with 
cytokines in the niche to promote cell adhesion (122). The incorporation of SCF onto the 
gel surfaces in conjunction with RODS caused an additive response by the cells in terms 
of32D cell adhesion. Binding to SCF through the c-kit receptor activates a5~1 integrins 
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on the cell surface to promote adhesion to RGDS (220, 239, 240). Because SCF is 
immobilized onto the hydrogel, there is sustained activation of the c-kit receptor, which 
maintains 32D cell adhesion. Additionally the SCF protein itself can act as a binding site 
for the HSCs further reinforcing their retention on the hydrogel surfaces. 
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Figure 3.7: At high concentrations of RGDS the effects of SCF are masked. On surfaces 
with high RGDS concentrations, SCF does not significantly alter the adhesion of 320 cells. Bars 
represent mean ± standard deviation (n=4) 
At higher concentrations of RGDS (250 J..tg/cm2), the effects of SCF are masked, 
and cell number is maintained at the same level with and without these proteins (Figure 
3.7). This may be due to the activation of similar signaling pathways by both RGDS and 
SCF. As aforementioned, binding to SCF through the c-kit receptor activates a5B1 
integrins, which in turn bind to RGDS. The presence of additional RGDS molecules on 
the surface at the high RGDS concentration (250 J..Lg/cm2) can also lead to an increase in 
32D adhesion (171, 198). The RGDS and SCF work through similar pathways to 
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encourage cell adhesion. At the high RGDS concentration, the addition of SCF likely 
does not enable greater adhesion because the integrins have already been activated by 
RGDS. However, the cell spreading differs greatly on these two surfaces indicating that 
the activation of c-kit is likely involved in cell spreading to some degree. These effects 
are discussed later in Section 3.3.4. 
3.3.3 32D Cell Proliferation 
In comparison to the medium RGDS concentration (25 J.Lg/cm2), the addition of 
SCF seems to slow the proliferation of 32D cells, though not significantly (Figure 3.8). 
The percent change in 32D cells over 48 hrs. was 48.1 ± 10.2% on the RGDS compared 
to 13.6 ± 42.0% on the SCF and RGDS combination. Note that the standard deviations 
of these changes were rather large due to the intrinsic heterogeneity of the 32D 
population. The slower rate of proliferation on immobilized SCF can be attributed to a 
couple of factors. 
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Figure 3.8: SCF does not affect the proliferation of 320 cells. 320 cells proliferated at a 
higher rate on gels without SCF in a 48 hr. time period, although the rates were not significantly 
different due to the heterogeneity of 320 cells. Bars represent mean + standard deviation (n=4) 
Firstly, as aforementioned, adhesive interactions between hydrogels and cells can 
be quite strong and adversely affect cells' abilities to proliferate (161). Cells may find it 
difficult or be unable to leave the surface and divide. Alternatively, SCF signaling could 
be acting to maintain the 32Ds in a more undifferentiated state. Typically, HSCs are in a 
quiescent state, proliferating at a very slow rate, while hematopoietic progenitors 
proliferate rapidly. Immobilized SCF allows for persistent activation of the c-kit receptor 
as well as promotes the expression of the VLA-4 and VLA-5 integrins, which all work in 
vivo to retain HSCs in the niche and have been implicated in the self-renewal of HSCs in 
vitro (122, 191-194, 208, 220, 227-229, 232-234). In combination with TPO and Flt3, 
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SCF has also been shown to prevent differentiation for short periods of in vitro culture 
(241 ). In addition, membrane bound SCF has been shown to maintain HSCs in culture 
for longer periods than its soluble form, indicating its role in slowing or preventing 
differentiation (209). The ability to influence the proliferation rates, and potentially the 
differentiation, of hematopoietic cells by altering the components of the hydrogel matrix 
demonstrates the potential of this culture system to drive cell behavior. The PEG 
hydrogel system is beneficial because it allows complete control over the interactions 
between the matrix and the cells. The immobilization of SCF on the hydrogel surface 
leads to an increase in cell adhesion potentially through the activation of the c-kit 
receptor and a5j31 integrins on the surfaces of 32Ds. 
3.3.4 32D Cell Spreading 
A better understanding of how SCF can affect cell behavior such as cell spreading 
can aid in the design of the hydrogel system. 32D cells spread extensively on gels with 
covalently bound SCF compared to groups with only RGDS presented on the surfaces. 
Figure 3.9 shows images of 32D cells whose nuclei and actin filaments have been stained 
with DAPI (blue) and phalloidin (green) respectively. High magnification images show a 
definitive morphological change in cells when SCF is present on the surface as compared 
to gels containing RGDS alone. 
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200x 400x 
Figure 3.9: 320 cells spread extensively on hydrogels containing SCF. 320 cells were 
stained with DAPI (nuclei , blue) and phalloidin (actin filaments, green). The left panel is at 200x 
magnification. The right panel is a 400x image of the area designated by the white box in the left 
panel. Cells were round and had very little actin on gels with only RGDS. In contrast, cells were 
more spread in the presence of SCF with distinct filopodia (white arrows) . Scale bars = 50 IJm 
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3 2Ds were more spread and many had distinct filopodia extending across the gel 
surfaces containing SCF, indicated by white arrows in Figure 3.9. In contrast, 32Ds on 
gels with only RGDS remain round and appear smaller in size. We also noted clear 
differences in cell number consistent with our cell adhesion data. On PEG-DA gels and 
gels with a lower RGDS concentration (25 J..tg/cm2), there are few cells present on 
surfaces after staining. In contrast, surfaces modified with SCF or high RGDS 
concentrations (250 J..tg/cm2), there were many 32D cells on the gel surfaces. 
To quantify the 32D cell areas on the hydrogels, individual cell areas were 
quantified using the phalloidin and DAPI images. 
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Figure 3.10: 320 cell area on bioactive hydrogels. 320 cells spread significantly on RGOS (25 
~g/cm2) with SCF (400 ng/cm2) compared to all other groups. The wide distribution of cell size is 
due to the heterogeneity of 320 cells. Bars represent mean ± standard deviation (* denotes 
significance compared to all other groups, + denotes significance compared to 2.5 and 250 
~g/cm2 RGOS, n=58 (2.5 ~g/cm2 RGOS), 130 (25 ~g/cm2 RGOS), 863 (250 ~g/cm2 RGOS) , 617 
(SCF) , p < 0.05) 
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When SCF was covalently immobilized on hydrogel surfaces there was a significant 
increase in the average cell size (Figure 3.1 0). The wide distribution of the data is a 
result of the heterogeneity of the 32D cell population. Cells are spread to different 
extents on the surfaces, which leads to a large range of cell sizes. To get a better sense of 
the distribution of cell sizes, the 32D cell areas were also plotted as histograms (Figure 
3.11). The SCF hydrogels (with 25 J..Lg/cm2 PEG-RGDS) were compared to gels with the 
high RGDS concentration (250 J..Lg/cm2) because these gels had statistically similar 
numbers of adherent 32D cells. 
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Figure 3.11: Distribution of 320 cell size on hydrogel surfaces. There is a shift in and 
broadening of the cell area distribution, indicating an increase in cell size on hydrogels containing 
SCF and 25 1-Jg RGDS/cm2 . (250 IJg RGDS/cm2 , SCF and 25 JJg RGDS/cm2) 
On hydrogels modified with PEG-RGDS alone, 75% of the cells are in the 100-300 J..Lm2 
range. With the addition of SCF, only 32% of the cells are in this range. There is a cell 
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area shift of approximately 1 00-200 f.llll2 and a broadening of the distribution to include 
cells that are much larger, even some reaching 800-900 J.Lm2 • 
With the addition of SCF onto gel surfaces, the cells had a more spread 
morphology. The average cell size was larger, and the distribution of cell area was wider 
and shifted slightly right ofPEG-RGDS alone. It is known that binding to both RGD and 
SCF activates multiple integrins on the cell surface (220). The integrins then cluster 
leading to the production of actin filaments and allowing the cells to move and spread on 
the gel surfaces. Integrin activation acts in a positive feedback loop causing a sustained 
upregulation of integrin expression and resulting in larger cell spread areas. In addition, 
many of these cells have a motile morphology indicated by filopodia extending outward 
from the cell centers. The binding of c-kit to SCF is known to promote cell motility, and 
we have mimicked this interaction and obtained this response by immobilizing SCF onto 
hydrogel surfaces (242-244). The addition of specific niche biomolecules to the gel 
surfaces has enabled control of32D cell adhesion and morphology. 
3.3.5 Primary Cell Expansion 
To evaluate the ability of the system to expand primary HSC populations, we 
cultured cells in gel wells for 14 days and quantified the percent change in the total cell 
population. With the inclusion of SCF in the hydrogel matrix, we observed a definitive 
increase in hematopoietic cell number over 14 days in culture. Figure 3.12 shows phase 
contrast images captured at varying timepoints throughout the culture period. When 
primary c-kit, lin- cells were cultured on CS 1 or RGDS alone, they tended to clump 
together in the center of the gel well. In hydrogel wells with SCF, the cells were more 
evenly distributed throughout the well, only forming clusters at later timepoints as 
available space on the gel surface diminished. 
CS1 + SCF RGDS + SCF 
Day 1 
Day? 
Day 13 
Figure 3.12: Primary cells cultured on immobilized SCF over 2 weeks. Primary cells 
proliferated on the hydrogels during two weeks in culture. Cells were well distributed over the 
hydrogel surfaces. Examples of cells with distinct morphological changes are designated with 
black arrows. Scale bars = 100 J.Jm. 
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The primary cells were positively selected for c-kit, which binds to SCF and aids 
in cell adhesion (208, 220, 227-229, 232-234). Therefore, as expected, the cells were 
able to bind to the SCF immobilized on the surfaces reducing their tendency to bind to 
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each other. In addition, as aforementioned, the interaction between c-kit and SCF helps 
upregulate integrin expression, which leads to cell adhesion to both RGDS and CS 1. 
This effect corresponds to 32D cell data previously shown, which indicated that the cells 
spread to a greater extent when hydrogel wells were modified with SCF in addition to 
adhesive peptides. 
On gels with SCF, the primary cells proliferated extensively. Figure 3.13 shows 
the percent change in cell number after 14 days in culture. On gels with RGDS alone cell 
number increased 4558.2 ± 943.8%. The addition of SCF resulted in a significantly 
greater increase in primary cell number (9370.0 ± 2688.9%), and a similar trend was seen 
with the CS1 peptide. On CS1 alone cell number increased 4089.0 ± 1927.0% whereas 
the differential was 6373.4 ± 1447.3% with the addition ofSCF to CSl. These results 
were not unexpected as SCF has been shown previously to act as a growth factor for 
HSCs and other hematopoietic cells, causing their proliferation (245, 246). The 
demonstration of an ability to trigger stem cell proliferation is significant since one of the 
major limiting factors in exploring new applications of HSCs in treating diseases is an 
insufficient HSC quantity. The inclusion ofSCF in the hydrogel system drives cell 
proliferation, and it appears that the selection of specific fibronectin-derived peptide 
sequences may allow control over proliferation rates. 
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Figure 3.13: The addition of SCF to hydrogel surfaces results in primary cell expansion. 
On hydrogels with SCF, there was a significant increase in primary cell number after 14 days in 
culture compared with adhesive peptides alone. Bars represent mean ± standard deviation (* 
denotes significance compared to CS1 and RGDS, n=3, p < 0.05) 
Interestingly, the cells cultured on the surfaces with the combination of CS 1 and 
SCF did not proliferative as extensively as those with RGDS and SCF. A previous study 
by Kapur et al. showed that hematopoietic progenitor cells proliferate in response to a 
combination ofSCF and the a5~1 binding portion ofFN (which contains RGDS) much 
more extensively than a combination of SCF and the a4~ 1 binding portion of FN (CS 1) 
or a combination of both FN domains (24 7). The proliferative differences may also be 
due to the fact that adhesion to CS 1 has been shown to expand HSCs with increased 
engraftment capabilities compared to the RGD fragment of FN (125). After an HSC 
transplant, only cells that are true L T -HSCs and have not begun to differentiate possess 
102 
the ability to engraft in host bone marrow and successfully repopulate the immune 
system. Again, hematopoietic cells that are less primitive proliferate at much faster rates 
than those that are undifferentiated. Thus, the differences in proliferation rates could 
indicate differences in the differentiation state of the cells. Another key factor in ex vivo 
expansion is the ability to prevent HSC differentiation. If the cells are no longer capable 
of self-renewal and engraftment, they will not be useful in therapeutic applications. As a 
result, the differentiation potential of expanded cells in the hydrogel wells was assessed 
with both a colony forming unit assay and flow cytometric analysis. 
3.3.6 Primary Cell Differentiation 
3.3.6.1 Colony Forming Unit Assay 
To evaluate the functional potential of expanded cells we first conducted a colony 
forming unit assay. Figure 3.14 displays the distribution of colonies resulting from cells 
in each sample group. Compared to RGDS alone, RGDS with SCF generated more total 
colonies. In contrast, the addition of SCF to surfaces with CS 1 decreased the number of 
colonies formed. However, neither of these changes was significant. 
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Figure 3.14: Colonies formed from expanded primary cells. Colonies formed in all groups. 
SCF promoted the formation of colonies from cells cultured on gels with RGDS but appeared to 
inhibit colony formation on gels with CS1 . Neither of these changes was statistically significant. 
Bars are mean, n=2. (R=RGDS, C=CS1 ; CFU-GEMM=Granulocyte, Erythrocyte, 
Megakaryocyte, Macrophage, CFU-GM=Granulocyte/Macrophage, CFU-G=Granulocyte, 
CFU-M=Macrophage). 
Figure 3.15 displays the colony data as a percentage of total colonies, and Figure 
3.16 separates the data by colony type. The groups with SCF formed significantly similar 
numbers of GEMM colonies compared to their counterparts containing peptides only. 
However, in the RGDS and SCF group, the total number of colonies formed was greater 
than RGDS alone, meaning that quantitatively there were more undifferentiated cells in 
this group even though as a proportion of total cell number there were less. Conversely, 
the addition of SCF to the CS 1 group not only reduced the percentage of primitive 
colonies, but also resulted in fewer primitive cells. Overall, the CS 1 only group produced 
the highest proportion of primitive colonies, ~32%, which resulted in approximately the 
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same total number of primitive cells as the RGDS + SCF group when taking total cell 
number into account. 
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Figure 3.15: Distribution of colonies formed from cells expanded on gels with surface 
immobilized SCF. The percentage of primitive colonies (both GM and GEMM) is not significantly 
different between any of the groups. However, the addition of SCF does appear to promote the 
formation of GM colonies. Bars are mean, n=2. (R=RGDS, C=CS1; CFU-GEMM=Granulocyte, 
Erythrocyte, Megakaryocyte, Macrophage, CFU-GM=Granulocyte/Macrophage, CFU-
G=Granulocyte, CFU-M=Macrophage). 
The ability to form colonies, particularly those with several different cell types, 
indicates that the cells are in a more progenitor-like state. Each colony begins from one 
cell that exists in a progenitor-like state. In the assay, cells receive signals from soluble 
cytokines that cause them to proliferate and differentiate. Colonies that are composed of 
more than one type of progenitor cell indicate that the initial cell was less differentiated 
because it was able travel along several different pathways to form multiple cell types. 
The primitive state of the cell helps to predict if the cells will be capable of engraftment 
in the bone marrow and repopulation after implantation. In all of the sample groups, cells 
were maintained for 14 days with the potential to form GEMM and GM colonies. This 
indicates that the system is capable of preventing the differentiation of some of the 
hematopoietic cells. 
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Figure 3.16: Individual colony formation organized by colony type from cells expanded on 
SCF functionalized hydrogels. The addition of SCF decreased GEMM formation in 
combination with CS1 and RGDS. There was an increase in GM formation on SCF with RGDS, 
but a slight decrease when SCF was in combination with CS1. However, none of these 
differences were significant. Bars are mean± standard deviation, n=2. (R=RGDS, C=CS1; A. 
CFU-GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, B. CFU-
GM=Granulocyte/Macrophage, C. CFU-G=Granulocyte, D. CFU-M=Macrophage) 
The largest proportion of colonies in each group is macrophage. This is expected since 
the initial cell population of cells contained HSCs, multi potent progenitors, and even 
some committed progenitors. In addition, SCF -c-kit signaling can promote and is 
required for the differentiation of progenitor cells. This may be why we observed no 
significant differences in GM or GEMM colony formation between groups. It is 
hypothesized that if a purer population of HSCs is utilized, the number of less potent 
colonies may decrease. In contrast, SCF can also promote the self-renewal of HSCs, 
which is evident in the RGDS and SCF group. Though, the proportion of each type of 
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colony is similar compared to the RODS only group, there is an increase in total colony 
number which means that all populations of cells are increasing, a condition that is only 
possible if the HSCs are self-renewing and not differentiating. Otherwise, there would be 
a significant shift in the proportion of macrophage and granulocyte colonies. It is 
interesting that the opposite trend occurs on the sample with both CS 1 and SCF. 
Proportionally, there is an increase in macrophage and granulocyte colonies in addition to 
a decrease in the number of colonies formed, which means that on this surface cells 
appear to be losing their multipotent capabilities. The signaling mechanisms that lead to 
these observed differences between combinations of SCF with either CS 1 or RODS are 
unclear. 
3.3.6.2 Flow Cytometry 
Flow cytometry analysis was performed to complement the results obtained in the 
colony assay. Cells were sorted for a population with known repopulation capabilities: c-
kit, Seal+, lin- (KSL). Plots generated from this data can be seen in Figure 3.17 (RODS 
+ SCF) and Figure 3.18 (CSl + SCF). The data shows that most ofthe cells are c-kif, 
Seal-, lin+ though a large proportion of total cells are still c-kit and a majority of the lin-
cells are c-kit. This was expected because many hematopoietic cells express c-kit until 
they become lineage-restricted progenitors (Figure 1.3). However, after 14 days in 
culture, a KSL population remains, indicating that the culture system is able to maintain 
this primitive population. This result also corresponds to the colony data, where a high 
number of colonies generated from more differentiated cells (such as macrophages), 
which could correlate with the large c-kit population. 
A 
250K 
200K 
'-Q) 
~150K 
(/) 
Q) 
"'C en 1ooK 
50K Cells 
75 
0 
0 50K 1 OOK 150K 200K 250K 
Forward Scatter 
c All cells 
105 
21 2.88 
104 
.: ... ·.·:;· .. ·... . . .. 
.. :: .. . . 
~ 
::t:. 
0103 
... : ...  ·. 
102 
0 
B 
300 
200 
.!!}, 
a; 
() 
=1:1:: 
100 
0 
D 
105 .., 
102 -: 
0:11! 
107 
0 102 103 104 
Lineage Markers 
Lin· Cells 
78.8 9.35 
• '•, • • ' • • ,. I ' 
11.1 0.57 
..... ,........,,. ' ',,,.w..;.., ft' TTl,, • ...-,,, ---r""T"T"''Ir'T"''M''' ,.----.r-r"T'T"'.,'ftl ,.,rr--'1.1"""'T'"T"'n jl I, ,• 
o 1 o2 1 o3 1 o4 1 o5 
Sca1 
Figure 3.17: Flow cytometry analysis of c-kit+, lin· cells after 14 days in culture on PEG-
RGDS with PEG-SCF. A. Particles were gated to count only cells. B. Cells were gated to include 
those that were lin-. C. A plot of all cells showing the fluorescence intensities of the Sca1 and c-
kit markers. Cells were gated to delineate between positive and negative cells. D. A plot of 
lineage negative cells gated similarly to those in C. Numbers on the graphs indicate the 
percentage of cells falling within that gate. 
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Figure 3.18: Flow cytometry analysis of c-kit+, lin· cells after 14 days in culture on PEG-CS1 
with PEG-SCF. A. Particles were gated to count only cells. B. Cells were gated for lin·. C. All 
cells gated to delineate between positive and negative cells. D. A plot of lineage negative cells 
gated similarly to those in C. Numbers on the graphs indicate the percentage of cells falling within 
that gate. 
In the quantification of this data, the percent changes in both the c-kit+, lin- and the KSL 
populations significantly increased when SCF was added to the RODS-containing 
hydrogel matrix, rising from 453.8 ± 65.0% to 1877.6 ± 1029.6% and 106.7 ± 99.2% to 
660.0 ± 376.8% respectively (Figures 3.19 and 3.20). This corresponds directly with 
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what was observed in the colony assay with the increase in GM and GEMM colony 
numbers when taking total cell number into account. The percent change inc-kit+, lin-
and KSL number also increases on CS 1 hydro gels with the addition of SCF from 308.4 ± 
130.7% to 730.9 ± 338.3% and from 2.0 ± 84.1% to 169.9 ± 98.5% respectively, but 
these changes were not significant (Figures 3.19 and 3.20). This is contradictory to the 
results seen in the colony assay. This leads us to believe that the relationship between 
CS 1 and SCF may be more complex and require further investigation. 
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Figure 3.19: SCF immobilized on gel surfaces results in an increase in the c-kit+, lin· 
population. Bars represent mean± standard deviation. (R = RGDS, C = CS1), (*denotes 
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Figure 3.20: The addition of SCF to hydrogel wells causes a significant increase in the KSL 
population. Bars= mean+ standard deviation. (*denotes significance compared to RGDS and 
CS1 , n=3, p < 0.05) 
SCF is known to signal proliferation of multiple hematopoietic lineages but can 
also maintain HSCs in an undifferentiated state for short time periods especially in 
combination with other soluble cytokines (248). In its membrane-bound form, SCF is 
able to maintain HSCs in culture for two weeks longer than in its soluble version (209). 
We observed this in the hydrogel group containing both RGDS and SCF, where cells 
were triggered to proliferate but retained their ability to form primitive colonies, and a 
small population of cells expressed the KSL markers after 2 weeks in culture. 
The combination of CS 1 and SCF on hydrogel surfaces had varying results in 
terms of the analysis of differentiation potential. A previous study demonstrated that 
adhesion to CS 1 is capable of preventing differentiation to a greater extent then RGDS 
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(125). This may be due to the fact that more primitive HSCs adhere specifically to CS1 
(122). This was seen in the colony assay where a higher proportion of colonies were 
primitive (GM or GEMM). However, a similar trend was not observed in the expression 
of surface markers indicative of a HSC population. In addition, when SCF was added to 
the surfaces with CS 1, we obtained contradictory results. In the colony assay, we 
observed a decrease in colony numbers as well as an increase in the proportion of more 
differentiated colonies. This could indicate that surface markers do not necessarily 
correlate with the colony-forming capabilities ofHSCs. Baldridge et al. demonstrated 
that they could expand primitive KSL populations in vivo with a cocktail of cytokines, 
but these cells had reduced engraftment capabilities in subsequent transplantation assays 
despite the expression of these specific surface markers (93). These results stress the 
need for multiple in vitro and in vivo evaluation techniques. 
3.4 Conclusions 
The results in this chapter demonstrate the ability to immobilize SCF onto 
hydrogel surfaces at physiologically significant levels while maintaining its bioactivity. 
32Ds adhere to surfaces with covalently bound SCF and RGDS at significantly greater 
levels than on hydrogels with RGDS alone. The cells were also able to spread to a 
greater extent on these surfaces and their cell area increased by 100-300 J.tm2 on average. 
However, there was not a significant difference in cell proliferation on these samples. 
This study emphasizes the importance of SCF -c-kit signaling on cell adhesion. It also 
shows that we are capable of controlling HSC behavior through the design of our 
hydrogel scaffold. 
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With primary cells, significant increases in total cell number were observed when 
SCF was added to either RGDS or CS1 samples, though cells proliferated to a greater 
extent on samples containing the RGDS peptide. In the RGDS group, there were 
significant increases in primitive populations in the presence of SCF as evidenced by 
both the colony assay and flow cytometric analysis. These increases were seen across all 
progenitor populations demonstrating that SCF is capable of expanding hematopoietic 
populations without adversely affecting their differentiation potential. Cells cultured on 
CS 1 containing hydro gels had varying results. In the colony assay, both the colony 
number and the proportion of primitive colonies decreased. However, the flow 
cytometric analysis showed an opposite trend. This inconclusive data prompts further 
investigation into the relationship between SCF and CS 1 signaling. 
In conclusion, these studies show that HSC behavior can be influenced by careful 
design of the scaffold. In addition, they demonstrate the sensitivity of these cells to their 
environment and stress the importance of critical analysis of the cells after expansion. In 
the future, in vivo experiments must be conducted to validate that the expanded cells are 
capable of reconstitution. 
Chapter 4: The Effects of Immobilized SDFla on Hematopoietic Cell 
Behavior in Hydrogel Wells 
4.1 Background 
Stromal derived factor la (SDFla) is a chemokine that can recruit HSCs to the 
bone marrow as well as retain them there. This chapter focuses on work conducted to 
investigate the effects of the chemokine SDFla on hematopoietic cell behavior. 32D 
cells and a primary murine hematopoietic cell population (c-kit, lin-) were cultured in 
hydrogel gel wells with surface immobilized SDFla in combination with one of the 
adhesive ligands CSl or RGDS. Cell adhesion, proliferation, spreading, and 
differentiation potential were quantified to characterize expanded hematopoietic cell 
populations. 
4.1.1 Stromal Derived Factor la 
SDFla was incorporated into the hydrogel matrix due to its substantial role in 
HSC homing to and lodging in the stem cell niche. SDFla is a small, 8 kDa cytokine 
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consisting of 89 amino acids (Figure 4.1 ). It was first isolated from bone marrow stromal 
cell lines and characterized as a growth factor for pre-B cells (249). It belongs to the 
chemokine superfamily, and similarly to SCF, it can be found in both membrane bound 
and soluble forms in both the endosteal and vascular niche (250). SDFla binds to CXC 
chemokine receptor 4 (CXCR4) on HSC membranes and is secreted and expressed by 
osteoblasts, endothelial cells, fibroblasts, and other stromal cells. 
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Figure 4.1: Structure of SDF1a. Image adapted from (251 ). 
HSCs migrate selectively towards SDFla and no other chemokines (252). This 
property means that SDFla plays an integral role in HSC homing to the bone marrow 
niche as well as HSC mobilization to injury sites (253-255). In fact, HSCs treated with 
blocking antibodies to CXCR4 were unable to engraft after transplant (256). SDFla is 
also expressed at high levels on the surfaces of reticular cells in the niche. Signaling 
between membrane-bound SDF 1 a and CXCR4 has been shown to maintain a pool of 
HSCs in an undifferentiated state in vivo, and it has been proposed that SDF1a supports 
the self-renewal ofHSCs (67). SDFla is also known to activate integrins on HSC 
surfaces and has been shown to stop rolling HSCs in flow experiments (239, 240). The 
ability of SDFla to both attract HSCs and promote integrin expression helps to recruit 
HSCs and retain them in the niche (28, 34, 56). 
4.1.2 Use of SDFla in Biomimetic Scaffolds 
SDFla has not been used extensively in the culture ofHSCs. Most in vitro 
experiments focus on HSC mobilization and migration in response to SDFla or the 
effects of SDFla and CXCR4 signaling on HSC engraftment. Bladergroen et al. worked 
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to create an in vivo niche by entrapping SDFla within collagen scaffolds and then 
implanting the scaffolds subcutaneously in mice. To gauge the success of the implants, 
the scaffolds were excised after 5 weeks and the cells populating the scaffold were 
counted and characterized. Implants with SDFla were populated with more 
hematopoietic cells than control scaffolds (257). Though this technique demonstrates a 
great deal of promise in supporting HSC development in vivo, it requires a source of 
HSCs within the transplant recipient to be successful and thus, may not be applicable in 
the treatment of certain diseases. In addition, some work has been done utilizing SDFla 
in biomaterial scaffolds for wound healing and angiogenesis applications (258-263). In 
one study, an alginate hydrogel scaffold with encapsulated SDFla was used to treat 
wounds created in the dorsal skin of mice and resulted in more rapid wound repair in 
seven days, as evaluated by remaining wound size, than control scaffolds (260). These 
studies demonstrate the ability to incorporate SDFla into a scaffold while maintaining its 
bioactivity, though in all of these studies SDFla was not covalently immobilized into the 
scaffold. 
The work in this chapter takes advantage of the homing and lodging effects of 
SDFla. SDFla was immobilized onto hydrogel surfaces to retain HSCs on the gel 
surface by activating both the CXCR4 receptor and the VLA-4 and VLA-5 integrins, 
which could in turn promote adhesion of HSCs to CS 1 and RGDS peptides also present 
on the surface. Hidalgo et al. demonstrated that SDFla could modulate HSC adhesion 
by upregulating the expression of the VLA-4 integrin (264). Peled eta/. observed that 
SDFla activated both the VLA-4 and VLA-5 integrins on primary HSCs and that these 
integrins played a critical role in transendothelial migration during the homing process 
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(239). Figure 4.2 shows a schematic of the interplay between SDF1a and the VLA-4 and 
VLA-5 integrins. The ability to maintain HSCs close to the hydrogel surface is beneficial 
in HSC culture. By covalently tethering SDF1a to hydrogel surfaces, HSCs can be 
retained on the gel surface, enabling them to interact with other biomolecules, such as 
RGDS and CS 1, which are also immobilized on the surface and can aid in HSC adhesion 
and expansion. In addition, SDFla itself could prove beneficial in the maintenance of 
primitive HSC populations. 
Figure 4.2: Process of transendothelial migration of HSCs triggered by the release of 
soluble SDF1a. 1. Circulating CXCR4+ HSCs are slowed by interactions with selectins 
expressed by endothelial cells (ECs) in the bone marrow. 2a. Cells that do not express CXCR4 
remain in the circulation following SDF1 a stimulation. 2b. After stimulation by SDF1 a and 
subsequent upregulation of LFA-1 and VLA-4 integrin expression, HSCs stop rolling and adhere 
to ECs. 3. The activation of CXCR4 increases both VLA-4 and VLA-5 expression and leads to 
transendothelial migration through adhesion to fibronectin and results in 4. The return of HSCs to 
the stem cell niche (homing). Figure adapted from (240). 
4.2 Materials and Methods 
All materials were obtained from Sigma unless otherwise noted. 
4.2.1 Polymer Synthesis and Characterization 
4.2.1.1 PEG-DA, PEG-RGDS, and PEG-CS1 
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PEGDA, PEG-RGDS, and PEG-CS1 were synthesized as described in Sections 
2.2.1.1, 2.2.1.2, and 2.2.1.3. 
4.2.1.2 PEG- SDF1 a 
To PEGylate SDF1a., the same technique was employed as for PEG-SCF (Section 
3.2.1.3). 3400 MW Acrylate PEG-SVA was reacted with carrier-free murine SDF1a. 
(R&D) at a molar ratio of 18:1 (PEG-SVA:SDF1a.). The reactions were conducted in 
PBS (pH 8.0) overnight at 4° C. To determine the degree of conjugation, a Western blot 
was performed on the PEGylated and unmodified forms of the proteins using a 15% Tris-
HCl precast polyacrylamide gel. The antibodies that were used included a rabbit 
polyclonal antibody to SDF1a. (Abeam) and a secondary goat polyclonal antibody against 
rabbit lgG conjugated with horseradish peroxidase (Abeam). To detect the proteins on 
the blot, the ECL chemiluminescent Western blotting analysis system was applied, and 
chemiluminescent images of the blot were captured using an LAS 4000. 
4.2.1.3 Bioactivity of PEG-SDF1 a 
To evaluate the bioactivity ofPEGylated SDF1a., a migration assay utilizing 
transwells with 3 J..Lm pores was performed. This pore diameter is required due to the 
relatively small size ofhematopoietic cells (10 J..Lm in diameter) and has been used in 
previous work to study hematopoietic cell migration (265). Three media formulations 
were put into the well plate below the transwells: control media (RPMI 1640 containing 
10% heat-inactivated FBS, 10% IL-3 culture supplement, and 1% penicillin, 
streptomycin), control media with SDF1a. (100 ng/ml), and control media with PEG-
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SDF1a (100 ng SDF1a/ml). 32D cells were seeded into the top ofthe transwell in the 
control media at 6000 cells/cm2. Images of the bottom of the well plate were taken after 
72 hrs. in culture (3 7°C, 5% C02), and migrated cells were counted using ImageJ 
software. 
4.2.1.4 Sutjace Immobilization and Quantification of SDF1a 
6 kDa PEG-DA hydrogel wells were fabricated as described in Section 2.2.2.1. 
PEG-SDF1a was covalently conjugated to the surfaces ofhydrogel wells in the same 
fashion as PEG-SCF (Section 3.2.1.5). A solution containing PEG-SDF1a, either PEG-
CS1 or PEG-RGDS, and the photoinitiator 2,2-dimethoxy-2-phenyl acetophenone (10 
J.tllml of polymer solution) in HBS was made. 10 J.tl ofthe solution was added to each 
well to obtain surface concentrations of 400 ng SDF1a per cm2 and 25 J.tg or 250 J.tg of 
PEG-peptide (CS 1 or RGDS) per cm2. Groups of four wells were exposed together 
underneath long wavelength UV light (365 nm, 10 m W/cm2) for 3 min. to crosslink the 
biomolecules into place. To determine the amount ofSDF1a on surfaces the 10 J.tl 
solution in each gel well was collected after crosslinking and analyzed using the 
Quantikine ELISA kit for SDF1a (R&D) similarly to the process described in Section 
3.2.1.6. Gels were soaked in PBS containing 0.1% NaN3 overnight to allow any 
uncrosslinked protein to diffuse out of the gel. The soak solution was also assayed with 
the ELISA kit. 
4.2.2 Cell Maintenance 
4.2.2.1 32D Cell Culture 
32D cells were kept in culture as previously described in Section 2.2.3.1. 
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4.2.2.2 Primary c-kit, lin- Cell Isolation and Culture 
Primary c-kit+, lin- cells were isolated from murine whole bone marrow and 
maintained as noted in Section 2.2.3 .2. 
4.2.2.3 Cell Seeding into Hydrogel Wells 
32D cells were seeded into the hydrogel wells at 5000 cells/cm2. The 
experimental groups consisted of wells with 400 ng/cm2 SDF1a and 25 ~g/cm2 RODS. 
PEG-DA and PEG-RODS gels (25 and 250 ~g/cm2) served as controls. Each group 
consisted of 4 gel wells. 32Ds were cultured for 6 days at 37°C and 5% C02 with media 
renewal every 2 to 3 days. 
c-kit+ lin- cells were seeded in gel wells ([SDF1a]=400 ng/cm2, [RGDS]=25 
~g/cm2 or ([SDF1a]=400 ng/cm2, [CS1]=25 ~g/cm2) at 13,000 cells/cm2• Gel wells with 
only RODS or CS1 (25 ~g peptide/cm2) served as controls. Each group consisted of 4 
gel wells. Media was added around gels to keep them hydrated. Cells were kept in 
culture for 14 days at 3 7°C and 5% C02 with media renewal every 2 to 3 days. After 
culture, the cells from each group were combined so that enough cells were available for 
flow cytometry. The experiment was conducted a total of three times. 
4.2.3 Evaluation of Hematopoietic Cells in Culture 
The adhesion, proliferation, and spreading of 32D cells were quantified as stated 
in Sections 2.2.4.1-2.2.4.3 to determine the effects of SDF 1 a on these properties. 
c-kit lin- cell expansion and differentiation potential were evaluated similarly to 
the methods in Sections 2.2.4.3-2.2.4.5 
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4.2.4 Statistical Analysis 
One-way ANOVAs and Tukey's post-hoc analyses were performed to evaluate 
statistical differences between groups in all studies using a 95% probability level 
(p<0.05). 
4.3 Results and Discussion 
4.3.1 Polymer Synthesis and Characterization 
4.3.1.1 PEG- SDFJ a 
Western blot analysis (Figure 4.3) confirmed PEGylation of SDFla. A band can 
be seen in the protein-only lane at 8 kDa, whereas, in the PEG-SDFla lane, there is a 
shift in molecular weight to 14 kDa. Additionally, there is a smear in this lane indicating 
that the protein has been decorated with multiple PEG chains. 
MW PEG-
~ SDF1a SDF1a 
184-
121-
85-
52-
41-
27-
21-
14-
11-
Figure 4.3: Western blot of SDF1a and PEG-SDF1a. There is a band present in the SDF1a 
lane near 8 kDa. In the PEG-SDF1a lane you can see a smear beginning around 14 kDa 
indicating the protein has been successfully conjugated to PEG chains. (MW=molecular weight) 
4.3.1.2 Bioactivity ofSDFla 
After confirming successful PEGy lation, a migration assay was performed to 
determine if the PEGylated form of SDFla maintained its bioactivity. The addition of 
SDFla and PEG-SDFla to the media promoted significant 32D cell migration through 
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the transwell membrane (Figure 4.4). However, the presence of the PEG chains did 
appear to diminish some of the SDFla bioactivity. In the future, the molar ratio of PEG-
SVA to SDFla can be optimized to reach native levels of bioactivity. In addition, the 
concentration of SDFla can be increased to compensate for the decrease in bioactivity. 
35 
30 * 
~ 
C) 
> 
0 25 -
"C 
a; 
Li: ]! 20 G) 
u 
c 
• N M 
"C 15 C) 
-e 
0) 
!i 
-
10 ~ 0 
... 
C) 
.Q 
E 
::::J 5 z 
0 
Control PEG-SDF1a SDF1a 
Figure 4.4: Bioactivity of PEGylated SDF1 a. 320 cells were seeded into the top well of a 
transwell plate. The bottom well contained control media, control media with SDF1 a, or control 
media with PEG-SDF1a. After 48 hrs., cells that migrated to the bottom well were counted. Cells 
migrated significantly in response to SDF1a and PEG- SDF1a compared to the control. Data is 
displayed as mean ±standard deviation. (* denotes significance compared to control and PEG-
SDF1 a, + denotes significance compared to control, n=54, p < 0.05) 
4.3.1.3 Quantification ofSDFla on Gel Surfaces 
To validate that SDFla was covalently immobilized on hydrogel surfaces we 
conducted an ELISA on the conjugation and gel soak solutions after surface conjugation. 
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The surface concentration ofSDF1a was calculated to be 98% ofthe initial protein added 
to the surface: 88.3 ± 0.5 ng/cm2• 
4.3.2 32D Cell Adhesion 
We observed a significant increase in adherent 32D cells when SDF1a (400 
ng/cm2) was added to the surfaces of gels with 25 J..tg/cm2 RGDS compared to RGDS 
alone (Figure 4.5). After 48 hrs., the number of cells on gels with SDF1a was 6577.2 ± 
2623.1 cells/cm2 compared to 2278.9 ± 1775.6 cells/cm2 on RGDS alone. The activation 
of the CXCR4 receptor on HSC surfaces has been shown previously to activate both the 
VLA-4 and VLA-5 receptors and help retain HSCs in the niche (240). We can 
continuously upregulate the expression of both of these integrins by surface immobilizing 
SDF1a onto the hydrogel. This stabilization not only prevents protein from being 
endocytosed or otherwise cleared away, but it also causes the SDF1a to act similarly to a 
membrane bound protein as opposed to a soluble cytokine, which could increase cell 
motility away from the hydrogel. In turn, the interaction of the CXCR4 receptor with 
SDF1a on the gel surface allows for close proximity of the upregulated VLA-5 integrins 
to the gel surface where they can bind to RGDS. 
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Figure 4.5: 320 cell adhesion on surfaces with immobilized SDF1a. On gels with RGDS 
concentrations of 25 J.,Jg/cm2, there was a significant increase in 320 cell adhesion when SDF1 a 
was also present on the surface. Data is displayed as mean ±standard deviation. (* denotes 
significance, n=4, p < 0.05) 
Interestingly, the addition of SDFla to gel surfaces with higher RGDS 
concentrations (250 f.lg/cm2) did not result in an increase in 32D cell adhesion (Figtire 
4.6). Recall that a similar response was seen with the SCF protein in Chapter 3. This 
finding could be attributed to the presence of more RGDS molecules, which allow the 
32Ds to adhere to the gel through multiple integrins. In addition, the activation of RGDS 
can act as a positive feedback loop resulting in the expression of more VLA-5 integrins 
thus promoting more cell adhesion (127). As a result, the addition of SDFla to the 
surface does not increase cell adhesion because the cells are already expressing sufficient 
integrins to bind to the surface at a high degree. 
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Figure 4.6: Cell adhesion on gels with high RGDS concentrations (250 1Jg/cm2). The 
addition of SDF1 a to the gel surfaces does not significantly affect cell adhesion. Data is 
displayed as mean± standard deviation. (n=4) 
4.3.3 32D Cell Proliferation 
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32D cell proliferation was evaluated by calculating the increase in adherent cells 
between days 2 and 4 and days 4 and 6 ( 48 hr. time periods) utilizing image analysis. 
The addition of SDF1a did not promote the proliferation of 32D cells (Figure 4.7). On 
gels with only RODS the increase in cell number over 48 hrs. was 48.1 ± 10.2% while the 
percent increase on gels with SDFla was 24.2 ± 13.3%. This could be due to a number 
of factors. Firstly, the concentrations of cells on the surfaces were very different. As 
shown by the adhesion data, there were twice as many cells on gels with SDFla 
compared to those with RODS alone. The higher density of the cells on the gel surfaces 
may be negatively influencing their proliferation through cell-cell signaling. Limited 
space on the gel surface may also result in proliferating cells leaving the surface. 32D 
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cells are a semi-adherent cell line that can survive in suspension, and the number of cells 
in the media was not quantified. Another possible explanation is that cells may not be 
able to proliferate as rapidly if they are adhering strongly to the gel surface (161, 266). 
As aforementioned, this has been previously reported on PEG hydrogels where smooth 
muscle cell proliferation decreased as the concentration of adhesive ligand increased 
(161). Furthermore, the cells may have returned to a more quiescent state. SDF1a has 
been shown to maintain a pool of HSCs in vivo, and signaling via the CXCR4 receptor 
could be turning on signaling pathways involved in HSC homeostasis during which HSCs 
proliferate quite slowly (35). However, the difference between the two proliferation rates 
was not significant and these alternative explanations require further study to warrant any 
definitive conclusions. 
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Figure 4.7: 320 cell growth over 48 hrs. on hydrogels with immobilized RGDS and SDF1a. 
Cell proliferation was not significantly affected by the addition of SDF1 a; however, the 
proliferation rate did decrease slightly. Data is displayed as mean± standard deviation. (n=4) 
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4.3.4 32D Cell Spreading 
To visualize and quantify 32D cell spreading on surfaces with RGDS and SDFla, 
cells were stained with DAPI (nuclei) and phalloidin (actin). Figure 4.8 shows 
representative images of cells spreading across the gels. Compared to cells on PEG-
RGDS, the cells on gels with SDF 1 a are more spread and have filopodia extending from 
their centers (denoted by white arrows). 
200x 400x 
Figure 4.8: 320 morphology on bioactive PEG hydrogels with covalently immobilized 
SDF1a. The left column is at 200x magnification, and the right column is a 2x magnification (total 
magnification 400x) of the dotted box outlined in the left column. Actin filaments are stained with 
phalloidin (green) and nuclei are stained with DAPI (blue) . With the covalent incorporation of 
SDF1 a onto the surfaces, the cells appeared more spread, and distinct filopodia can be seen 
extending from many of the cells (denoted with arrows). Scale bars = 50 ~m 
Cells are well dispersed across the entire surface of the gels. To determine the average 
cell area, the area of phalloidin staining was quantified and divided by the number of 
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nuclei (Figure 4.9). We chose to compare the SDF1a group to RGDS gels with the high 
concentration of RGDS (250 J..tg/cm2) due to similarity in cell density (resulting in similar 
available areas/cell for spreading). The average cell area increased significantly from 
260.6 ± 175.1 J..tm2 to 366.5 ± 246.9 J..tm2 with the incorporation ofSDF1a onto surfaces. 
Similarly to surfaces with both SCF and RGDS, the average cell areas had large standard 
deviation due to the heterogeneity of the 32D cell population. 
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Figure 4.9: Average 320 cell area on hydrogels with immobilized RGDS and SDF1a. The 
average cell size significantly increased with the addition of SDF1a (400 ng/cm2) onto gel 
surfaces. Data is displayed as mean± standard deviation. (*denotes significance, n=863 (250 
1Jg/cm2 RGDS), 631 (SDF1a), p < 0.05) 
The diversity of cells on the surfaces resulted in a wide distribution of cell sizes. Thus, 
the cell area was also plotted as a histogram of cell sizes (Figure 4.1 0). On surfaces 
containing only RGDS, the highest percentage of cells was centered around 100 - 300 
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J.lm2 ; with the addition of SDFla onto the surfaces, there is a shift in cell size to center on 
200 - 400 J.lm2 and an increase in the percentage of cells that range from 400-1000 J.lm2• 
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Figure 4.10: Distribution of 320 cell sizes on surface immobilized RGDS and SDF1 a. With 
the addition of SDF1 a (400 ng/cm2) onto surfaces with RGDS (25 1Jg/cm2), there is a shift in cell 
size from 100-200 1Jm2 to 200-300 1Jm2 . There is also a higher percentage of cells at larger areas 
on surfaces with SDF1 a. (250 IJ9 RGDS/cm 2 , SDF1 a and 25 IJ9 RGDS/cm 2) 
SDFla is a critical signaling molecule in HSC mobility. The capability ofHSCs 
to move into and out of the HSC niche depends on their ability to adhere to extracellular 
matrix proteins as well as other cells through integrins on their surface. Thus, the 
interplay between activation of the CXCR4 receptor and integrin expression has been the 
subject of numerous studies. The expression ofVLA-4 and VLA-5- as well as other 
integrins - is upregulated as a result of SDFla signaling (239, 240, 264). This appears to 
be the case on gel surfaces with immobilized SDFla. The CXCR4 receptor is 
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continuously activated triggering the expression ofVLA-5 integrins, which in turn bind 
to multiple RGD molecules causing the cells to spread. The presence of filopodia on the 
surface may also signify that cells are moving across the surface. Intracellularly, SDFla 
signaling can result in actin polymerization in megakaryocytes (267). Furthermore, 
Fruehauf et al. observed podia formation in 32Ds in response to stimulation with SDFla. 
The podia formation was associated with cell motility on fibronectin coated glass 
surfaces. (250). As aforementioned, SDFla is a chemokine that is specific for 
hematopoietic cells. In vivo, cells migrate exclusively towards soluble SDFla released 
by injured tissues during mobilization and by the bone marrow during homing. The 
podia formation suggests that SDFla has triggered the 32Ds to migrate across the gel 
surfaces. Time-lapse studies could be employed in future studies to study the effects of 
immobilized SDFla on cell migration. 
4.3.5 Primary Cell Expansion 
The effects of SDFla on primary cell expansion were also investigated. c-kit lin-
primary hematopoietic progenitor cells were cultured on hydrogel surfaces with SDFla 
in combination with either CSl or RGDS for 14 days. Figure 4.11 shows representative 
images of the cells on both sets of gels during the culture period. Cells were fairly well 
dispersed after 24 hrs. but over time the cells began to cluster. Morphological changes in 
the cells were not observed until later timepoints (black arrows on Day 13 images in 
Figure 4.11). 
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Day 1 
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Day 13 
Figure 4.11: c-kit, lin· primary hematopoietic cells on hydrogels with surface immobilized 
SDF1 a with PEG-CS1 or PEG-RGDS. Cells were maintained on the gels throughout the two 
weeks. After 14 days, some cells had started to spread (denoted with black arrows). The cells 
tended to clump together and were not evenly dispersed across the entire gel surface. (Scale 
bars = 100 1-Jm) 
With the inclusion of SDF1a in the hydrogel matrix, we did not see a significant 
change in cell expansion when compared to the peptides alone (Figure 4.12). On gels 
with CSl and SDFla, the percent change in cell number rose from 4089.0 ± 1927.0 
percent to 5747.9 ± 2730.1 percent. On gels with RODS and SDF1a there was a very 
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small decrease in the percent change in cell number from 4558.2 ± 943.8 to 4304.0 ± 
1892.1 percent. 
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Figure 4.12: The total expansion of primary cells on surface immobilized SDF1a after 14 
days in culture. Expansion was not significantly affected by the presentation of surface SDF1a, 
though there was a slight increase in cell number on gels with both CS1 and SOFa, though it was 
not statistically significant. (R=RGDS, C=CS1) Data is displayed as mean ± standard deviation 
(n=3). 
Most in vitro studies performed with SDF 1 a have shown its role in cell migration 
and adhesive interactions with the ECM and stromal cells. Very little work has 
investigated the effect SDFla has on hematopoietic cell proliferation. Rosu-Myles eta/. 
demonstrated that the addition of SDF 1 a to primary hematopoietic cell cultures promoted 
the expansion and maintenance of committed progenitor cells (268). However, a 
significant change in cell expansion was not observed with the immobilization of SDF1a 
onto hydrogel surfaces. One reason for this may be that the initial population of cells 
expressed c-kit and none of the lineage markers, meaning they had not necessarily 
132 
become committed progenitors. There was a trend of differential effects on expansion 
depending on the adhesive peptide sequence that was used in conjunction with SDF1a.. 
When CS1 was used with SDF1a., there was an increase in primary cell expansion. This 
implies that the effects of SDF 1 a on cell expansion depend on adhesion through the 
VLA-4 integrin. Hidalgo et al. showed that VLA-4 dependent adhesion to CS 1 could be 
upregulated by SDF1a., which establishes a relationship between the two molecules. In 
addition, a lack ofVLA-4 expression has been shown to negatively impact HSC self-
renewal (269). Taken together, these findings suggest that the activation of multiple 
VLA-4 integrins in response to SDF1a. signaling via the CXCR4 receptor results in the 
proliferation of hematopoietic progenitors. 
Furthermore, though total cell expansion is not significant compared to peptide 
only controls, SDF1a. could be promoting or slowing the proliferation of certain cell 
types. Cells that are less differentiated tend to proliferate at slower rates than those that 
have become more committed progenitors (127). Li et al. found that by using a small 
peptide analogue of SDF1a. in HSC culture they could improve the engraftment potential 
of HSCs though they did not observe an increase in total cell number (270). In addition, 
the reduced bioactivity ofPEG-SDF1a. may be hindering its ability to interact with 
primary HSCs. To further study how SDFla. affected hematopoietic cell behavior the 
differentiation potential of the final cell populations on the gel surfaces was analyzed. 
4.3.6 Primary Cell Differentiation 
4.3.6.1 Colony Forming Unit Assay 
To assess the differentiation potential of cells grown in the hydrogel wells, a 
colony assay and a flow cytometric analysis were performed. Figure 4.13 shows the 
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number and distribution of colonies formed from cells collected from hydrogel surfaces 
after 14 days in culture. As we observed on SCF, the colonies that formed were 
predominately macrophage. The total number of colonies increased in samples from gels 
containing SDF1a and RGDS but decreased slightly on SDF1a and CSl. Figure 4.14 
displays the same colony data as a percentage of total colonies. On samples with SDF 1 a, 
there were a higher percentage of primitive GM and GEMM colonies compared to the 
peptides alone. 
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Figure 4.13: Colony distribution of colonies formed from cells expanded on gels with 
surface immobilized SDF1a. Total colony number increased on samples expanded on SDF1a 
in combination with RGDS. Bars are mean, n=2. (R=RGDS, C=CS1 ; CFU-
GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, CFU-
GM=Granulocyte/Macrophage, CFU-G=Granulocyte, CFU-M=Macrophage) 
Figure 4.15 presents the data as individual colony formation, which demonstrates the 
same trends. However, none of the noted differences were statistically significant. This 
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is likely due to a low sample size, and thus, the experiments should be repeated to 
determine if the findings are a true response by the primary cells to the addition of 
SDFla. 
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Figure 4.14: Distribution of colonies formed from cells expanded on gels with surface 
immobilized SDF1 a. The percentage of primitive colonies (both GM and GEMM) is not 
significantly different between any of the groups. However, the addition of SDF1 a does appear to 
promote the formation of GEMM and GM colonies particularly in combination with CS1. Bars are 
mean, n=2. (R=RGDS, C=CS1; CFU-GEMM=Granulocyte, Erythrocyte, Megakaryocyte, 
Macrophage, CFU-GM=Granulocyte/Macrophage, CFU-G=Granulocyte, CFU-
M=Macrophage) 
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Figure 4.15: Individual colony formation organized by colony type from cells expanded on 
SDF1a functionalized hydrogels. The addition of SDF1a in combination with CS1 increased 
GEMM formation. There was an increase in GM formation on all samples with SDF1 a. However, 
none of these differences were significant. Bars are mean ±standard deviation, n=2. (R=RGDS, 
C=CS1; A. CFU-GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, B. CFU-
GM=Granulocyte/Macrophage, C. CFU-G=Granulocyte, D. CFU-M=Macrophage) 
4.3. 6.2 Flow Cytometry 
Figures 4.16 and 4. 17 display the flow cytometry plots generated by samples with 
SDF1a. When comparing the two, we note that both the lin- and c-kit populations are 
greater in cells cultured on CS1 and SDF1a than those cultured on RGDS and SDF1a. 
However, the percent increases in the c-kit, lin- population are fairly similar: 350-450% 
(Figure 4.18). The percent increase in the primitive KSL population does not change 
significantly with the addition of SDF1a though there is a trend of increasing KSL 
population on gels with both CS1 and SDF1a (Figure 4.19). 
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Figure 4.16: Flow cytometry analysis of c-kit+, lin· cells after 14 days in culture on PEG-
RGDS with PEG-SOFa. A. Particles were first gated to count cells. B. Cells were then gated for 
those that were lin-. C. A plot of all cells gated for positive and negative Sca1 and c-kit 
expression. D. A plot of lineage negative cells gated exactly as in C. Numbers on the plots 
indicate the percentage of cells falling within that gate. 
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Figure 4.17: Flow cytometry analysis of c-kit+, lin- cells after 14 days in culture on PEG-C51 
with PEG-SDF1 a A. Particles were gated to count cells. B. All of the cells were gated for those 
that did not express lineage markers. C. A plot of all cells gated for positive and negative Sca1 
and c-kit expression. D. A plot of lineage negative cells with gates described in C. Numbers on 
the graphs indicate the percentage of cells falling within that gate. 
The data from these studies is somewhat inconclusive. Similarly to previous 
work in this thesis, there is a significant amount of differentiation occurring during the 
culture period. This is expected since a heterogeneous population of progenitor cells is 
used, many of which have already begun the differentiation process before being seeded 
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into the hydrogel wells. In previous work, SDF1a has been shown to aid in the 
maintenance of a primitive pool of HSCs in vivo and may be implicated in HSC self-
renewal (271). The presence ofSDF1a on gel surfaces did not promote significant cell 
proliferation, but it appeared to inhibit some degree of differentiation particularly in 
combination with CS 1. Preliminary results in both the colony assay and flow cytometry 
supported this theory. When SDF1a was immobilized on gel surfaces with RGDS the 
effects on the proliferation and differentiation potential of primary cells seem to be 
minimal. These results may be due to an additive effect ofCS1 and SDF1a. As 
previously described, the binding ofCXCR4 to SDF1a results in activation ofVLA-4 
(240, 264). In addition, binding to CS1 via the VLA-4 integrin has been shown to 
maintain HSCs in a less differentiated state (122, 125). The ability to keep the HSCs 
undifferentiated in an in vitro system is critical because only the most primitive HSCs are 
capable of successful engraftment after transplantation. This work shows that the 
immobilization ofSDF1a onto the surfaces ofhydrogel wells can prevent some degree of 
HSC differentiation. 
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Figure 4.18: Increase inc-kit+, lin· cells over 14 days in culture. The addition of SDF1a to 
surfaces had no significant effect on c-ki(, lin- cell proliferation, though there was a slight 
increase in cell number on gels with the combination of CS1 and SDF1a compared to CS1 alone. 
Data is displayed as mean ±standard deviation. (n=3) (R=RGDS, C=CS1) 
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Figure 4.19: Expansion of the primitive KSL population on gels with covalently 
immobilized SDF1 a. On gels with RGDS and SDF1 a, the primitive cell population was 
unchanged compared to controls with RGDS alone. On gels with CS1 and SDF1a, there was an 
increase in the KSL population compared to controls. However, this increase was not deemed 
significant. Data is displayed as mean + standard deviation. (n=3) (R=RGDS, C=CS1) 
4.4 Conclusions 
SDFla was included in the hydrogel matrix in an attempt to retain HSCs on the 
gel surface and inhibit their differentiation. In addition, the inclusion ofSDFla on gel 
surfaces could theoretically help to select for HSCs that are positive for the CXCR4 
receptor, which is the protein that SDFla binds to in vivo. CXCR4 expression is 
correlated with the ability to successfully home to the bone marrow cavity after 
transplantation, and overexpression of CXCR4 has been shown to improve this 
repopulation ability (272-274). 
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SDF1a was successfully PEGylated though its bioactivity was reduced as a result 
ofthis process. With 32D cells, there was an increase in the number of adherent cells 
after 48 hrs. when cells were cultured on immobilized SDF1a. Surface bound SDF1a 
also caused a decrease in cell proliferation and a corresponding increase in total cell area. 
Primary cells cultured in hydrogel wells functionalized with SDF1a did not proliferate 
significantly compared to peptide only controls. However, cells cultured on SDFla were 
able to form more primitive colonies than peptide controls, particularly cells cultured on 
SDFla in combination with CSl. This suggests that there may be an additive effect of 
surface immobilized SDFla and CSl in terms ofmaintaining primitive HSC populations, 
though the data was not significant. In future studies, SDFla could be used in 
combination with SCF to ascertain whether these two proteins can work together to both 
promote proliferation and inhibit differentiation. 
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Chapter 5: Effects of Surface Immobilized Jaggedl on the Expansion of 
Hematopoietic Stem Cells in Hydrogel Wells 
5.1 Background 
SCF and SDFla. were found to promote hematopoietic stem cell expansion and 
inhibit differentiation, respectively. These successes led to the investigation of another 
niche molecule, Jagged! (JAGI). Unlike SCF and SDFla., which are found in both 
soluble and membrane-bound forms, JAG 1 is only expressed in the endosteal and 
vascular niches as a transmembrane protein. Several types of stromal cells in the HSC 
niche display JAG 1, which plays an integral role in HSC fate. The interaction between 
JAG 1 and Notch1 has been implicated in HSC self-renewal and the prevention of 
differentiation. This chapter focuses on the effects of surface immobilized JAG 1 on HSC 
behavior. HSCs were cultured within JAG 1-modifed hydrogel wells for 14 days, and the 
differentiation potential of the expanded cells was characterized by the ability to form 
primitive colonies and the expression of surface markers indicative of HSC populations. 
5.1.1 Jaggedl 
JAG 1 is a transmembrane protein that is a member of the Notch family of 
receptors. The Notch signaling pathway is conserved between many mammalian species 
and has roles in many basic cell functions including growth and differentiation (71). The 
signaling is intracellular occurring between Notch receptors (Notch 1-4) and Notch 
ligands (Jagged 1 and 2 and Delta-like 1, 3, and 4). When Notch ligands bind to Notch 
receptors, the Notch receptor is cleaved by proteases and the intracellular portion of the 
receptor travels to the nucleus where it promotes or suppresses gene expression (Figure 
5.1) (69). In the HSC niche, JAGl is expressed by osteoblasts whereas HSCs, 
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hematopoietic progenitors, and mature blood cells all express the Notch1 receptor, which 
binds to JAG 1 (275-277). 
This signaling pathway has been shown to influence HSCs self-renewal and 
differentiation during in vitro and in vivo experiments (72, 278-282). Stier eta/. 
transduced hematopoietic progenitor cells to express Notch1 and found these cells 
preferentially engaged in self-renewal over differentiation (279). Varnum-Finney eta/. 
also transduced cells to overexpress Notch1 and found that they could maintain HSCs 
with repopulation capabilities for up to 8 months compared to cells that were not 
transduced and died within 25 days in culture. The expression ofNotch1 can also inhibit 
the differentiation of HSCs even in the presence of cytokines that normally drive 
differentiation (72). The inhibition ofNotch signaling has led to accelerated 
differentiation ofHSCs in vitro and a depletion ofthe HSC pool in vivo (281). However, 
JAG1 and Notch1 are not necessary for these processes as shown by in vivo animal 
experiments in which these proteins are knocked out indicating some redundancies in this 
family of signaling molecules (73-76). 
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Figure 5.1: Jagged-Notch signaling pathway. When Jagged binds to Notch, the intracellular 
domain of Notch is proteolytically cleaved and translocates to the nucleus where it can alter gene 
expression. Figure adapted from (283). 
5.1.2 JAGl for HSC Expansion 
JAG 1-Notch signaling has been exploited for use in the in vitro expansion of 
HSCs (1 03 , 275, 277, 284). After hematopoietic progenitor cells were cultured on 
stromal cells expressing JAG 1, they were able to form four times as many colonies as 
control cells (275). Karanu et al. added soluble JAG 1 to HSC cultures to promote 
proliferation and obtained populations of HSCs capable of in vivo reconstitution (1 03). 
Furthermore, the immobilization of JAG 1 onto micro beads has been shown to promote 
the expansion of primitive HSC colonies in vitro (277, 284), 
These studies show the potential for using JAG 1 in an ex vivo culture system. 
However, they are all limited to some extent. The use of a stromal cell feeder layer 
triggers many signaling pathways that make the system difficult to control. Soluble 
factors are cleared quickly and must be constantly replenished into the media. 
Immobilizing the proteins on a sepharose bead addresses these issues, but it does not 
allow the complex tunability that is available in the PEG hydrogel system. The following 
work investigates how the incorporation of JAG 1 onto PEG hydrogel surfaces affects 
HSC behavior. 
5.2 Materials and Methods 
All materials were obtained from Sigma unless otherwise noted. 
5.2.1 Polymer Synthesis and Characterization 
5.2.1.1 PEG-DA, PEG-RGDS, PEG-CSJ 
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PEG-DA, PEG-CSI, and PEG-RGDS were synthesized as previously described 
(Sections 2.2.1.1 and 2.2.1.3). PEG-RGDS made using the PEG-SV A derivative was 
employed for these studies. 
5.2.1.2 PEG-JAGJ 
PEG-JAG 1 was synthesized following the same methods as the production of 
PEG-SCF and PEG-SDF1a (Sections 3.2.1 and 4.2.1). A chimeric protein composed of 
the extracellular domain of rat JAG 1 and the Fe portion of the human lgG1 antibody 
(R&D) was reacted with PEG-SVA at a molar ratio of84.7:1 (PEG-SVA: JAG1) 
overnight in PBS (pH= 8.0) at 4° C. The extracellular domain of rat Jagged1 shows 99% 
homology with the murine extracellular domain. 
To confirm PEGylation, a Western blot was conducted on the PEGylated and 
naturally occurring forms of the proteins using a 15% Tris-HCl precast polyacrylamide 
gel. A primary rabbit polyclonal antibody to rat JAG 1 (Abeam) and a secondary goat 
polyclonal antibody against rabbit lgG conjugated with horseradish peroxidase (Abeam) 
were used to stain the blot. To detect the proteins, the ECL chemiluminescent Western 
blotting analysis system was applied, and chemiluminescent images of the blot were 
taken using an LAS 4000. 
5.2.1.3 Bioactivity of PEG-JAGJ 
To determine if the activity of the protein was maintained after PEGylation, a 
functional ELISA was performed. Rat Notchl (R&D) was immobilized on 
immunoabsorbent 96 well plates at concentrations of0.5 J.tg/ml overnight at 4° C. A 
sandwich ELISA was then performed on JAG1 and PEG-JAG1 using the Rat Jagged1 
Duo Set (R&D) to determine the degree ofbinding to Notch1. 
5.2.1.4 Surface Immobilization and Quantification 
JAG 1 in combination with either RGDS or CS 1 (25 J.tg/cm2) was immobilized 
onto the surfaces of hydrogel wells at concentrations of 200 and 400 ng/cm2 using 
methods detailed in Section 2.2.2.2. To quantify the concentration of protein on the 
hydrogel surface, an ELISA was performed as previously described (Section 3.2.1.6) 
using the Rat Jagged1 Duo Set. 
5.2.2 Cell Maintenance 
5.2.2.1 Primary c-kit, lin- Cell Isolation and Culture 
Primary c-kit, lin- cells were isolated from murine whole bone marrow and 
maintained as described in Section 2.2.3.2. 
5.2.2.2 Cell Seeding into Hydrogel Wells 
c-kit lin- cells were seeded in gel wells ([JAG1]=400 ng/cm2, [RGDS]=25 
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J.tg/cm2 or ([JAG1]=400 ng/cm2, [CS1]=25 J.tg/cm2) at densities of 13,000 cells/cm2. Gel 
wells with only RGDS or CS 1 (25 J.tg peptide/cm2) served as controls. Each group 
consisted of 4 gel wells. Media was added around gels to keep them hydrated. Cells 
were kept in culture for 14 days at 37°C and 5% C02 with media renewal every 2 to 3 
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days. After culture, the cells from each group were combined so that enough cells were 
available for flow cytometry. The experiment was conducted a total of three times. 
5.2.3 Evaluation of Expanded Hematopoietic Cells 
Primary cell expansion and differentiation potential (colony forming unit assay 
and flow cytometry) were performed as previously described in Sections 2.2.4.3-2.2.4.5. 
5.2.4 Statistical Analysis 
One-way ANOVAs and Tukey's post-hoc analyses were performed to evaluate 
statistical differences between groups in all studies using a 95% probability level 
(p<0.05). 
5.3 Results and Discussion 
5.3.1 Polymer Synthesis and Characterization 
5.3.1.1 PEG-JAGJ 
To confirm JAG 1 had been successfully PEGylated, a Western blot was 
performed. Figure 5.2 shows the results of this assay. There is a band present at 180 
kDa, the molecular weight of the chimeric JAG 1 protein, in the JAG 1 lane. In the PEG-
JAG 1 lane, a smear can be seen with an increased molecular weight. This indicates 
successful PEGylation of JAG 1. 
PEG- JAG1 MW JAG1 kDa 
Figure 5.2: Western blot of PEG-JAG1. There is an increase in molecular weight (MW) after 
the conjugation reaction indicating that JAG1 has been successfully PEGylated . The smear 
occurs as a result of multiple PEG chains reacting with the protein. 
5.3.1.2 Bioactivity of PEG-JAGJ 
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A functional ELISA was conducted to determine the activity of PEG-JAG 1. The 
PEG-JAG 1 demonstrated the ability to bind successfully to Notch1 as indicated by a 
detectable colorimetric change upon completion of the ELISA. However, the change was 
quite low and suggests that PEGylation may have affected the activity of the protein. In 
future work, this assay will require optimization to accurately quantify the degree of 
JAG 1 :Notch1 binding. 
5.3.1.3 Quantification of JA Gl on Gel Surfaces 
An ELISA was used to quantify the concentration of JAG 1 on the hydrogel 
surfaces. Approximately 99% of the solution that was added to the gel was covalently 
immobilized onto the surface resulting in approximately 87.92 ± 1.27 ng of JAG1 on 
each well surface. 
5.3.2 Primary Cell Expansion 
c-kit, lin- cells were cultured in hydrogel wells for 14 days. Figure 5.3 shows 
phase contrast images of cells at varying timepoints during culture. The cells mostly 
remain rounded. At early timepoints, cells are evenly distributed, but over time, the cells 
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cluster together in the center of the gel well. 
CS1 + JAG1 RGDS + JAG1 
... 
Day 1 
Day? 
Day 13 
Figure 5.3: c-kit+, lin· cells on hydrogel surfaces modified with JAG1 and CS1 or RGDS. 
Primary cells were cultured for 14 days in hydrogel wells. The images show an increase in cell 
number over time indicating cell proliferation. (Scale bars= 100 1-Jm) 
The expansion of c-kit, lin- cells was quantified by calculating the percent 
change between initial cell number and final cell number at day 14 (Figure 5.4 ). This 
data shows no significant changes in cell number with the addition of JAG 1 to gel 
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surfaces. The percent change in all groups is approximately 4000%. 
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Figure 5.4: Total cell expansion on bioactive hydrogel surfaces functionalized with JAG1 
after 2 weeks in culture. There was not a significant effect on cell expansion when JAG1 was 
added to the surfaces. Bars are mean± standard deviation. (n=3) (R=RGDS, C=CS1) 
Previous work has demonstrated the ability to add JAG 1 to HSC cultures through 
expression by stromal cell feeder layers and immobilization on beads to promote HSC 
expansion (275, 277, 284). However, cell expansion in response to JAG 1 in this system 
was not significantly affected, positively or negatively. One reason for this could be a 
diminished activity of the JAG 1 protein by PEGylation and subsequent immobilization 
on the hydrogel surface. The bioactivity assay suggested that the JAG 1 was somewhat 
limited in its ability to bind Notch1, and ifthis were the case, the ability of JAG1 to 
signal cell expansion through binding to Notch1 would be diminished. Another 
explanation is that the JAG 1 does not have an additive effect in combination with the 
RGDS and CS 1 peptides. A survey of the literature found that no previous studies had 
151 
been conducted with both JAG 1 and either of these peptides (or FN) for the purposes of 
HSC expansion or maintenance. The addition ofRGDS or CS1 to the surface was shown 
to promote expansion compared to FN plates and PEG-DA in Chapter 2, and the cell 
expansion observed in response to these peptides might mask any effects that JAG 1 has 
on the culture. This was seen previously in Chapters 3 and 4 where high RODS 
concentrations masked the effects ofSCF and SDF1a on 32D cell adhesion and 
spreading. 
In addition, the heterogeneity of the initial cell population could have lead to 
increases in some cell populations with corresponding decreases in others even though 
the total cell expansion was not increased compared to controls. Some studies have 
demonstrated that JAG1 does not promote significant HSC expansion (103, 278). Its 
main effect was the ability to retain HSCs in a more quiescent, undifferentiated state. A 
great deal of work has shown that triggering the JAG 1-Notch signaling pathway can 
prevent HSC differentiation (72, 103, 278, 279, 281, 282). Therefore, the differentiation 
potential of the cell populations on hydrogels was also evaluated after two weeks in 
culture. 
5.3.3 Primary Cell Differentiation 
5.3.3.1 Colony Forming Unit Assay 
To first evaluate the differentiation potential of the expanded c-kit, lin- cells, a 
colony assay was conducted. After expansion, primary cells were cultured in 
methylcellulose media for 10-14 days, and the colonies that formed were counted and 
scored. Four types of colonies were evaluated: CFU -G, -M, -GM, and -GEMM 
(G=Granulocyte, M=Macrophage, GM=Granulocyte, Macrophage, and 
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GEMM=Granulocyte, Erythrocyte, Macrophage, Megakaryocyte). As shown in Figure 
5.5, similar number of colonies formed from cells cultured in all groups, ranging from 
around 70 from cells cultured on CS 1 +JAG 1 functionalized gels to 90 on the CS 1 only 
control. 
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Figure 5.5: Colony formation from cells expanded on gels with surface immobilized JAG1. 
There is no significant difference in colony formation between groups. With the addition of JAG1 
to the RGDS surface, there were more primitive GM and GEMM colonies than the other groups. 
In the CS1 +JAG1 group, the highest number of GEMM colonies formed. Bars are mean, n=2. 
(R=RGDS, C=CS1 ; CFU-GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, 
CFU-GM=Granulocyte/Macrophage, CFU-G=Granulocyte, CFU-M=Macrophage) 
The cells cultured on hydro gels functionalized with both RGDS and JAG 1 formed the 
most primitive GM and GEMM colonies, whereas in the CS 1 and JAG 1 group, the most 
GEMM colonies formed. This can be seen more clearly in Figure 5.6, which displays a 
distribution of the colonies that grew as a percentage of the total number of colonies, and 
Figure 5.7, which shows individual colony formation for each group. 
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Figure 5.6: Distribution of colonies formed from cells expanded on gels with surface 
immobilized JAG1. The percentage of primitive colonies (both GM and GEMM) is highest in the 
RGDS and JAG1 group. The addition of JAG1 also seems to promote the formation of the most 
primitive, GEMM colonies in combination with CS1. Bars are mean, n=2. (R=RGDS, C=CS1 ; 
CFU-GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, CFU-
GM=Granulocyte/Macrophage, CFU-G=Granulocyte, CFU-M=Macrophage) 
These results suggest that the addition of JAG 1 to the surfaces of the hydrogels is helping 
to maintain the HSCs in a more primitive state. However, none of the differences 
between the groups were significant. This can be attributed to a small sample size as well 
as diversity amongst the primary cell populations that were used. Flow cytometric 
analysis was done on the cells to further confirm and better quantify these results. 
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Figure 5.7: Individual colony formation organized by colony type from cells expanded on 
JAG1 functionalized hydrogels. The addition of JAG1 increases GEMM formation in 
combination with CS1 and GM formation with RGDS. Concurrently, there is an increase in M 
formation on gels with only RGDS or CS1. However, none of the differences were statistically 
significant. Bars are mean ±standard deviation, n=2. (R=RGDS, C=CS1; A. CFU-
GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, B. CFU-
GM=Granulocyte/Macrophage, C. CFU-G=Granulocyte, D. CFU-M=Macrophage) 
5.3.3.2 Flow Cytometry 
Flow cytometry was employed to evaluate the expression of specific surface 
markers by primary cells after the culture period. The pattern of expression was then 
compared to the initial expression of these molecules to determine differences between 
the initial and final cell populations. The total cell number was taken into account to 
consider the absolute changes in the population. Cells were stained with c-kit, Seal, and 
a cocktail of lineage markers. 
Representative plots from the analysis (one sample) can be seen in Figures 5.8 
and 5. 9. These data show that there is an increase in the expression of lineage markers 
and a decrease in the expression of c-kit and Seal markers after 14 days in culture as 
compared to immediately following sorting (Figure 2.11 ). 
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Figure 5.8: Flow cytometry analysis of c-kit+, lin· cells after 14 days in culture on hydrogels 
functionalized with PEG-RGDS and PEG-JAG1. A. Particles were gated to count cells. B. 
Cells were then gated to count those that were lineage negative (lin-). C. A plot of all cells gated 
for expression of Sca1 and c-kit. D. A plot of lineage negative cells gated similarly to C. Axes 
without units are relative fluorescent intensity. Numbers on the plots denote the percentage of 
cells within that specific gate. 
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Figure 5.9: Flow cytometry analysis of c-kit, lin· cells after 14 days in culture on hydrogels 
functionalized with PEG-CS1 and PEG-JAG1. A. Particles were gated to count cells. B. Cells 
were then gated for expression of lineage markers. C. A plot of all cells gated for positive or 
negative expression of Sca1 and c-kit. D. A plot of lineage negative cells gated similarly to C. 
Axes without units are relative fluorescent intensity. Numbers on the plots denote the percentage 
of cells within that specific gate. 
This data correlates with what has been observed previously in the culture system with 
SCF and SDF1a in Chapters 3 and 4. However, as can be seen in Figure 5.10, there is an 
increase in the c-kit+, lin· population from gels functionalized with both RGDS and JAG 1 
that is higher than RGDS alone, and there is a slight increase in this population on gels 
with CS1 and JAGl. The same trend is seen with the KSL population (Figure 5.11), and 
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these observations correlate with the results of the colony assay. Though none of the 
increases is statistically significantly, the fact that similar results were obtained from the 
two assays suggests that JAG 1 is helping to keep cells in a more primitive state. 
1400 
1200 
~ 
G) 
.Q 
E 
:::s 1000 z 
"i (J 
.5 800 
+ 
-:i2 
I 
u 
.5 600 
CP 
0) 
c 
ca 
.r:. 400 (J 
-c G) 
~ 
Q) 200 a. 
0 ' - r 
RGDS R+JAG1 CS1 C+JAG1 
Figure 5.10: Increase in c-kit•, lin· population during 14 days in culture on gels 
functionalized with JAG1. The addition of JAG1 to gel surfaces resulted in slight increases to 
the c-ki( lin- population compared to the peptides alone. However, neither of the differences was 
significant. Data is displayed as mean± standard deviation . (n=3) (R=RGDS, C=CS1) 
JAG 1 has been shown in previous work to be capable of maintaining HSCs when 
added to culture media or immobilized on beads (275, 277, 284). Though some work has 
shown the ability to utilize JAG 1 for HSC expansion, other contradictory work shows 
relatively little effect on HSC proliferation (1 03 , 278). 
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Figure 5.11: Expansion of the primitive KSL population on gels with covalently 
immobilized JAG1. On gels with RGDS and JAG1 , the primitive KSL population increased 
compared to controls with RGDS alone. On gels with CS1 and JAG1, there was also an increase 
in the KSL population compared to controls with CS1 alone. However, the increases were not 
calculated to be significant. Data is displayed as mean+ standard deviation. (n=3) (R=RGDS, 
C=CS1) 
In one study, cells were cultured in media containing JAG 1. JAG 1 did not affect cell 
expansion compared to controls but the cells cultured in media with JAG 1 were capable 
of repopulation in irradiated hosts (103). In a similar study, Walker et al. cultured HSCs 
on a feeder layer of stromal cells expressing JAG 1. HSCs cultured in these conditions 
did not expand significantly but were retained in an undifferentiated state (278). The 
culture of HSCs on hydrogel wells functionalized with JAG 1 supports these findings. 
The addition of JAG 1 to the gel surfaces did not significantly alter the proliferation of the 
HSCs compared to controls. It did, however, result in cell populations that were able to 
both form primitive colonies and express specific markers that denote HSC populations. 
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5.4 Conclusions 
JAG 1-Notch signaling within the HSC niche has been shown to play a role in the 
maintenance of HSCs. To recapitulate this interaction, JAG 1 was successfully 
PEGylated while retaining its bioactivity. The PEGylated protein was surface 
immobilized onto hydrogel wells in combination with RGDS or CS 1 and the effects of 
JAG 1 on HSC expansion and differentiation were evaluated. Though the total cell 
expansion was not affected by the incorporation of JAG 1 into the hydrogel matrix, there 
were increases in the absolute numbers of cells within primitive HSC populations. These 
results suggest that hydrogel wells with covalently immobilized JAG 1 are capable of 
maintaining the HSCs in an undifferentiated state through signaling via the Notch 
receptor expressed on HSC membranes. The ability to maintain HSCs ex vivo utilizing 
the hydrogel system could greatly benefit HSC research field by enabling the generation 
of large HSC populations as well as providing a way to study basic HSC biology. 
Chapter 6: Hematopoietic Stem Cell Behavior in Hydrogel Wells 
Functionalized with IFNy 
6.1 Background 
Interferon-y (IFNy) is known to play a significant role in the immune system. 
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Recent studies have shown that it can influence HSC behavior, specifically proliferation 
and differentiation. As opposed to previous work detailed in this thesis that was 
dedicated to preserving the multi potency of HSCs, the following studies investigate the 
ability to use IFNy to promote HSC differentiation. The ability to trigger differentiation 
along specific pathways using PEG hydrogel wells would broaden the clinical 
applicability of the system. In the following work, IFNy was functionalized onto 
hydrogel well surfaces and its effects on primary HSC proliferation and differentiation 
were evaluated after 14 days in culture. 
6.1.1 Interferon y 
IFNy is part of a larger interferon family that was first discovered in 1957 due to 
its ability to impede viral replication (285, 286). IFNy is an inflammatory cytokine 
produced by T helper cells to help regulate immune responses to infection (287). The 
overexpression of IFNy has been linked to several anemic diseases though the mechanism 
through which this occurs is still under investigation (92). IFNy binds to a heterodimeric 
receptor on the surfaces of hematopoietic cells, interferon gamma receptors 1 and 2, and 
stimulates the Jak/Stat signaling pathway (92) (Figure 6.1 ). 
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Figure 6.1: Structure of IFNy and its receptor. A. The crystal structure of IFNy complexed with 
its heterodimeric receptor (IFNy Receptors 1 and 2, IFNGR1-2). Image adapted from (288) B. 
The signaling cascade triggered by the binding of IFNy with IFNGR1-2. Upon this binding, Jak1/2 
phosphorylate Stat1, which forms a homodimer and translocates to the nucleus where it can 
promote/suppress gene expression. Image adapted from (92). 
IFNy is considered a negative hematopoietic regulator and has been shown to aid 
in myeloid and lymphoid homeostasis by inhibiting overproduction (289, 290). Typically 
this results in a suppression ofhematopoiesis or in cell apoptosis (291-295). In some 
hematopoietic populations, IFNy has been shown to promote differentiation, specifically 
down myeloid pathways (92, 296, 297). In contrast, IFNy can also promote the 
proliferation of primitive hematopoietic stem cells in vivo and in vitro, particularly in 
combination with other cytokines and growth factors. As a result, it has been 
investigated for use in ex vivo expansion systems. 
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6.1.2 IFNy for HSC Expansion 
IFNy can stimulate the proliferation ofHSCs and in vitro hematopoiesis when 
added to culture media (93, 287, 296, 298-302). This effect is typically seen in 
conjunction with other cytokine cocktails where the presence of IFNy can augment cell 
proliferation but does not promote it singularly. For example, Hwang et al. demonstrated 
that the addition of IFNy could rescue cells from apoptosis and enhance HSC growth but 
only in the presence of SDF1a (296). Shiohara et al. (1993, 1994) observed similar 
effects with SCF. When SCF and IFNy were added together to an in vitro culture, there 
was an increase in the development of both primitive and mature hematopoietic 
populations (298, 299). These results suggest that IFNy can play a dual role in the 
hematopoietic system, triggering both proliferation and apoptosis depending on other 
signaling factors that are present. 
Zhao et al. and Baldridge et al. both demonstrated that long-term repopulating 
HSC (LT -HSC) populations can be triggered to proliferate by the addition of exogenous 
IFNy to in vitro cultures (93, 287). In addition, Baldridge et al. injected IFNy into mice 
and subsequently collected whole bone marrow for transplantation (93). They observed 
an increase in in vivo L T-HSC number in donor mice, but a reduced ability of these cells 
to engraft in transplant recipients. Other studies have also demonstrated that this increase 
in proliferation is accompanied by the differentiation of the cells (287, 297). Due to its 
ability to act on primitive HSC populations, IFNy was immobilized onto the surfaces of 
hydrogel wells in an attempt to drive HSC proliferation and differentiation. The ability to 
better control and understand these processes can aid in the design of an expansion 
system with clinical relevance. 
6.2 Materials and Methods 
All materials were obtained from Sigma unless otherwise noted. 
6.2.1 Polymer Synthesis and Characterization 
6.2.1.1 PEG-DA, PEG-RGDS, PEG-CS1 
PEG-DA, PEG-CS1, and PEG-RGDS were synthesized as aforementioned 
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(Sections 2.2.1.1 and 2.1.1.3). PEG-RGDS made using PEG-SV A was utilized in these 
studies. 
6.2.1.2 PEG-IFN'f 
PEG-IFNy was synthesized with the methods used in the production ofPEG-SCF, 
PEG-SDF1a, and PEG-JAG1 (Sections 3.2.1.3, 4.2.1.2, 5.2.1.2). Murine IFNy (R&D) 
was reacted with PEG-SVA at a molar ratio of 100:1 (PEG-SVA: IFNy) in PBS (pH= 
8.0) at 4° C overnight. To confirm PEGylation, a Western blot was performed on the 
PEGylated and naturally occurring forms of the proteins using a 15% Tris-HCl precast 
polyacrylamide gel. A primary rabbit polyclonal antibody to murine IFNy (Abeam) and a 
secondary goat polyclonal antibody against rabbit lgG conjugated with horseradish 
peroxidase (Abeam) were used to stain the blot. To detect the stained proteins, the ECL 
chemiluminescent Western blotting analysis system was applied, and chemiluminescent 
images of the blot were taken using an LAS 4000. 
6.2.1.3 Bioactivity of PEG-IFN1 
To evaluate the activity ofiFNy after PEGylation similar methods were used as 
when determining the activity ofPEG-SCF in Section 3.2.2. 32D cells were seeded into 
TCPS plates at a density of 5,000 cells/cm2 in three formulations of media: control media 
(RPMI-1640 with 10% IL-3 supplement), control media with IFNy (200 ng/ml) and 
control media with PEG-IFNy (200 ng IFNy/ml). The cells were imaged at 24 hand 5 
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days. The number of cells at each timepoint was counted using ImageJ software as 
described in Section 2.2.4.1, and the percent increase in 32D cell number was quantified. 
6.2.1.4 Surface Immobilization and Quantification 
PEG-DA hydrogel wells were functionalized with IFNy at concentrations of200 
and 400 ng/cm2 in combination with either RODS or CS 1 (25 J.Lg/cm2) as previously 
described (Section 2.2.2.2). To quantify the concentration ofiFNy on the gel surface, an 
ELISA was conducted as explained in Section 3.2.1.6 using the mouse IFNy Quantikine 
ELISA Kit. 
6.2.2 Cell Maintenance 
6.2.2.1 Primary c-kit, lin- Cell Isolation and Culture 
Primary c-kit, lin- cells were isolated from murine whole bone marrow and 
maintained as described in Section 2.2.3.2. 
6.2.2.2 Cell Seeding into Hydrogel Wells 
c-kit lin- cells were seeded in gel wells ([IFNy]=400 nglcm2, [RGDS]=25 J.Lg/cm2 
or ([IFNy]=400 ng/cm2, [CS1]=25 J.Lg/cm2) at densities of 13,000 cells/cm2 in volumes of 
10 J.Ll. Gel wells with only RODS or CS 1 (25 J.Lg peptide/cm2) served as controls. Each 
group consisted of 4 gel wells. Media was added around gels to keep them hydrated. 
Cells were kept in culture for 14 days at 3 7°C and 5% C02 with media renewal every 2 to 
3 days. After culture, the cells from each group were combined so that enough cells were 
available for flow cytometry. The experiment was conducted a total of three times. 
6.2.3 Evaluation of Expanded Hematopoietic Cells 
Primary cell expansion and differentiation potential (colony forming unit assay 
and flow cytometry) were assessed as stated in Sections 2.2.4.3-2.2.4.5. 
165 
6.2.4 Statistical Analysis 
One-way ANOVAs and Tukey's post-hoc analyses were performed to evaluate 
statistical differences between groups in all studies using a 95% probability level 
(p<0.05). 
6.3 Results and Discussion 
6.3.1 Polymer Synthesis and Characterization 
6.3.1.1 PEG-IFN"' 
To determine ifiFNy was successfully PEGylated, a Western blot was conducted. 
Figure 6.2 shows an image of the blot after staining. There is a band in the IFNy lane at 
12-15 kDa that reflects the molecular weight of the monomer and band near 30 kDa that 
represents the IFNy dimer. In the PEG-IFNy lane, there is a smear beginning at 25 kDa. 
The increase in molecular weight indicates that the protein has been PEGylated with 
multiple PEG chains. 
MW 
(kDa) 
250 
150'--....., 
100--
75--
50--
37--
25--
166 
PEG-
IFNy IFNy 
Figure 6.2: Western blot image of IFNy. There is an increase in molecular weight (MW) after 
the conjugation reaction indicating that IFNy has been successfully PEGylated. The smear 
occurs as a result of multiple PEG chains reacting with the protein. The MW of IFNy is -12-15 
kDa. 
6.3.1.2 Bioactivity of PEG-IFNr 
To assess the activity of the protein after PEGylation, 32D cells were cultured in 
control media as well as media containing 200 ng/ml IFNy or PEG-IFNy. After 5 days in 
culture, the percent change in cell number was calculated. Cells proliferated significantly 
in media containing IFNy or PEG-IFNy when compared to the control media (Figure 
6.3). In addition, there was no significant difference between the percent changes in cell 
number in the IFNy and PEG-IFNy groups. These results demonstrate that the 
PEGylation of the protein did not significantly affect its activity. 
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Figure 6.3: Bioactivity of PEGylated IFNy. 320 cells were cultured in control media and in 
media containing 200 ng/ml IFNy or PEG-IFNy. There was a significant increase in the percent 
change in cell number in wells with either IFNy or PEG-IFNy compared to control media. There 
was not a significant difference between IFNy and PEG-IFNy. Bars are mean± standard 
deviation. (*denotes significance compared to control, n=8, p < 0.05) 
6.3.1.3 Quantification of Surface IFNr 
An ELISA was used to quantify the percentage of IFNy that was not conjugated to 
the hydrogel surface, and the surface concentration was back calculated from this data. 
Approximately 99% of the PEGy lated protein that was added to the gel was covalently 
immobilized onto the surface resulting in 87.26 ± 0.213 ng of IFNy on each hydrogel 
well surface. 
6.3.2 Primary Cell Expansion 
One of the main objectives of an in vitro HSC culture system is the promotion of 
HSC self-renewal. To monitor c-kit, lin- cell expansion on hydrogels functionalized 
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with IFNy, phase contrast images were taken at varying timepoints throughout the 2 week 
culture period (Figure 6.4). Cell proliferation is sustained on both gel surfaces containing 
IFNy, but it appears that the cells proliferated to a greater extent on surfaces containing 
both RGDS and IFNy. The cells maintain their rounded shape and remain approximately 
10 Jlm in diameter. The percent change in cell number was quantified by counting the 
final cell number from each group and comparing it to the initial number (Figure 6.5). 
This data correlates with the phase contrast images, showing a significant increase in cell 
number on gels with surface immobilized RGDS and IFNy compared to all other groups. 
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Figure 6.4: c-kit+, lin- cells on hydrogels functionalized with IFNy and RGDS or CS1. Cells 
proliferated extensively within gel wells with both RGDS and IFNy, as indicated by increasing 
number of cells present in the field of view over time. Scale bars = 100 ~m. 
Traditionally, IFNy has been regarded as a negative regulator of hematopoiesis 
and a cytokine that often triggers apoptosis (92, 291, 303). In contrast, several groups 
have shown success in using IFNy to stimulate hematopoietic cell proliferation (93, 287, 
296-302). Interestingly, most studies that report HSC proliferation are performed with 
other cytokines, such as SDFla, SCF, IL-3 or TPO, present in the media. Shiohara et al. 
(1993 , 1994) have shown that the combination of soluble SCF and IFNy can work 
together to promote HSC expansion (298, 299). 
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Figure 6.5: Total cell expansion on hydrogel surfaces with immobilized IFNy after 2 weeks 
in culture. There was a significant increase in cell expansion on gels with both RGDS and IFNy 
compared to all other samples. Bars are mean ± standard deviation. (R=RGDS, C=CS1 ; RGDS, 
*denotes significance compared to all other groups, n=3, p < 0.05) 
The results described in this chapter support these findings; primary cells were cultured 
on hydro gels functionalized with IFNy in media containing soluble SCF. The cells 
proliferated significantly in gel wells in response to the IFNy and RGDS on the surfaces. 
However, when IFNy was added to gel wells with CS 1, there was no significant effect on 
cell proliferation. This is similar to what was observed with SCF and CS1 in Chapter 3. 
When in combination with RGDS, cells on gels functionalized with SCF and IFNy 
proliferate extensively, but this does not occur when the proteins are immobilized with 
CS 1. Previous work has shown differing effects of binding via the a4~ 1 integrin, the 
171 
integrin that binds to the CS 1 portion of fibronectin. Kapur et al. found that binding via 
the a4P 1 integrin led to the apoptosis of erythrocyte progenitor cells, while binding with 
the a5P1 integrin led to cell survival and proliferation (247). However, other studies 
have shown hematopoietic cell proliferation in response to binding via both integrins 
(122, 191). Additionally, HSC culture on CS1 has resulted in cells that were less 
differentiated when compared to RGDS (122, 125). This was also seen in Chapter 4 
where cells cultured on gels modified with a combination ofCS1 with SDF1a. It is 
unclear why HSCs in the culture system do not proliferate in response to cytokines such 
as SCF and IFNy when they are cultured on surfaces with immobilized CS 1 as 
significantly as when these cytokines are immobilized in combination with RGDS. It is 
possible that adhesion to CS 1 is helping to retain HSCs in a quiescent state, which in 
turn, slows their proliferation rate. To better characterize the cells expanded in hydrogel 
wells with surface immobilized IFNy, a colony forming assay and flow cytometric 
analysis of stem cell surface markers were performed. 
6.3.3 Primary Cell Differentiation 
6.3.3.1 Colony Forming Unit Assay 
The colony assay was conducted as a functional assay to determine which 
pathways the expanded cells could differentiate down. Four types of colonies were 
evaluated: CFU -G, -M, -GM, and -GEMM. Figure 6.6 shows the colonies that formed 
from the expanded cells as a function of the hydrogel surface. 
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Figure 6.6: Colony formation from cells expanded on gels with surface immobilized IFNy. 
The group with both RGDS and IFNy formed the most colonies. There is also appears to be an 
increase in total primitive colonies on RGDS and IFNy compared to RGDS and a decrease in the 
formation of these colonies on CS1 and IFNy. Bars are mean, n=2. (R=RGDS, C=CS1; CFU-
GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, CFU-
GM=Granulocyte/Macrophage, CFU-G=Granulocyte, CFU-M=Macrophage) 
Cells expanded in gel wells functionalized with RGDS and IFNy formed the highest 
number of colonies: 100 colonies/1 04 cells, and CS 1 and IFNy formed the lowest around 
75 colonies/104 cells. Figures 6.7 shows the colony distribution per group displayed as a 
percentage of the total colony formation. 
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Figure 6.7: Distribution of colonies formed from cells expanded on gels with surface 
immobilized IFNy. The percentage of primitive colonies (both GM and GEMM) is not significantly 
different between any of the groups. However, the addition of IFNy appears to limit the formation 
of the most primitive GEMM colonies. Bars are mean, n=2. (R=RGDS, C=CS1; CFU-
GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, CFU-
GM=Granulocyte/Macrophage, CFU-G=Granulocyte, CFU-M=Macrophage) 
Though the percentage of GM and GEMM colonies appears to be relatively similarly 
between all groups, there is a slight decrease in GEMM formation from cells cultured on 
hydro gels with surface immobilized IFNy in both the RGDS and CS 1 groups. This can 
be seen more clearly in Figure 6.8 where individual colony data is displayed. Though 
none of the differences are significant, these results suggest that IFNy is triggering 
differentiation to some extent. Primitive GM colonies are still forming, but there is a loss 
in the ability to form the most primitive GEMM colonies compared to controls without 
IFNy. 
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Figure 6.8: Individual colony formation organized by colony type from cells expanded on 
IFNy functionalized hydrogels. The addition of IFNy decreased GEMM formation in 
combination with CS1 and RGDS. There was a slight increase in GM formation on RGDS with 
IFNy, but on CS1 and IFNy this number decreased. Bars are mean± standard deviation. (n=2) 
(R=RGDS, C=CS1; A. CFU-GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage, 
B. CFU-GM=Granulocyte/Macrophage, C. CFU-G=Granulocyte, D. CFU-M=Macrophage) 
6.3.3.2 Flow Cytometry 
To further confirm these results, flow cytometry analysis was performed to 
quantify the expression of specific surface markers known to denote primitive HSC 
populations. Cells were stained for c-kit, Seal , and lineage markers. Figures 6.9 and 
6.10 show representative plots of the flow cytometry data. Similarly to previous work in 
the hydrogel system, there is a decrease in the percentage of total cells that are lin- and c-
kit+. However, this decrease does not seem to be as extensive as with other proteins. 
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Figure 6.9: Flow cytometry analysis of c-kit+, lin- cells after 14 days in culture on hydrogels 
functionalized with PEG-RGDS and PEG-IFNy. A. Particles were gated to count cells. B. Cells 
were then gated to count those that were lineage negative (l in-). C. A plot of all cells gated for 
expression of Sca1 and c-kit. D. A plot of lineage negative cells gated similarly to C. Axes without 
units are relative fluorescent intensity. Numbers on the plots denote the percentage of cells 
within that specific gate. 
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Figure 6.10: Flow cytometry analysis of c-kit+, lin- cells after 14 days in culture on 
hydrogels functionalized with PEG-CS1 and PEG-IFNy. A. Particles were first gated to count 
cells. B. Cells were then gated for those that did not express lineage markers. C. A plot of all 
cells gated for positive and negative Sca1 and c-kit markers. D. A plot of lineage negative cells 
gated similarly to C. Axes without units are relative fluorescent intensity. Numbers on the plots 
denote the percentage of cells within each gate. 
Figure 6.11 shows the percent change in the number of c-kit+, lin- cells during the 
14 day culture. c-kit, lin- cells cultured on gels with RODS and IFNy expanded 
significantly compared to all other groups. Cells cultured on gels with CS 1 and IFNy 
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showed a slight increase in the c-kit, lin- population compared to CS1 alone though this 
change was not significant. 
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Figure 6.11: Increase inc-kit+, lin· population during 14 days in culture on gels 
functional ized with IFNy. The addition of IFNy to surfaces with RGDS significantly increased 
the total population of c-ki( lin- cells. There was also a slight increase in cell number on gels with 
the combination of CS1 and IFNy, though this change was not significant. Data is displayed as 
mean ± standard deviation. (R=RGDS, C=CS1; * denotes significance compared to all other 
groups, n=3, p < 0.05) 
The percent changes in the primitive KSL population ofHSCs can be seen in Figure 6.12. 
The KSL population increased significantly on samples with both RODS and IFNy 
compared to all other groups. However, the combination of CS 1 and IFNy did not 
demonstrate a significant change in the KSL population though it was slightly higher than 
CS1 alone. 
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Figure 6.12: Expansion of the primitive KSL population on gels with covalently 
immobilized IFNy. On gels with RGDS and IFNy, the primitive KSL population increased 
significantly compared to all other groups. On gels with CS1 and IFNy, there was also an 
increase in the KSL population compared to controls with CS1 alone, though this change was not 
significant. Data is displayed as mean+ standard deviation. (R=RGDS, C=CS1; *denotes 
significance compared to all other groups, n=3, p < 0.05) 
These results are somewhat counterintuitive when taking the colony results into 
account. Previous work has demonstrated that IFNy triggers differentiation during in 
vitro culture (93 , 292, 297). Baldridge et a!. showed that cells expanded in vivo with 
IFNy showed a reduced ability to engraft (93). Yang eta!. also showed that IFNy could 
trigger HSC proliferation but led to differentiation (297). The CFU assay results support 
these findings. Cells expanded on gel surfaces with surface immobilized IFNy showed a 
reduced ability to form GEMM colonies. However, the flow cytometry data shows a 
significant increase in the KSL population when cells were grown on IFNy functionalized 
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hydrogels. This suggests that IFNy can prevent the differentiation of the HSCs. 
However, we do not see the same result on surfaces with IFNy and CS1; the percent 
change in the KSL population is minimal, though greater than on control gels with CS 1 
only. This supports the results from the CFU assay and suggests that the hypothesis that 
the combination of CS 1 and IFNy prevents differentiation is inaccurate. 
The conflicting colony and flow cytometry data for samples with RGDS and IFNy 
is likely because the two assays evaluate distinct cell properties. The colony assay 
evaluates HSC functionality whereas the flow cytometric analysis assesses the expression 
of primitive surface markers. Baldridge et al. demonstrated that while they were able to 
expand the KSL population, the cells showed reduced engraftment potential (93). The 
cells maintained their expression of the primitive KSL markers but they were no longer 
able to home to the bone marrow and repopulate the immune system upon 
transplantation. This indicates that they have started down the differentiation pathway. 
This is similar to what I observed. Cells expanded on IFNy and RGDS still expressed the 
primitive surface markers but were unable to form GEMM and GM colonies that are 
composed of more than one colony. This demonstrates a reduced ability to differentiate 
down multiple pathways. These results show that the functionalization of the hydrogel 
with IFNy can drive and support differentiation, which makes the system more versatile 
and could lead to the generation of more mature blood cell populations. However, the 
somewhat contradictory results of the colony assay and flow cytometry analysis 
emphasize the need to conduct multiple in vitro and in vivo assay to characterize the cell 
populations grown within the hydrogel wells. 
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6.4 Conclusions 
IFNy has been used successfully to promote HSC expansion at the expense of 
driving HSC differentiation. This work demonstrated the ability to PEOylate IFNy while 
retaining its activity. Primary c-kit+, lin- cells were cultured in hydrogel wells 
functionalized with IFNy and either RODS or CS 1 for two weeks. Cells expanded on 
gels with surface immobilized RODS and IFNy showed significant cell proliferation 
compared to controls. In contrast, the combination of CS 1 and IFNy did not promote cell 
proliferation. Though the cells cultured on RODS and IFNy showed high percent 
changes in both the c-kit, lin- and KSL populations, the colony data demonstrated the 
inability of these cells to form primitive OEMM colonies. These results show the 
versatility of the hydrogel system. In the previous chapters, bioactive factors were added 
in an attempt to retain the differentiation potential of HSCs. In contrast, the work in this 
chapter functionalized the hydrogel surface with a cytokine known to initiate 
differentiation and triggered the cells to begin this process. 
Chapter 7: Encapsulation of Hematopoietic Stem Cells in Bioactive 
Degradable Hydrogels 
7.1 Background 
The ability to recapitulate the bone marrow microenvironment in three 
dimensions has the potential to maintain HSCs in culture for long periods because a 
three-dimensional system would better represent the native bone marrow architecture. 
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This chapter focuses on the translation of the two-dimensional hydrogel well system into 
a three-dimensional biomimetic hydrogel. In preliminary, proof-of-concept studies, 
primary c-kit hematopoietic cells were encapsulated within protease sensitive hydrogels 
and viability was assessed after encapsulation. After culture for 2 or 4 weeks, hydrogels 
were degraded to retrieve the hematopoietic cells and the differentiation potential of the 
cells was evaluated. 
7.1.1 Cell Encapsulation within Degradable PEG Hydrogels 
Poly( ethylene glycol) hydro gels can be rendered enzymatically biodegradable by 
flanking a degradable peptide sequence, targeted to a specific enzyme, with 
monoacrylated PEG chains (167, 183). The PEG chains can subsequently be 
photopolymerized to form a hydrogel that has protease sensitive molecules within its 
matrix. Cells can also be included in the prepolymer solution and become entrapped 
within the hydrogel matrix during polymer crosslinking (See Figure 2.3). Several 
protease sensitive peptide sequences have been studied and characterized. Patterson et a/. 
(2010, 2011) studied the ability ofthree proteases to degrade an array of peptide 
sequences and discovered varying degrees of sensitivity to the proteases as well as 
significant effects on degradation rate (181, 182). The selection of a peptide sequence for 
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cell encapsulation relies heavily on the application and the enzyme activity of cells that 
are being encapsulated. 
Encapsulation strategies have been used for the engineering of numerous three-
dimensional tissues ranging from the pancreas to bone (304-310). In these studies, cells 
are first entrapped within a polymer scaffold. Over time, the cells release proteases to 
gradually remodel and degrade the scaffold and create a functional tissue absent of 
synthetic components. There have been some attempts to encapsulate cells for 
hematopoietic stem cell expansion; however, most of these studies have focused on the 
encapsulation of stromal cells for HSC maintenance (11 0, 311 ). Encapsulation allows 
stromal cell-HSC signaling through soluble cytokines and prevents cell-cell contact, 
which is beneficial for clinical applications since xenogeneic stromal cells are often used. 
A couple of groups have investigated the use of encapsulation strategies for ex 
vivo HSC expansion. Levee eta/. encapsulated whole bone marrow within an alginate-
poly-L-lysine copolymer and observed total cell growth after 16-19 days in culture, 
though most ofthe cells were more differentiated hematopoietic progenitors (312). Yuan 
eta/. demonstrated the ability to encapsulate cord blood hematopoietic stem cells within 
alginate scaffolds; their results showed an improvement in hematopoietic cell expansion 
after 12 days in their three-dimensional scaffolds compared to conventional two-
dimensional cell culture (313). These studies demonstrate the ability to encapsulate 
hematopoietic cells and culture them in three dimensions. However, alginate scaffolds do 
not offer the same degree of tunability as the PEG hydrogel based system. As opposed to 
alginate scaffolds, PEG hydrogels are biologically inert. PEG gels can be rendered 
bioactive by covalently immobilizing individual biomolecules into the hydrogel matrix, 
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allowing researchers to investigate the effects of individual molecules on cell behavior 
(151). In addition, alginate scaffolds degrade slowly over time due to hydrolysis, 
whereas the degradation rate of synthetic PEG scaffolds can be tailored by the inclusion 
of specific degradable peptide sequences (151, 314). Sections 2.1.1-2.1.3 contain a more 
extensive discussion of the advantages of synthetic PEG hydro gels. 
7.1.2 Advantages of Encapsulation for HSC Expansion 
The encapsulation of HSCs within a three-dimensional hydrogel matrix mimics 
the native structure of the bone marrow cavity more accurately than two-dimensional 
culture on hydrogel surfaces. A precise recapitulation of the in vivo microenvironment 
will likely lead to the ability to maintain HSCs in ex vivo culture (32, 62). Physical 
entrapment also helps to contain these highly motile cells during culture. In two-
dimensional systems, cells frequently leave the surface and grow in suspension. 
Furthermore, encapsulation ensures HSC interaction with biomolecules covalently 
tethered to the hydrogel matrix, such as RGDS or SCF, which can help control HSC 
behavior. 
Fedorovich et al. demonstrated that photopolymerization of mesenchymal stem 
cells (MSC) within a methacrylated hyaluronic acid hydrogel did not negatively impact 
the cells' viability or differentiation potential (315). The ability to successfully 
encapsulate MSCs, which are also bone marrow derived, suggests that the 
photopolymerization process may not be harmful to HSCs. The speed of the 
photopolymerization process ensures that the cells are distributed homogenously 
throughout the scaffold. 
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The peptide sequence GGGPQGIWGQGK (PQ) was selected for incorporation 
into the PEG backbone due to its ability to be degraded by several MMPs (183). This 
peptide sequence has been successfully incorporated into PEG hydrogels to promote the 
vascularization of tissue-engineered constructs (31 0). Moon et al. encapsulated a 
coculture of endothelial cells and pericyte precursors within a degradable PEG-PQ-PEG 
hydrogel and observed degradation of the hydrogel as vascular networks formed (31 0). 
In contrast, significant degradation of the hydrogels by the HSCs is not expected 
because the encapsulated cells are retained within a synthetic niche environment and not 
stimulated by outside signals to mobilize. During homeostasis, HSCs are lodged within 
the niche and their enzymatic activity is fairly low. Matrix metalloproteinase (MMP) 
activity is upregulated during the mobilization and homing processes; specifically, MMP 
2 and 9 expression increases on mobilized hematopoietic cells (57). This allows cells to 
both exit and enter the bone marrow. After ex vivo culture, a protease solution will be 
added to the media to degrade the hydrogel and allow retrieval ofthe expanded cells for 
analysis. 
7.2 Materials and Methods 
All materials were obtained from Sigma unless otherwise noted. 
7.2.1 Polymer Synthesis and Characterization 
7.2.1.1 Peptide Synthesis 
NH2-GGGPQGtiWGQGK-COOH (PQ) was synthesized using solid-state peptide 
synthesis following the principles ofFmoc chemistry with an Apex 396 peptide 
synthesizer (AAPPTec, Louisville, KY). The arrow denotes the site of cleavage within 
the sequence. The peptide was cleaved from the resin with trifluoroacetic acid (TF A). 
The TF A was removed by rotary evaporation followed by peptide precipitation and 
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washing in diethyl ether. To confirm successful synthesis, the peptide was analyzed 
using matrix-assisted laser desorption ionization time of flight mass spectrometry 
(MALDI-ToF; Bruker Daltonics, Billerica, MA). 
7.2.1.2 PEG-PQ-PEG Synthesis 
PQ peptide was reacted with PEG-SV A at a molar ratio of 1:2.2 (PQ:PEG-SV A) 
in PBS (pH 8.0) at 4°C overnight to form PEG-PQ-PEG (Figure 7.1). The sample was 
then dialyzed against milliQ water to remove unconjugated peptide from the sample. The 
solution containing the peptide was lyophilized and then run on GPC to confirm 
successful conjugation to PEG. 
+ NHt"GGGPQGIWGQGK-COOH 
Acrylate-PEG-SVA 
0 0 
PBS 
pH =8.0 
II 
~O~~O/~'-GGGPQGIWGQGK/~,0~~ 
0 0 
Acrylete-PEG-PQ-PEG-Acrylate 
Figure 7.1: PEG-PQ-PEG synthesis. PEG-SVA is reacted with GGGPQGIWGQGK (PQ) at a 
2.2:1 molar ratio in PBS at pH 8.0 at 4 oc overnight. The resulting product is a diacrylate PEG 
chain with the degradable PQ sequence sandwiched between the two PEG segments. The site 
of degradation occurs between G and I. The acrylate groups on each end of the chain can 
crosslink together, similarly to PEG-DA, to form a hydrogel. 
7.2.1.3 PEG-Biomolecule Synthesis 
PEG -RGDS, -SCF, -JAG1, and -IFNy were all synthesized as previously 
described in Sections 2.2.1.3, 3.2.1.3, 5.2.1.2, and 6.2.1.2 respectively. 
7 .2.2 Cell Encapsulation and Maintenance 
7.2.2.1 Primary Cell Isolation and Culture 
Primary murine whole bone marrow was isolated and purified as described in 
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Section 2.2.3.2. Whole bone marrow was magnetically sorted using the EasySep® 
Mouse CD117 (cKIT) Positive Selection Kit (Stem Cell Technologies) following the 
manufacturer's protocol. Sorted cells were immediately counted and encapsulated within 
the PEG-PQ-PG hydrogel. 
7.2.2.2 Encapsulation Procedure 
A solution containing 10% (w/v) PEG-PQ and 2 mM PEG-RGDS was made in 
HBS (pH 7.4) containing 1.5% triethanolamine. PEG-SCF, PEG-JAGl, and PEG-IFNy 
were also added to individual polymer solutions at concentrations of 400 ng/ml. Eosin Y 
was added to the solution at a concentration of 10 f.1M in conjunction with 3.5 f..Ll/ml NVP 
to serve as a photoinitiator for polymer crosslinking. This solution was sterilized via 
filtration in a laminar flow hood using a 0.22 f..Lm PES syringe filter. Cells were 
centrifuged at 200 x g for 5 min. and resuspended in the polymer solution at a 
concentration of20 x 106 cells/ml. Four 10 f..Ll cell-laden polymer droplets were pipetted 
onto a Sigmacote-modified glass slide. Two 380 f..Lffi PTFE spacers were placed on the 
edges of the slide, and an untreated glass slide was rested on these spacers to sandwich 
the gel solution between the slides. The slides were clamped together and placed under a 
white light lamp (250 mW/cm2) (Fiber Lite, Dolan Jenner, Boxborough, MA) for 45 sec. 
A schematic of the process can be seen in Figure 7 .2. After crosslinking, gels were 
immediately transferred to ultra-low attachment 48 well plates with 400 f..Ll media using a 
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sterile spatula. Cells were maintained in StemSpan media supplement~d with 50 ng/ml 
soluble SCF. 
White light, 45 s 
PEG-PO-PEG 
J- PEG-Peptide 
~ , PEG-Protein 
~) HSC 
Photoinitiator 
} 
~EGchain =PO Peptide 
Figure 7.2: Encapsulation of HSCs in degradable PEG-PQ-PEG hydrogels. Four 10 ~I 
droplets containing PEG-PQ-PEG (1 0% w/v), 2 mM PEG-RGDS, 400 ng/ml PEG-Protein , the 
Eosin Y photoinitiator, and HSCs (20 x 106 cells/ml) are pi petted onto a Sigmacoted glass slide. 
Two PTFE spacers are placed on either side of the droplets, and an untreated glass slide is 
placed on top. The slides are clamped together and exposed to white light for 45 s. The resulting 
hydrogels have cells entrapped within the polymer matrix. To collect cells after culture, a 
collagenase solution is added to degrade the gels by cleaving the PQ peptide and thus the 
polymer chains. 
7.2.2.3 Culture Parameters 
Gels were maintained in culture for 2 and 4 week time periods in incubators with 
5% C02 at 37°C. Media was replenished every 2-3 days by removing half the media 
volume per well and replacing it with fresh media. 
7.2.2.4 Viability Assessment 
To determine the viability of the primary cells after encapsulation and during the 
culture period, we stained cells contained in gels with the Live/Dead® Cell 
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Viability/Cytotoxicity Kit for mammalian cells (Invitrogen) after 3, 7, 10, and 14 days 
and 5 weeks. A Live/Dead solution of PBS containing 2 J.d/ml ethidium homodimer (2 
mM) and 0.5 ~1/ml calcein AM ( 4 mM) was made. Media was removed from gels and 
the Live/Dead solution was added followed by incubation for 20 min. at 37°C with 5% 
C02. After the incubation period, the gels were imaged on an inverted Zeiss Axiovert 
135 inverted microscope equipped with an EXFO X-Cite 120 Fluorescent Illumination 
System, using a Jenoptik ProgRes C5 CCD camera. Images in both the "live" 
(excitation/emission: 494/517 nm) and "dead" (excitation/emission: 517/617 nm) 
channels were captured. To quantify the percentage oflive cells, live and dead cells from 
the same field of view were counted in ImageJ software using a similar protocol as in 
Section 2.2.4.1. The number of live cells was divided by the total number of cells for 
each field of view to determine the percentage of live cells. Ten fields of view for three 
gels were analyzed at each timepoint. 
7.2.3 Cell Retrieval 
After the culture period, cells were retrieved from gels by placing gels in a new 
well plate in an HBS solution containing 0.1 mg/ml collagenase type IV (MMP-2) and 
0.36 mM CaCh. The gels were degraded in an incubator at 37°C with 5% C02 for 1 hr. 
During the incubation time, the gels were agitated every 10 -15 min. to aid in the 
degradation process. After hydrogel degradation was complete, the cells were 
immediately centrifuged at 200 x g for 5 min., resuspended in media, and counted. 
7 .2.4 Cell Proliferation 
To monitor cell proliferation within the gels over the time course of the studies, 
phase contrast images were captured using the Zeiss Axiovert 135 inverted microscope 
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and Jenoptik CCD camera. Cell proliferation was quantified by counting cells retrieved 
from each gel after degradation. The starting cell density and initial cell viability were 
used to determine the initial cell number/gel. 
7 .2.5 Evaluation of Differentiation Potential 
7.2.5.1 Colony Forming Unit Assay 
To assess the differentiation potential of cells after encapsulation within 
hydrogels, a colony forming unit assay was performed as described in Section 2.2.4.4. 
Briefly, 10,000 cells per sample were resuspended in 1 ml ofMCM, plated into 6 wells of 
a low attachment 48 well plate, and incubated at 3 7°C with 5% C02• The colonies that 
formed were counted and characterized after 10-14 days in culture. MCM was added to 
wells that appeared to be drying out or contained rapidly proliferating colonies (indicated 
by colorimetric changes in the phenol red containing MCM). 
7.2.5.2 Flow Cytometry 
To support results seen in the colony assay, we analyzed cells using flow 
cytometry if there were sufficient cells remaining after cell retrieval (> 100,000 cells). 
Cells were stained for c-kit, Seal, and lineage markers using the protocol described in 
Section 2.2.4.5. 
7 .2.6 Statistical Analysis 
One-way ANOVAs and Tukey's post-hoc analyses were performed to evaluate 
statistical differences between groups in all studies using a 95% probability level 
(p<0.05). 
7.3 Results and Discussion 
7.3.1 Polymer Synthesis and Characterization 
7.3.1.1 Peptide Synthesis 
To confirm that we synthesized the correct peptide sequence, we used mass 
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spectrometry to determine the molecular weight of the final product. The mass 
spectrometry data in Figure 7.3 shows a peak at ~ 1140 kDa, which matches the molecular 
weight of the PQ sequence. Though this does not validate the correct order of the 
sequence, the ability to degrade in a collagenase solution (described in Section 7.2.3), 
supports that the sequence was synthesized in the correct order. 
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Figure 7.3. Mass spectrometry plot of PQ peptide. There is a peak at -1140 kDa indicating 
the presence of a molecule at the predicted molecular weight of the PQ peptide. 
7.3.1.2 PEG-PQ-PEG 
GPC was performed on the sample to confirm PEGylation of the PQ peptide. 
Figure 7.4 shows the resulting plot. After conjugation, there is a peak that appears much 
earlier during data collection than when the PEG-SV A control is run by itself. This shift 
indicates an increase in molecular weight. It is possible that the peptide was only 
functionalized with one PEG chain, but the ability to form a gel from the polymer 
indicates that two acrylated PEG chains flank the PQ. The conjugation efficiency was 
calculated to be near 80%. 
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Figure 7.4: Gel permeation chromatography (GPC) analysis of PEG-PQ-PEG. PEG-PQ-PEG 
flows more quickly through the column and is detected earlier than PEG-SVA. This indicates an 
increase in molecular weight after the reaction and successful conjugation to the peptide. The 
percent conjugation was calculated to be approximately 80%. 
7.3.2 Cell Viability within PEG Hydrogels 
To ensure that the cells remained viable after the encapsulation process, a 
live/dead assay was conducted. Fluorescent images of primary c-kit+ cells entrapped 
within gels can be seen in Figure 7.5. Live cells are able to process calcein AM to create 
a fluorescent product that appears green in the images. Ethidium homodimer binds to 
DNA and then fluoresces red; it can only enter cells whose membranes have been 
compromised, such as dead cells. The images show that primary cells are viable after 
encapsulation and that viability is maintained throughout the culture period despite the 
presence of some dead cells. 
Figure 7.5: Viability of encapsulated c-kit+ cells within PEG-PQ-PEG hydrogels with 
immobilized RGDS. Cells that are viable appear green and those that are dead appear red . 
The images were taken 24 h (01), 3 days (03), 7 days (07), and 5 weeks (SW) after 
encapsulation. Viable cells remained after one week in culture and appeared to proliferate in 
clusters, indicated by the increase in viable cell size over time. Scale bars = 100 IJm. 
Figure 7.6 displays the quantification of the viability data. At day 3, 
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approximately 30% of the cells remain alive. Though this is fairly low, the cell viability 
appears to recover at 7, 10, and 14 days, indicating that cells are not only alive but are 
also replicating. The percent increase in cell viability is significant at all timepoints 
compared to day 3. This demonstrates that a portion of the HSC population can 
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withstand the encapsulation procedure and is able to proliferate within the gel. 
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Figure 7.6: Primary cell viability in PEG-PQ-PEG hydrogels. Cell viability was assessed at 
Days 3, 7, 10, and 14 using the Live/Dead Viability/Cytotoxicity Assay. The percentage of live 
cells was determined by counting the number of live and dead cells and dividing the live cells by 
the total number of cells. Cells were counted using lmageJ software. After three days, only 30% 
of the cells were viable, but at later timepoints the cells appeared to recover. The viability 
increased to approximately 50% and was maintained at this level. Bars are mean ± standard 
deviation. 
Though the cell viability is lower than what has been previously observed with 
other cell types (314, 316, 317), these results confirm the ability to maintain initial HSC 
viability over time. Furthermore, the percent of viable cells increases over time, 
signifying that the cells are proliferating. Previous work has shown that cell types have 
varying sensitivity to photo initiators (316). Intrinsically, HSCs may be more affected by 
the photoinitiator system and could have increased susceptibility to cell death due to their 
primitive nature and recent harvest. Besides sensitivity to the photoinitiator, the low 
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percentage of viable cells at early timepoints could be the result of several other factors. 
Primarily, there are no steps devoted to the removal of dead or dying cells between the 
cell harvest and the encapsulation process. Thus, cells that die as result of the isolation 
process contribute to the total percentage of dead cells after encapsulation. 
There are several steps in the procedure that can contribute to cell death. The 
isolation procedure from the bone marrow is fairly harsh. Cells are flushed from the bone 
and then washed multiple times with several steps that involve centrifugation. Secondly, 
during the magnetic sorting, cells are sorted in a laminar flow hood but are outside of an 
incubator setting for a prolonged period. Thus, once cells are ready to undergo the 
encapsulation procedure, they have been significantly stressed and may not be robust 
enough to survive the encapsulation procedure. It is possible that allowing the cells to 
recover from the harvest and sorting procedures in media within an incubator before 
encapsulation could increase the cell viability percentage. However, the differentiation 
potential ofHSCs is highly time-sensitive, and waiting just a few hours before placing 
the cells into the culture system could negatively impact the differentiation potential of 
the cells. Conversely, the LT-HSC portion of the c-kit+ hematopoietic progenitor 
population may be more sensitive to the encapsulation process and may make up a larger 
percentage of the dead cells within the gel. Thus, waiting to encapsulate may be crucial 
to ensuring that a greater number of primitive HSCs survive. Future work includes 
studies to determine the ideal timeframe for cell isolation, purification, and encapsulation 
that maximizes both cell viability and differentiation potential. 
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7.3.3 Cell Proliferation within Gels 
Figure 7. 7 shows phase contrast images at various timepoints. The black arrows 
designate clusters of cells that are proliferating within the gel. These clusters also 
support the hypothesis that the HSCs are unable to degrade the gel. They are able to 
displace the gel to create space for new cells, but the clusters are tightly packed 
throughout the culture period and cells do not seem to spread within the gel matrix. Cells 
also appear to proliferate on the surfaces of the gels. 
To quantify the increase in cell number in the gel, cells were counted after the 
degradation of the gel. In all groups, a decrease in cell number was observed. This does 
not correlate with what was observed in the well plates and the phase contrast images in 
Figure 7. 7. After the cells are retrieved from the hydrogel, they are highly susceptible to 
sticking to the low attachment well plates. To remedy this, degradation was performed in 
a microcentrifuge tube in later studies. This resulted in more efficient retrieval, and in 
preliminary studies with this method, there was an approximately 50% increase in cell 
number after 4 weeks in culture. However, the process will need to be repeated to 
determine significance. 
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Day 1 
Day 14 
Figure 7.7: Representative phase contrast images of c-kit+ cells encapsulated within 
degradable biomimetic PEG-PQ-PEG hydrogels at days 1 and 14. Cells are disperse and 
less dense after 24 h. At day 14, cells have proliferated within and on top of the gel. The cells do 
not degrade the gel, but displace it to make space for forming cell clusters. Black arrows denote 
these cell clusters. Scale bar = 100 ~min A-D, Scale bar= 50 ~minE-H. Immobilized bioactive 
factors within the PEG-PQ-PEG hydrogel: A. 2 mM RGDS; B, C, E, G. 2 mM RGDS and 400 
ng/ml SCF; D, F, H. 2 mM RGDS and 400 ng/ml IFNy 
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7 .3.4 Differentiation Potential 
The ideal ex vivo culture system should not only maintain the viability of the cells 
but should also prevent rapid differentiation of the HSCs. To evaluate the differentiation 
potential of encapsulated cells after 2 or 4 weeks in culture, two assays were performed: 
the colony forming unit assay and flow cytometric analysis. 
7.3.4.1 Colony Forming Unit Assay 
The results from the colony forming unit assay are displayed in Figure 7 .8. All 
sample groups were able to form colonies, which is a characteristic of less differentiated 
cell types. 
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Figure 7.8: Colonies formed from c-kit+ cells after 14 days of encapsulation. Cells 
encapsulated in RGDS formed the most colonies, 124, and the cells were still able to form 
primitive GM and GEMM colonies. Though cells encapsulated in gels with SCF and JAG1 did not 
form as many colonies as in RGDS alone (90 and 72 respectively), the cells still retained the 
ability to form primitive colonies. In gels with IFNy, the cells were not able to form GEMM 
colonies and the total colony number was much lower than other sample groups. (R=RGDS; 
CFU-M=Macrophage, CFU-G=Granulocyte, CFU-GM=Granulocyte/Macrophage, CFU-
GEMM=Granulocyte, Erythrocyte, Megakaryocyte, Macrophage) 
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The RGDS group formed the most colonies while the sample with IFNy formed the least. 
However, the changes were not significant due to a small sample size. The distribution 
of colonies is shown in Figure 7.9. The samples with RGDS only, SCF, and JAG 1 
exhibited similar distributions of colonies. RGDS had the highest percentage of GEMM 
colonies (12%) while SCF had the highest percentage of primitive GM and GEMM 
colonies ( 45% ). The IFNy group had the highest percentage of more committed colonies 
(G and M) at around 65%. 
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Figure 7.9: Colony distribution as a proportion of total colony number. The distribution of 
colonies was fairly similar between RGDS, SCF and JAG1. The group containing RGDS only 
formed the highest percentage of GEMM colonies (-12%), while the group with SCF had the 
most primitive colonies (GM and GEMM) at around 42%. IFNy had the highest percentage of 
more committed progenitors (G and M) at around 80%. (R=RGDS; CFU-M=Macrophage, CFU-
G=Granulocyte, CFU-GM=Granulocyte/Macrophage, CFU-GEMM=Granulocyte, 
Erythrocyte, Megakaryocyte, Macrophage) 
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7.3.4.2 Flow Cytometry 
Due to the large loss of cells during the degradation procedure (described above), 
there were a limited number of samples that could be analyzed with flow cytometry. 
Figure 7.10 displays data collected on cells encapsulated within a PEG-PQ hydrogel 
functionalized with PEG-RGDS. There are a high percentage of cells, approaching 90%, 
that remain c-kit+ after 4 weeks in culture. In addition, 67% of the cells are lin-, and 9% 
of the cells make up a KSL population. This is an improvement on what was observed on 
gel surfaces with surface immobilized RGDS, where 45% of the cells are c-kit+, 7% are 
lin·, and 5% make up the KSL population after expansion. Even though the initial 
population was broader, the percentage of KSL cells is increased when compared to cells 
cultured on surfaces. However, this is data collected from only one sample (three gels) 
and will need to be repeated to verify these results. 
Taken together, this data shows that the encapsulation procedure can aid in 
maintaining HSCs in an undifferentiated state. The reduced number of differentiated 
cells could be due to the morphology of the cell inside the gel. Because the cells were 
not able to degrade the gel and spread significantly, they retained their rounded shape. 
This may help signal the cell to remain in its multipotent state. Several groups have 
investigated at the effects of cell shape on the differentiation of another bone marrow 
derived stem cell, mesenchymal stem cells (MSC), and have observed that cell shape is a 
critical factor in the pathways along which the cell differentiates (318-321 ). McBeath et 
al. showed that cell shape affects endogenous RhoA activity. By promoting this activity, 
MSCs differentiate down osteogenic pathways, and by blocking this activity, MSCs 
become adipogenic (318). Kilian et al. observed similar results on surfaces with adhesive 
ligands of similar surface areas but of distinct shapes. MSCs differentiated down 
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adipogenic or osteogenic pathways, independent of soluble signaling, due to differences 
in cytoskeletal tension, a downstream effect of Rho A signaling (320). Thus, the shape of 
HSCs may play a critical role in the differentiation status of HSCs. 
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Figure 7.10: Flow cytometric analysis of c-kit+ cells after culture in degradable PEG 
hydrogels with 2 mM RGDS. A. Particles were gated to exclude debris and cell aggregates. B. 
The cells were gated to include those that did not express lineage markers. C. Cells were gated 
to delineate between c-kit and Sca1 positive and negative cells. D. Lineage negative cells were 
gated as in C. Axes that do not have units are relative fluorescent intensity. Numbers on the 
graphs denote the percentage of cells within each gate. 
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Interestingly, these results contradict some of what was seen in two-dimensional 
culture. In three dimensions, the addition of proteins to the polymer matrix resulted in 
reduced total colony formation and only slight differences in the distribution of colonies 
compared to the RGDS alone. In contrast, in two-dimensional culture, it was observed 
that the addition of SCF to the hydrogel surface led to greater colony formation and no 
differences in the distribution of the colonies when compared to RGDS. In addition, cells 
cultured on hydrogels with surface immobilized JAG 1 formed similar numbers of 
colonies but a greater number of primitive colonies compared to RGDS in two-
dimensions. On IFNy, the cells formed more total colonies compared to the peptide alone 
in two dimensions but showed a reduced ability to form primitive colonies in both two 
and three dimensions. Thus, in each group, there was a marked difference between two 
and three-dimensional culture. It is unclear what the source of these differences is. It 
may be related to the way the proteins are displayed in three-dimensional culture. In 
addition, because the cells form such large clusters, it is possible that the HSCs are 
responding more to stimuli from one another as opposed to cues from the matrix, 
particularly cells in the centers of the clusters. However, the colony data is preliminary 
and only represents one experimental group; thus, the findings should be confirmed 
before making any definitive claims. 
The encapsulation process keeps HSCs in constant contact with the gel. They are 
unable to leave, and as a result are in close proximity to immobilized adhesive peptides 
and signaling proteins within the gel. The continuous interaction with these factors and 
subsequent activation of specific surface receptors like c-kit, Notch, and the VLA-4 and 
VLA-5 integrins can help maintain HSCs in a state of self-renewal and prevent their 
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differentiation. By functionalizing the gel with proteins known to trigger differentiation, 
like IFNy, the potential of the cells could be altered as shown by the limited ability of 
cells in these samples to form less primitive GM and GEMM colonies. The ability to 
affect HSC fate through the encapsulation process and signaling molecules immobilized 
within the gel is a powerful tool in the development of an ex vivo culture system. 
7.4 Conclusions 
A three-dimensional system that accurately recapitulates the in vivo HSC 
microenvironment could enable the generation of HSC populations with clinical 
applicability. These studies show that HSCs can be successfully encapsulated within 
hydrogels in a manner that maintains their viability and allows them to proliferate 
without compromising their differentiation potential. Incorporating different proteins 
within the hydrogel matrix altered the differentiation potential of the cells. For example, 
the addition of IFNy to the gels prevented the cells from forming primitive GEMM 
colonies. This system exhibits great promise in the maintenance ofHSCs in long-term 
culture though several more studies should be conducted to confirm these preliminary 
results. Future studies will focus on the clinical applicability of the cells after 
encapsulation and culture. 
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Chapter 8: The Biomimetic PEG Hydrogel System for HSC Expansion 
8.1 Introduction 
Hematopoietic stem cells (HSC) have been successfully used in bone marrow 
transplants to treat blood cancers and other diseases. They have the potential to be used 
in therapies for numerous other diseases, and research using HSCs for the treatment of 
diabetes, chronic ischemia, liver disease, as well as others, is currently underway. 
However, the expansion of HSCs into other therapeutic applications is hindered by a 
shortage of HSC donors and the inability to culture HSCs ex vivo since the cells rapidly 
begin to differentiate or apoptose when removed from their in vivo microenvironment. 
The development of a culture system that recapitulates the HSC niche could aid in the 
generation of clinically relevant populations of HSCs. The work in this thesis 
demonstrated the ability to utilize a bioactive PEG hydrogel to mimic the HSC 
microenvironment and expand these cells ex vivo in both two and three dimensions. 
8.2 32D Cell Culture in PEG Hydrogel Wells 
The design of the hydrogel system began with the formation of PEG hydrogel 
wells. Wells were utilized to prevent cell migration off of the hydrogel and ensure 
interaction between cells and specific biomolecules immobilized on the gel surfaces. To 
begin this process, a mold consisting of photoresist pillars was created using 
microfabrication techniques. Unmodified PEG-DA was polymerized around the pillars 
to create a hydrogel well base, and the bottoms of the hydrogel wells were subsequently 
functionalized with biomolecules. 
In initial experiments, 32D cells, a myeloid progenitor cell line, were used to 
observe how RGDS-a fibronectin-derived adhesive peptide sequence, SCF-a cytokine 
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involved in HSC self-renewal, and SDFla-a chemokine integral in HSC homing and 
mobilization-affect cell adhesion, spreading, and proliferation. These studies 
demonstrated that the incorporation ofRGDS, SCF, and SDFla onto gel surfaces could 
encourage cell adhesion. By increasing the surface RGDS concentration, the number of 
adherent 32D cells was increased after 48 hrs. in culture. The inclusion of either SCF or 
SDFla with RGDS (25 J.Lg/cm2) allowed a significantly greater number of32D cells to 
adhere compared to the peptide alone at similar concentrations. The degree of cell 
spreading was also influenced by the presence ofSCF and SDFla. When compared to 
RGDS surfaces (250 J.Lg RGDS/cm2) with similar 32D cell densities, cells spread to a 
significantly greater extent and exhibited distinct filopodia. A histogram of the cell areas 
showed that there was an approximately 100-200 J.Lm2 increase in the average 32D cell 
size and a higher percentage oflarge cells (>700 J.Lm2) on gels with surface immobilized 
SCF and SDFla. 
These studies demonstrated the functional potential of the hydrogel culture system 
and allowed for the optimization of hydrogel parameters such as the surface 
concentration of biomolecules. Hydrogel wells successfully retained hematopoietic cells 
on the gel surface, and biomolecules tethered to the gel surfaces maintained their 
bioactivity and were capable of altering hematopoietic cell behavior. Though the 
scaffold was capable of modulating certain 32D cell behavior, the effects on primary 
HSCs also required investigation to determine the ability of the hydrogel system to 
maintain HSCs in an undifferentiated state. 
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8.3 Primary Cell Culture in Bioactive Hydrogel Wells 
To gain a better understanding of the effects of the culture system on primary 
HSC expansion and differentiation, c-kit, lin· cells were isolated from murine whole 
bone marrow. RGDS, CSl, SCF, SDF1a, JAG1, and IFNy were covalently immobilized 
on the surfaces ofhydrogel wells, and c-kit, lin· primary cells were cultured in the gel 
wells for two weeks. JAG 1 is a transmembrane protein expressed by stromal cells in the 
niche that can promote HSC expansion while retaining HSCs in an undifferentiated state. 
In contrast, IFNy is a cytokine that can encourage HSC proliferation at the expense of 
initiating the differentiation process. 
When RGDS and CS 1 were added to gel surfaces, there was an increase in total 
cell expansion compared to PEG-DA and FN plate controls. The combination of SCF or 
IFNy with RGDS or CS 1 on gel surfaces significantly increased total cell expansion as 
compared to the peptides alone. JAG 1 and SDF1a displayed minimal effects on total cell 
expansion. Figure 8.1 displays the quantified data for total cell expansion for all groups. 
The ability of the gel to encourage self-renewal is a fundamental necessity in a culture 
system for generating large HSC populations. These findings demonstrate that the 
inclusion of specific bioactive elements into the hydrogel culture system can promote 
HSC self-renewal. 
In a clinical setting, only undifferentiated HSCs are able to repopulate the 
immune system of the host after transplantation. Therefore the differentiation potential 
of expanded cells was evaluated with two assays to predict the likelihood of success in in 
vivo engraftment experiments. The colony forming unit (CFU) assay was used to assess 
the functional capability of the cells to differentiate down multiple pathways. In addition, 
flow cytometric analysis was used to investigate the expression of specific surface 
markers indicative of HSCs, c-kit and Seal, and the absence of lineage markers. 
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Figure 8.1: Percent change in total cell population after 14 days in culture within hydrogel 
wells functionalized with biomolecules. Bars are mean ± standard deviation (* denotes 
significance compared to peptide, PEG-DA, and FN controls, • denotes significance compared 
to PEG-DA and FN controls, +denotes significance compared to PEG-DA control, n=3, p < 0.05) 
(R=RGDS, C=CS1) 
A compilation of the results from the CFU assay from all samples is displayed in Figure 
8.2 while the results from flow cytometry are shown in Figures 8.3 and 8.4. In all 
samples, with the exception ofPEG-DA, CFU-GEMM colonies, the most primitive, were 
able to form from expanded cells, indicating that cells have remained in a more 
undifferentiated state. In addition, there was a small KSL population present in all 
groups after the two-week culture period, though the percentage ofKSL cells out of the 
total population decreased in all groups. 
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Figure 8.2: Colony formation of c-kit+, lin- cells cultured for 14 days on hydrogel surfaces 
functionalized with biomolecules A. Total colony formation B. Distribution of colonies as a 
percent of total colony number. Bars are means, n=2. (CFU-M=Macrophage, CFU-
G=Granulocyte, CFU-GM=Granulocyte/Macrophage, CFU-GEMM=Granulocyte, 
Erythrocyte, Megakaryocyte, Macrophage) 
The cells that were expanded on hydrogel wells functionalized with CS 1 and 
RGDS formed more primitive colonies than cells from the control groups on PEG-DA 
and FN plates. In contrast, the controls had a high quantity of KSL cells, though the 
expression of these markers does not necessarily signify that the cells are able to 
differentiate down multiple lineages. Due to its significant effect on HSC proliferation, 
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samples with SCF generated the highest quantity of undifferentiated cells, which was 
supported by data from both the colony assay and flow cytometry. JAG 1 was able to 
preserve the cells in an undifferentiated state, but it did not significantly expand the cells 
meaning it did not generate a large HSC population in culture. The presence of SDF1a. 
resulted in no apparent improvement on cell expansion, but it did retain the 
differentiation potential of cells when it was functionalized on hydrogel surfaces with 
CS 1 compared to RGDS and CS 1 controls. IFNy expanded primary cells significantly 
but also lead to substantial HSC differentiation. Similarly to cells expanded on PEG-DA 
and FN controls, the cells on IFNy could not form primitive colonies, but they did 
express surface markers indicative ofundifferentiated HSCs. Table 8.1 gives an 
overview of the effects of each biomolecule on hematopoietic cell behavior. The "+" 
designates that the biomolecule(s) promoted the desired cell behavior while the"-" 
denotes that the behavior was inhibited. Note that a"+" for differentiation potential 
means the immobilized biomolecule prevented HSC differentiation. The number of 
pluses and minuses shows the relative degree of the effect compared to other bioactive 
factors. 
It is interesting that there were differential effects on cell behavior depending on 
the peptide that was immobilized on gel surfaces in combination with proteins. It 
suggests that there may be synergistic or antagonistic effects of these combinations of 
molecules on HSC signaling pathways. Further investigation could help to elucidate 
these effects in more detail. These findings demonstrate the ability to design the 
hydrogel system to alter HSC expansion and differentiation. Controlling these processes 
more precisely may lead to the generation of HSC populations that can be used clinically. 
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Figure 8.3: Percent change in c-kit+, lin· population after 14 days in culture within hydrogel 
wells functionalized with biomolecules. Bars are mean + standard deviation (n=3) (* denotes 
significance compared to peptide control , R=RGDS, C=CS1) 
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Figure 8.4: Percent change in KSL population after 14 days in culture within hydrogel wells 
functionalized with biomolecules. Bars are mean + standard deviation (* denotes significance 
compared to peptide control, n=3, p < 0.05) (R=RGDS, C=CS1) 
8.4 Primary HSC Culture in Three-dimensional Bioactive PEG Hydrogels 
HSCs were cultured in a three-dimensional PEG hydrogel to more accurately 
mimic the in vivo microenvironment. Furthermore, entrapping cells within the hydrogel 
prevents significant cell migration and keeps cells in close contact with bioactive 
elements incorporated into the polymer matrix. HSCs were encapsulated within a 
biodegradable PEG scaffold and cultured for 2-5 weeks. The results showed the ability 
of the three-dimensional hydrogel to maintain HSC viability for a period of 5 weeks, 
though there is some cell death at early timepoints likely due to both the isolation and 
encapsulation procedures. Within the hydro gels, HSCs proliferate to form cell clusters, 
which are unable to degrade the gel substantially. After culture, cells were retrieved 
through degradation of the gel in collagenase-containing media and evaluated for 
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differentiation potential using both the CFU assay and flow cytometry. Preliminary 
results indicate that encapsulation helped to maintain the HSCs in an undifferentiated 
state though, based on results from the colony assay, it appeared that the addition of SCF, 
JAG 1, and IFNy all lead to differentiation. This is somewhat contradictory to what was 
seen in two-dimensions, with the exception ofiFNy, but may be due to a low sample size. 
This technique showed great potential in the generation of HSC population ex vivo but 
still requires additional investigation to confirm these promising results. 
Table 8.1: Overview of the effects of surface immobilized bioactive factors on 
hematopoietic cell behavior. "+" signifies that the surface promoted the desired behavior while 
"-" signifies that the surface inhibited the desired behavior. (Note: for differentiation potential, the 
plus signifies that it retained the differentiation potential of the cells.) The number of pluses or 
minuses indicates a relative degree compared to other samples. 
D1fferent1at1on Potent1al 
320 Cell 32DCell Primary Cell Colony Assay Flow Adhesion Spreading Expansion Cytornetry 
RGDS ++ 
-
+ + + 
R+SCF +++ ++ +++ + ++ 
R + SDF1a +++ ++ + ++ + 
R + JAG1 N/A N/A + ++ + 
R+ IFNy N/A N/A +++ 
--
++ 
CS1 N/A N/A + + -
C+SCF N/A N/A ++ ++ + 
C + SDF1a N/A N/A + ++ + 
C + JAG1 N/A N/A + + + 
C+ IFNy N/A N/A. + - -
PEG-DA - - - - + 
FN N/A N/A 
- - + 
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8.5 Conclusions and Future Work 
The aim of the work in this thesis was the development of an ex vivo culture 
system capable of expanding HSC populations while preventing significant 
differentiation. Currently this is not possible, and the ability to generate large HSC 
populations has tremendous clinical relevance. The PEG-DA hydrogel system was 
designed to mimic the in vivo HSC microenvironment or niche. The advantage of using a 
PEG-based system resides in the ability to easily tailor its properties. The PEG-DA 
matrix is not intrinsically bioactive, but biomolecules can be selectively incorporated 
within the PEG matrix allowing one to study the effects of individual molecules on cell 
behavior. The studies in this thesis functionalized hydrogels with molecules from the 
niche known to affect HSC expansion and differentiation. The results demonstrated the 
ability to control HSC fate by tethering specific biomolecules or combinations of 
biomolecules to the polymer scaffold in both two and three dimensions. This system 
shows the potential to maintain HSCs ex vivo and with further optimization and 
refinement, it could one day be used for therapeutic applications. 
However, to reach that point, there are still many experiments that need to be 
conducted before this system can be used clinically. Thus far, the culture system has 
been utilized for the culture of a heterogeneous population with many highly proliferative 
progenitors. The use of a more primitive population for future studies may result in the 
generation of HSC populations with fewer macrophage progenitors. In addition, several 
of the experiments with primary cells can be repeated to obtain significant differences 
between experimental groups and uncover the source of conflicting results. Because the 
experiments were performed with cells from different populations of mice, there are 
similar trends but different quantitative results from each experiment, which results in 
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large standard deviations. Repeating the studies will help to confirm that the results that 
were obtained are significant. In addition, most of the studies in this thesis were limited 
to two weeks. Previous work has demonstrated the ability to successfully maintain HSCs 
in culture for similar time periods. The ability of the PEG hydrogel system to extend this 
time frame still requires further investigation. 
Several more experiments could also be conducted combining the different 
bioactive factors. For example, IFNy has been shown to expand HSCs when it is used in 
combination with SCF and SDF1a (296, 298, 299). Perhaps, IFNy works to encourage 
HSC proliferation while SCF and/or SDF1a can retain HSCs in an undifferentiated state. 
Combinations of SCF or IFNy with JAG 1 could also cause significant proliferation while 
maintaining differentiation potential. Furthermore, other cytokines like erythropoietin 
(EPO), a hormone that triggers erythrocyte production in vivo, could be investigated in 
combination with SCF or IFNy to generate populations of mature blood cells. A 
combination of SCF and EPO was previously shown to promote the proliferation and 
survival of erythroid progenitor cells (322). This is incredibly relevant to clinical 
applications as blood shortages are common, particularly for rare blood types. These 
kinds of studies could assist in the biological design of a hydrogel that has better control 
over HSC behavior. 
Most importantly, in vivo studies are required to investigate engraftment 
capabilities of expanded cells. The ability to form colonies or express a combination of 
surface markers is irrelevant if the cells are unable to repopulate the immune system. 
HSCs that are implanted after expansion should be able to home to the bone marrow, 
engraft, and reconstitute the immune system. Furthermore, bone marrow cells from the 
transplant recipient should also be capable of these processes when implanted into a 
secondary recipient. If this system shows success in in vivo experiments, it will likely 
have significant clinical benefits. 
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Appendix 
A 
c 
Figure A1: Colonies formed during the colony forming unit assay. A. CFU-M, Cells are 
distinct, uniform, and large in size compared to cells in CFU-G colonies; B. CFU-G, Cells are 
smaller and distinct; C. CFU-GM, Colonies are large, and cells are distinguishable and multiple 
cell sizes are present; D. CFU-GEMM , Colonies are large and individual cells are 
indistinguishable at the colony centers. There is also a brown or reddish hue to the colonies. 
Multiple cell sizes are present. 
